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Advancements in technology allow for longer lifespans, creating the need for improved 
medical devices, especially in orthopaedics.  New technologies like additive manufacturing 
(AM) allow the creation of patient-specific implants with complex shapes and controlled 
porous structures.  This project aimed to exploit AM for the development of novel materials 
and devices within bone regeneration.  
Several glass-ceramics are bioactive, presenting a similar composition to human bone, and 
improved mechanical properties. Here, we investigate the use of Apatite-Wollastonite (AW) 
as feedstock for AM techniques. Alumina-doped AW powders and polymer ceramic 
biocomposites were developed and their manufacturing processes optimized. Characterization 
of the materials, physicochemical and biological, proved the devices suitability for bone 
regeneration.  The effect of alumina on the surface of AW particles on material processing, 
crystallization mechanism and mechanical properties was investigated. AW containing 0.13 
wt% alumina at the surface was printed using binder jetting. Samples presented low open 
porosity and flexural modulus, but their bioactivity was preserved, including 
osteoconductivity. To explore the potential of unsintered AW glass composition, two 
biodegradable composite filaments were developed, with particles or fibres as fillers, at 5 wt% 
loading. Printed struts prepared with Fused Filament Fabrication showed mechanical 
properties comparable to cancellous bone and induced the differentiation of mesenchymal 
stromal cells to osteoblasts. It was determined that both composites expressed bioactivity, 
further enhancing cell biomineralisation, but the fibre filler expressed enhanced ion leaching 
and flexural modulus. In considering the use of AW glass and glass-ceramic as feedstock for 
AM processes, it is concluded that it is versatile biomaterial, in both powder and fibre form, 
and processable via different routes. Exploring the effects of its morphology and composition 
allows for higher freedom in material design, widening the application range within the 
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Chapter 1. Introduction 
 
1.1 Background and clinical need 
A need to invest in the orthopaedic area has emerged in the past years due to an increase in 
life expectancy. The development of an adequate bone substitute, economical and 
bioresorbable, has been a major challenge for orthopaedic, and reconstructive surgeons. 
Autografts have been the most common solution for bone defects, but with major drawbacks: 
1) inconvenient for patients with degenerative bone diseases; 2) impractical for large defects 
as bone harvesting sites are limited. Allografts and xenografts report a high rate of rejection 
by the host due to antigenicity issues (Fujita et al., 2000; Wang and Yeung, 2017). The 
current solutions for joint replacement or fracture fixation are mainly metal based, which 
leads to the problem of stress shielding, causing the bone to weaken and consequently the 
failure of the implant Metal implants, commonly titanium (Ti) based, are known for their 
ability to integrate within the body, and some studies claim an ability to create calcium (Ca) 
precipitation in vitro. These results do not translate directly in vivo, as researchers agree on 
the material’s osteoconductivity but doubt the osteoinductivity (Shah, Thomsen and 
Palmquist, 2019). Most metal-based implants are bioinert, and the cell survival on them is an 
issue, in addition to bacterial infection. These problems are usually addressed with coatings 
and surface functionalisation, adding more steps to the manufacturing process (Zhang et al., 
2018). Such information turned the attention to other materials such as bioceramics and 
composites. New solutions were drafted based on the use of synthetic materials, capable of 
mimicking bone and withstand the needed loads of the application site. These materials would 
be used as support and regeneration platforms, and the base of the new investigative fields of 
Tissue Engineering (TE) and Regenerative Medicine (RM) (Ratner et al., 2004; Wang and 
Yeung, 2017). These devices, support and enable tissue growth, and they can be 
bidimensional (2D) as films and 3D as scaffolds (Khang  Kim, Moon Suk, Less, Hai Bang 
and Ltd., 2007; Meyer Thomas et al., 2009). The access to additive manufacturing techniques, 
introduces a whole new range of possibilities in the TE and RM area. This additive approach 
increases the range in terms of design, shape and material choice for the scaffolds production 
(Butscher et al., 2011). The technology has been used widely since it allows the design and 
fabrication of a device based on the patient’s anatomical information, obtained by computer 
tomography (CT), or other techniques, and later converts it into a three-dimensional (3D) 
model. This offers an alternative to traditional manufacturing which is based on a subtractive 




Haleem, 2019). For bone, glass-ceramics such as Apatite-Wollastonite (AW) have been used 
as scaffolds to study several pathologies because they combine bioactivity with mechanical 
strength (Wopenka and Pasteris, 2005; Xiang and Spector, 2006; Zwingenberger et al., 2012; 
Gomes, Zocca and Guenster, 2015). In terms of applications, AW has been used as a bone 
repair scaffold,  implant and filler (Fujita et al., 2000; Kokubo, Kim and Kawashita, 2003; 
Ohtsuki, Kamitakahara and Miyazaki, 2009; Gomes et al., 2014; Gomes, Zocca and Guenster, 
2015). Recent studies report the processing of AW via binder jetting printing, followed by 
sintering, for load bearing applications (Alharbi, 2016; Mancuso et al., 2017). The method of 
producing AW with Maltodextrin (MD) scaffolds using binder jetting printing showed 
successful primary results, with the scaffolds presenting mechanical properties mimicking 
those of cortical bone and osseointegration, when implanted in rat calvaria (Alharbi, 2016). 
AW is a versatile material but has not  been studied as reinforcement of polymer and metallic 
matrices of biocomposites to enhance fixation and osteoconductivity (Juhasz et al., 2004; 
Navarro et al., 2008). Since biodegradability is desirable, many polymers with mechanical 
properties within the range of bone have been explored, e.g. poly (L-lactic acid) (PLLA). The 
reaction of the cells upon implantation is also under study, being the main goal the translation 
from osteoconductive to osteoinductive (Zwingenberger et al., 2012; Winkler et al., 2018). A 
material that is osteoconductive can support osteoblast growth and proliferation whilst being 
osteoinductive implies the differentiation of bone progenitor cells into osteoblasts. The 
addition of a bioactive material such as hydroxyapatite (HA) and AW, is known to promote 
tissue growth adjacent to the implant and could possibly enhance the differentiation of human 
mesenchymal stem cells (Boccaccini and Maquet, 2003; Wang, 2003; Ahmed et al., 2011). 
Up to date, studies on biocomposites using AM are limited, with most of them consisting of 
polymer matrices reinforced with CaP particles (Yasa and Ersoy, 2018). Fibre-reinforced 
composites have proved to enhance mechanical properties, whilst promoting osteoconduction 
(Ahmed et al., 2011; Felfel et al., 2013). Multiple combinations can be used in terms of fibre 
configuration and length, but most studies have focused on long fibres, in a continuous or 
random configuration. For short fibres, the effect of this form on the bioactivity are unknown, 
however the influence of ion leaching from Ca-doped phosphate short glass fibres is reported 
and appears to contribute for the biomineralization of human Mesenchymal Stromal Cells 





1.2 Aims and objectives 
The aim of this project is to investigate the physicochemical and biological properties of 
bioceramics and biocomposites, based on AW provided by Glass Technology Services 
(Sheffield, United Kingdom) and produced via AM, as devices for bone repair. A priority was 
to create a repeatable manufacturing process encompassing the development of biomaterials 
with a good combination of mechanical properties, chemical composition, resorption rate and 
osteoconductive and osteoinductive abilities. 
The main objectives consist on: 
• Literature review of biomaterials used for bone repairs and their processing 
techniques, including AM.  
• Development and characterization of biomaterials for bone applications; 
• Development and optimization of manufacturing processes for the selected 
biomaterials, using AM to produce complex 3D structures capable of mimicking bone 
architecture;  
• Assess the combination of mechanical and biological properties of the developed 
structures in terms or suitability for medical devices. 
 
1.3 Thesis structure 
This first chapter has presented the introduction to the subject as well as the aim of the project 
and the objectives drawn to achieve it. The second chapter reviews bone biology, biomaterials 
in orthopaedics, and manufacturing techniques previously and currently used to prepare bone 
implants and scaffolds. The third chapter is the materials and methods and is divided into two 
sections: 1) standard materials and methods; 2) developed materials and methods.  The fourth 
chapter is based on a collaborative work, initiated in the beginning of the PhD project. This 
chapter presents the optimisation of AW sintering process, by exploring the influence of 
alumina as an impurity, and as dopant. This would allow the production of AW implants 
using binder jetting and sintering, described in the fifth chapter. The knowledge obtained in 
the fourth chapter creates the base for the understanding of the results obtained for the 
structural and mechanical properties of the printed parts.  Taking advantage of AW properties, 
namely the bioactivity, and using a well-known biocompatible polymer, the sixth chapter 
focuses on the development of two types of PLLA-AW biocomposites, consisting on a matrix 
of PLLA containing AW in the form of particles or fibres. An overall discussion chapter 




promising materials and devices for clinical applications. This leads to the conclusions and 
























Chapter 2. Literature Review 
 
In order to understand and design effective solution for tissue repair or substitution, it is 
essential to know its composition, properties and self-maintenance mechanisms. This section 
gives an overview on bone properties and composition alongside its regeneration 
mechanisms, related to bone loss. It then introduces the materials used in orthopaedics 
alongside the explanation on their properties and main applications. An in-depth approach is 
taken for the bioceramics and biocomposites since they are the materials developed in this 
project. Finally, an overview of AM of ceramics and composites is done, and the applications 
targeted.  
 
2.1 Bone composition and morphology 
The human body is composed of 213 bones, excluding sesamoid bones, which are modelled 
during an individual’s lifetime. Bones are connected through joints to form a stable and 
flexible structure, the skeleton. The skeleton is responsible for muscle support, organ and soft 
tissue protection, body motion, and mineral storage. Histologically, bone is considered a 
connective tissue, which is composed by two phases: a type I collagen, an organic matrix that 
incorporates living cells, and the mineral phase containing hydroxyapatite (HA) crystals (D. 
W. Buck and Dumanian, 2012).  
 
2.1.1 Physicochemical properties of bone   
Composition and microstructure 
Bone tissue consists of two phases, organic and inorganic. The inorganic portion consists of a 
mineral phase, HA, with a base chemical composition Ca5(PO4)3X, where X could be either 
an OH- ion or a CO2-3, depending on the area and the age (K.H. Jürgen Buschow, Robert W. 
Cahn, 3001). The mineral phase accounts for 60% of bone weight and provide its consistency. 
The remaining 40% include 30% of organic type I collagen matrix and 10% of water. Volume 
wise, the percentages change faintly, with approximate values of 40% for the mineral phase, 
25% for the water and 35% for the organic matrix. Most water in bone is located around the 
collagen fibres and ground substances, but an important part remains in the cavities that 
contain bone cells, and in nutrient delivery canals that feed and clean bone tissue (Frankel and 
Margareta, 2012).  
At a macroscopic level, an adult skeleton is made of cortical and cancellous bone, with a 




phases, as well as their internal organization (Ratner et al., 2004; D. W. Buck and Dumanian, 
2012). Cortical bone is structured into single units, the osteons, which are composed of 
concentric layers that form around the Haversian canal. These layers are intercepted by blood 
vessels that pass through the Volkmann’s canals, a system of canaliculi responsible for blood 
supply to the osteon layers. Osteons are highly compacted in the periosteal layer, which leads 
to cortical bone’s high density (90-95%) and mechanical strength, needed to support cyclic 
loads without breakage. On the other hand, cancellous bone is highly porous due to its 
organization into a mesh of trabeculae, with a diameter varying between 150 µm and 300 µm. 
This design results in porosity values ranging from 50 to 90%, consequently a greater surface 
area. This translates into an improved flow of growth factors and nutrients. The overall result 
is an increase of remodelling, and a fast response to mechanical stimuli (Ratner et al., 2004; 
D. W. Buck and Dumanian, 2012). All bones, excluding the joint area, are surrounded by the 
periosteum, a dense fibrous layer permeated with blood vessels and nerve fibres. On its inner 
side, the periosteum possesses an osteogenic layer containing osteoblasts, that will promote 
bone growth and repairing. Long bones have another membrane, the endosteum, located at the 
medullary cavity, encompassing giant multinucleated osteoclasts, and osteoblasts, that also 
aid on bone growth and remodelling. Altogether, the assembly of these layers provide bone 
with its mechanical properties, characteristic of a biphasic composite material made of a 
flexible matrix with brittle crystals embed in it. The combination of these materials result on a 







Figure 1 - Bone anatomy and histology. Illustration of bone tissue organisation, at 
macroscopic and microscopic level (D. W. Buck and Dumanian, 2012).  
 
Bone changes in size and shape using specific processes controlled by the conjugal activity of 
bone cells and biofactors (Marion and Mao, 2006; D. W. Buck and Dumanian, 2012). The 
cells responsible for bone formation, maintenance, protection and resorption are osteoblasts, 
osteocytes, lining cells and osteoclasts, respectively (figure 2). These cells differ in both 
function and origin. Osteoblasts, lining cells and osteocytes originate from MSCs, the 
osteoprogenitor cells, whilst osteoclasts originate from hematopoietic stem cells (HSCs). 
Regarding their position in bone, osteoblasts, bone lining cells and osteoclasts are located at 




it. Cells development and placement within the bone formation mechanism is also 
demonstrated on figure 2. The activation and control mechanisms involved in bone formation 
rely on intricate interactions between an individual's genetic potential, surrounding 




Figure 2 - The evolution of osteoblasts and osteoclasts in bone formation. Adapted from 
(Rahman et al., 2015).  
 
Mechanical properties 
The most important mechanical properties of bone are strength, stiffness and toughness (table 
1). The mineral phase of bone is known for the contribution towards the tissue’s strength, but  
the collagen matrix is fundamental for toughness and post-yield properties (Wang et al., 2000; 
Frankel and Margareta, 2012). Studies performed by Wang et al. showed a decrease in bone’s 
toughness after denaturating the collagen, with an overall strength loss of 60%. They unravel 
the connection between collagen content and failure energy, pointing towards a relation 
between type I collagen and the energy required for matrix failure, despite size or geometry. 
The results plotted in figure 3 relate to bone phases and their stress-strain relationship. Stress 
is considered the load applied to the sample and is measured in Newtons per meter squared 
(N/m2) or Pascal (Pa). Strain is the deformation resultant from the load application, obtained 
from the division of the linear deformation by the original length, the reason why it is non-




between stress and strain before and after denaturation. The results show a decrease in stress 
after denaturation, which has implications on the bone health and performance under loading. 
Figure 3b demonstrates the deformation of cortical bone under tension test. From A to B, 
bone presents an elastic behaviour, therefore it can return to its initial shape. Past point B the 
plastic domain is inserted and any deformation induced is permanent, up to point C where the 














Cortical 50-150 2-12 100-230 7-30 
Trabecular NA NA 2-12 0.05-0.5 
Table 1 - Cortical and Trabecular bone mechanical properties (Jones and Hench, 2006). 
 
 
Figure 3 - Stress-strain curves in MPa for: a) collagen network mechanical behaviour under 
heat and enzyme treatment. Weakening of the network upon collagen denaturation. b) 
Tension test on cortical bone sample. A considered the initial point. Point B representing the 
transition point of elastic to plastic, where permanent deformation occurs. B’ represents the 
yield stress value, load per unit per area, preceding plastic deformation, and B’’ the yield 
strain, referring to the deformation caused by B’. The ultimate failure point and respective 
causing load and consequent deformation, are represented by C, C’ and C’’ respectively 
(Frankel and Margareta, 2012).  
 
Both bone phases behave distinctly under loading, however they act as a single composite 
structure. Material characterization demands the standardisation of testing conditions and 
specimens, to guarantee the results uniformity. Bone’s stress and strain can be measured by 
pulling the ends of the sample and monitoring the middle section between the two-gauge arms 




toughness, the materials’ energy storage capacity, mainly the amount of energy needed to 
deform the material. The ability of the material to deform, stiffness, is provided by the 
Young’s Modulus (E), which is obtained when stress (σ) is divided by strain (ε) in a 




  𝐺𝑃𝑎    𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛  (1) 
Cortical bone is stiffer than trabecular bone, meaning it can withstand higher loads, and 
deforms less before fracturing. Experiments performed by Keaveny and Hayes in 1993 
demonstrated that, in vitro, cortical bone sustained 1.5% to 2% of the strain before yielding 
while trabecular bone values raised to 50% before yield starts. Elastic properties change with 
age, being young bone more ductile and older bone more brittle, due to the loss of bone 
density. Loading rate is also important once its increase leads to a faster yielding. Under 
tension (figure 4b), yielding happens due to osteon debonding in areas with microfractures. 
Under compression, it results from cracking of osteons and/or interstitial lamellae (Keaveny 










Figure 4 - Tension test of a standardized bone sample (cortical and trabecular). a) Tensile 
strength testing machine where the strain between the two-gauge arms is measured with a 
strain gauge. Stress is calculated from the total load measured. b) Load-deformation curve of 
a standardized bone sample (Frankel and Margareta, 2012)  
 
Cortical and trabecular bone possess different limits when faced with loading (table 2), e. g. 
cortical bone can withstand up to 190 MPa, under compression, while trabecular bone will fail 
after 50 MPa. Tension values follow the same fashion, with 130 MPa and 8 MPa for cortical 





bone experiencing a decrease of 17 GPa to 11 GPa when load changes from longitudinal/axial 
to transverse. The values for strength and Young’s modulus of cortical bone, according to the 








modulus (GPa) Tension Compression 
Longitudinal 133.00 193.00 17.00 
Transverse 51.00 133.00 11.00 
Shear 68.00 3.30 
Table 2 - Average biomechanical properties of cortical bone according to the direction of the 
load (Burstein, Reilly and Martens, 1976; Frankel and Margareta, 2012). 
 
2.1.2 Bone healing mechanisms 
Bone undergoes several and continuous transformations during life: growth, modelling and 
remodelling. These mechanisms aim to maintain bone mass and bone shape daily, most 
importantly after fractures or arising defects. Bone modelling consists on bone overall re-
shaping process in response to a mechanical and/or physiological stimulus.  This shape is 
maintained through the remodelling process, where old bone is resorbed by osteoclast and 
new bone is produced by osteoblast, resulting in a new osteon (D. W. Buck and Dumanian, 
2012). According to Wolff’s law, a long bone’s shape adapts to accommodate the loads 
placed on it, in the absence of stress bone is resorbed whilst in stressed areas it is reinforced. 
This knowledge justifies bone resorption for cases like edentulous mandibles, where the lack 
of mastication forces leads to bone resorption, impeding a prosthesis application. Areas with 
bone grafts, shielded from mechanical stresses, can also weaken due to resorption, leading to 
either a fracture or defects at the implantation site (Clarke, 2008; D. W. Buck and Dumanian, 
2012).  
The understanding of how bone regenerates is essential for the development of healing 
strategies. The healing process occurs in the presence of bone loss, e.g. due to fracture or 
upon tumour removal.  Bone’s healing cascade is demonstrated in figure 5. It is initiated by 
chondrocyte proliferation, followed by hypertrophy and calcification. The regeneration is 
triggered by an inflammatory response that leads to the formation of a hematoma, shadowed 




endochondral tissue that spreads in between the fracture ends and the periosteal sites. The 
callus chondrocytes proliferate and hypertrophy causing the matrix calcification, making it 
unfertile. During hypertrophy, the chondrocytes release alkaline phosphatase and angiogenic 
factors, leading to a capillary ingrowth and migration of osteoprogenitor cells, that later 
differentiate into osteoblasts. The mineralized cartilage is then resorbed and replaced by new 
bone (D. W. Buck and Dumanian, 2012; Marsell and Einhorn, 2012).  
 
 
Figure 5 - Bone healing process, divided by metabolic stages. The transformation at a 
morphological level between the first day of injury and the completion of the regeneration 
process. Cell action alongside the major stages and their contribution for the morphological 
changes. Adapted from (Einhorn and Gerstenfeld, 2015). 
 
2.2 Clinical approaches for bone defects  
The main goal of defect treatment is to speed up the healing whilst avoiding significant 
deformity or limb shortening. The treatment used depends on the location and type of defect, 
the muscle and body loading, and the various passive soft tissue constraints such as ligaments 
(Nordin and Frankel, 2012). The determining factors for an optimal treatment method are: 
• mechanical loading and its type (tension, bending and/or torsion) and magnitude of 
the forces acting on the site (cyclic means additional strength will be needed to 




• quality of the bone where the device will be fixed; 
• nature of the original injury and the amount of soft tissue damage; 
• other surgical and anatomic considerations such as exposure (possible scarring and 
vascular compromise), device fitting and neurovascular structures at risk (Nordin 
and Frankel, 2012). 
 
2.2.1 Cell and tissue-based therapies 
To optimize the care of patients with bone disease or suffering bone fractures, it is imperative 
to understand the mechanisms that led to the problem. Surgeons frequently encounter cases 
where the successful outcome depends on this knowledge. The clinical solutions developed 
included the application of Wolff’s law, on distraction osteogenesis (DO), and bone transfer 
to the fracture site, bone grafting (BG). DO consists on the creation of a bone gap that is 
submitted to tension. The constant tension prevents callus mineralization and causes the area 
to divide into zones, where the following processes elapse: 1) collagen fibre formation; 2) 
early bone formation; 3) matrix mineralization and organization into lamellae. Despite the 
success of DO, BG became the gold standard procedure to heal bone damage (D. Buck and 
Dumanian, 2012).  
The first experiment performed using BG dates from 1611-1666, with the work of Mekeeren, 
but its popularity arose in 1800s and the 1900s (Haeseker, 1988; D. Buck and Dumanian, 
2012). In 1975, Taylor et al. demonstrated the success of the first vascularized graft, from a 
free fibula flap, on the healing of a mandible defect, implementing the practice. The technique 
was later modified by Kokosis et al. in a work published in 2016 (Kokosis et al., 2016). The 
grafts are harvested from both cortical and cancellous bone, being the common harvesting 
sites the iliac crest, femur and tibia (table 3). The main advantages of BG are the rapid 
vascularization, immediate mechanical strength and low donor-site morbidity, however, for 
bigger defects, tissue availability is limited. For some grafts, slow vascularization and 
incorporation might jeopardize the patient’s recovery requiring another intervention, which 
increases clinical costs. Another important factor for bone graft incorporation is the patient’s 
health state. If treatments such as chemotherapy and radiotherapy, are being applied to the 
body, a negative response could endanger the patient’s life. Despite the disadvantages, bone 
grafts contributed for the study of bone morphogenic proteins (BMPs) and its regenerative 
capacities. This allowed the exploration of new alternatives such as synthetic materials, 
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Table 3 - Bone grafts applications, advantages and disadvantages (D. Buck and Dumanian, 
2012). 
In summary, the bone healing pathway can follow an electrical, mechanical or biological 
approach, or a combination of these. The strategies used range from biological enhancement 
of the process using BMPs, or growth factors, to electrical shock waves. Recently, RM in 
association with TE provided other solutions based on the use of osteogenic cells and 
bioactive molecules that are seeded onto scaffolds, i.e. tissue supporting platforms (Johnson, 
Urist and Finerman, 1992; Mistry, 2005; Giannoudis, Psarakis and Kontakis, 2007). 
 
2.2.2 Biomaterials as bone replacements 
Biomaterials are present in our society since prehistorical times, e.g. linen, which was used by 
the Egyptians, 32 000 years ago, to suture big wounds. The term biomaterials is defined as 
‘‘any substance or combination of substances, other than drugs, synthetic or natural in 
origin, which can be used for any period of time, which augments or replaces partially or 
totally any tissue, organ or function of the body, in order to maintain or improve the quality 




The ability of a material to be integrated within an organism, without an adverse response by 
the host, was defined as biocompatibility (Ratner et al., 2004; D. Buck and Dumanian, 2012). 
In orthopaedics, biomaterials can be used as bone healers and/or substitutes, e.g. partial or 
total joint replacement prosthesis, fixation devices, implants, cements and bone fillers. Some 
examples of biomaterials and their application in orthopaedics and dentistry are shown in 




































Plates, screws, Total joint 
arthroplasty (TJA) 
components (non-bearing 




(AESCULAP implant systems, 
no date) 
LCU® Classic uncemented - 
LINK® (LINK, no date) 
Continuum® acetabular 
system, Trinca® and Trinica® 
select anterior cervical plate 
system, Dental temporary 
abutment - ZIMMER® 





Revitan® revision hip system, 
CPT® hip system, Maxera™ 
cup - ZIMMER® 
Stainless steel 
TJA components, screws, 
plates, cabling 
DVR anatomic plate® - 
Biomet (Biomet, no date) 
Protosul S30 – Sulzer (now 





Vertebro X - 
SOMATEX(Technologies, no 
date) (≈90€ per piece) 
CEMFIX 3, GENTAFIX – 
Teknimed (Medical Expo, no 
date) 
Calcium phosphates 
(HA and β-TCP) 
Small bone defects 
IngeniOs® HA or β-TCP   
Bone Graft Substitute - 
ZIMMER® 
Maxresorb® - Botiss (65€ per 
0.5ml) 
Maxresorb® injectable - Botiss 
(105€ per 0.5ml) 




Bone devices can be made of: 
1. Polymers 
a. Natural, e.g. cellulose, collagen and alginate; 
b. Synthetic, e.g.  PMMA for cementation and ultrahigh molecular weight 
polyethylene (UHMWPE) as low friction inserts for TJA; 
2. Metals, e.g. stainless steel and Ti alloys for fixation plates, screws and TJA 
components; 
3. Ceramics, glasses and glass-ceramics (bioceramics and bioactive glasses and glass-
ceramics), e.g. alumina and zirconia as bearing surfaces on TJA, Bioglass 45S5® 
and Ceravital® as implants and bone fillers; 
4. Composites, e.g. UHMWPE reinforced with carbon fibre and HA-poly (ethylene) 
(Ratner et al., 2004). 
A device targeting bone defects or fractures, including load bearing applications, must be 
mechanically strong, making ceramics and metals highly considerable. Despite their high 
mechanical strength and fracture toughness, metals cause stress shielding and bone resorption 
due to the big difference in material properties comparing to bone, and the absence of an 
osteoinductive character. Alongside these faults, they are not biodegradable, one of the market 
requisites (Kokubo, 2008). Ceramics such as calcium phosphates (CaP) and bioglasses, have 
similar composition to bone mineral phase (HA which is a CaP) and a bioactive character 
(Kokubo, 2008). Another advantage is the growing market for these materials for orthopedic 
applications, estimated at United States dollars (USD) $ 16.3 billion by 2020. A compound 
annual growth rate of 6.4% between 2015 and 2020 has been driven by development and 
evolution of new dental and orthopaedic implants, alongside their increasing global demand 
(marketsandmarkets.com, 2016). A second report on bioactive ceramics was performed by 
Technavio for the period of 2016-2020, registering an increase to USD $ 2.14 billion on the 
investment. These values are justified mainly by an increased demand from organ failure and 
replacement procedures, orthodontics, and several other coating applications, with special 
emphasis on the aging population. The support from the scientific community on research 
carried out in the field of oncology is another prominent driver for the market (Technavio, 
2016). Based on these values, the next section describes the potential of RM, properties of 





2.3 Regenerative medicine applied to bone defects 
To address the problem with present therapies for bone defects, a shift in the clinical approach 
from synthetic implants and tissue grafts to RM, was done. RM involves implantation of a 
new generation of acellular or cell seeded scaffolds, immediately after injury or bone removal. 
Depending on the application and the target tissue, implants can be made of a variety of 
biomaterials, and processed using different techniques (Butscher et al., 2011).  
 
2.3.1 Tissue-implant interaction vs material nature 
When designing a device, the first step to guarantee the implantation success is the tissue 
attachment. The tissue attachment to the implant surface depends on the material reactivity, 
which influences the thickness of the layer between bone and implant. There are 4 types of 
implant, according to its nature:  
1. Inert: dense, nonporous, inert materials where bone grows into the surface 
irregularities, cementing the device into the tissues.  
2. Porous: bone ingrowth is the major cause of fixation, called biological fixation, 
regardless of the material. The ingrowth of tissue into the implant pores increases 
interfacial area, resulting in inertial resistance to the movement. However, the high 
degree of porosity compromises mechanical performance, making them unsuitable for 
load bearing applications.  
3. Resorbable: materials such as CaPs and some polymeric bone fillers degrade gradually 
with time, then are replaced by the host’s tissue. It is ideal short-term, but not for long 
term applications where maintaining the strength and stability of the interface is key.  
4. Bioactive: bioactive glasses and some glass-ceramics, stimulate the formation of a 
hydroxycarbonate apatite (HCA) layer, which works as the interface between tissue 
and implant allowing bonding to both hard and soft tissues (Jones and Hench, 2006). 
The chemical process for the formation of HCA layer is demonstrated on figure 6. 
The bioactivity process 
The HCA layer formed for bioactive materials is chemically equivalent to bone’s mineral 
phase and capable of handling a substantial mechanical load. In cases where it was tested, the 
failure would commonly be verified on the implant or the bone itself, not for the interface. To 
avoid failure, it is necessary to quantify the time necessary for these changes to happen, 
respective to material type. The rate of HCA layer formation and posterior crystallization is 
essential for the success of the bonding and varies greatly. Extremely slow rates of formation 





Figure 6 - Surface reaction stages in the interface between bioactive ceramics and bone 
(Hench, 1998). 
 
2.3.2 Bone regeneration in defect sites: requisites and state of the art 
Bone implants are meant to mimic bone tissue’s chemical and physical characteristics, 
alongside the microstructure. According to Hutmatcher et al. (Hutmacher, 2000), a bone 
implant should be biocompatible and bioresorbable, with a controlled degradation rate to 
match the tissue regeneration. The surface chemistry should promote cell attachment, 
proliferation and differentiation. For bone, 3D highly interconnected porous structures are 
desirable, to allow nutrient flow and cell migration (Hollister, 2005). Bone is porous and 
supports cyclic loads daily, meaning a balance between porosity and mechanical properties is 
sought. Pore size and distribution must be carefully defined and adapted to the application, 
namely defect size and location within the body. Such balance relies highly on the material 
properties, namely the similarity to bone composition, mechanical strength and bone cells 
stimulation (both proliferation and differentiation) (Nordin and Frankel, 2012; Henkel et al., 
2013). Some common requisites for bone regeneration implants are listed in table 5. These 








Maximum possible to maintain mechanical 
stability 
Pore size 200-400 µm 
Pore structure Interconnected 
Table 5 - Base requisites to design a porous implant for bone regeneration (Chu  Liu, 
Xuanyong, 2008). 
 
2.3.3 Bone regeneration in fracture fixation devices 
The use of metals is common, with Ti plates and screws on the top of the market, but 
problems like stress shielding lead to bone weakening, resulting on implant loosening or 
secondary fractures. The therapies used in bone fracture fixation are listed on table 6, 
alongside their advantages and disadvantages. An implant targeting bone fractures, possibly in 
load bearing areas, demands a strong material. Metals are not biodegradable or bioactive, 
therefore, in the context of RM, they are not suitable. Ceramics such as CaPs and bioglasses, 
are a highly-studied option, not only for their similar composition to bone mineral phase 
(HA), but for their bioactive character (Kokubo, 2008). Composites, namely fibre reinforced 
have been studied for this application, consisting mostly of polymer matrices with 
bioceramics fillers. Common fillers are phosphate glass and silane-treated alumina-silicate 


















Mimics the body’s 
electrical stimulus 
Constant stimulation of 
the bone increases patient 
compliance 
Synovial pseudarthrosis 
Does not address deformity problems 
• Possible electrode dislodgement 
and surgical procedure needed to 
insert and remove the electrodes 
(increased risk of infection) 
• Dose dependant 
• Device must be worn between 30 
min to 24h resulting in skin 






High levels of stability 







Damage to soft and nervous tissue 
Infection on pin-site, risks or 
thrombosis and pulmonary embolism 
Invasive and aggressive to the patient 






Can be done with limited 
exposure of bone to 
maintain vascularity and 
decrease infection 
Manages malalignment 
Increases periosteal blood 
supply 
Osteotomy and adequate soft tissue 
coverage is required 
Might need bone grafting 
Initially destroys endosteal blood 
supply 








Good callous formation 
ratio to progenitor cells 
High cost 
Limited availability of tissue grafts 
Conflicting studies for BMP’s 
Table 6 - Advantages and disadvantages of therapies applied to bone fracture (Healey et al., 
1990; Cain, 2002; Poitout, 2004; Einhorn, Joint and Am, 2007; Peterson and Bronzino, 2008; 
Kokosis et al., 2016). 
 
2.4 Bioceramics in orthopaedics  
The discovery of fire triggered society evolution and the development of processes such as 
clay transformation into a ceramic, for varied applications. Ceramics usage started as simple 
tools to improve lifestyle, e.g. pottery and furnaces. With time their application extended to 




flasks and carriers for enzymes and anti-bodies (Jones and Hench, 2006; Kokubo, 2008). 
Ceramics provide advantages such as resistance to microbial attack, pH changes, solvent 
conditions, temperature and packing under pressure, making them suitable for a varied range 
of applications. Biocompatible ceramics used for biomedical applications are referred as 
bioceramics (Ratner et al., 2004).  
 
2.4.1 Types of bioceramics 
Being applied to orthopaedics mainly, these materials can repair and restore parts of the 
musculo-skeletal system. They can be presented in the form of single crystals, polycrystalline, 
glass, glass-ceramics or composites. The most common applications for these materials are 
joint replacement, teeth repairing and/or replacement, and bone filling (figure 7) (Hench, 
1991). A limitation for most bioceramics is their unpredictable behaviour under complex 
stress states, reporting slow crack growth and cyclic fatigue in many clinical applications. To 
improve their mechanical performance, it is necessary to increase flexural strength and strain 
to failure. The mechanical properties of highly studied bioceramics are listed on table 7 
















Table 7 - Mechanical properties of commercial bioactive ceramics used clinically. (Y-TZP) 
Yttrium stabilised tetragonal zirconia. (Christel et al., 1989; Kokubo, Kim and Kawashita, 
2003; Kokubo, 2008; Alharbi et al., 2015). 
Inert materials are used when a reaction or stimulation is not needed upon implantation. 
Materials such as single crystal alumina are attractive for their high density and non-porous 
character, ideal for morphological fixation where a press-fit of the device into the defect is 
needed. These implants must be produced at high standard conditions to avoid failure. When 
processed correctly, it has been predicted it could last 30 years under 1200 N loading. This 
allied to low friction coefficient makes it resistant to wear turning it into a “super tribological 
material”, being used in orthopaedic surgery since 1971 (Kokubo, 2008; Adamovic, Ristic 
and Zivic, 2018).  Studies on total hip arthroplasty showed a decrease of 25-30% on the ball-
socket interface for alumina/UHMWPE when compared to metal/UHMWPE. For alumina-
alumina, the wear was close to 0. Other materials such as zirconia (figure 8) and porcelain are 
used in dentistry as laminates, crowns and implants for the same reasons (Ovsianikov, Yoo 






























Alumina 345 2100 300 3.50 
Y-TZP >1000 2000 200 9-10 
β-TCP 140-154 460-687 33-90 ---- 
HA 115-200 500-1000 80-110 1 
Bioglass® 45S5 42 (tensile) ---- 35 ---- 





Figure 8 – a) Customized zirconia implant on front tooth (white pin). b) Intraoral view of 
cemented zirconia restoration (Manicone, Rossi Iommetti and Raffaelli, 2007).  
 
Zirconia became a second-generation material, aiming to substitute alumina in hip implants, 
and was later introduced on knee implants. Mostly seen under the form yttria stabilized 
tetragonal zirconia (Y-TZP), it is superior to alumina in terms of wear resistance, fracture 
toughness and strength, providing more safety on the long term. Despite its high mechanical 
properties, fast ageing under humid environments caused the implants to fail faster. 
Roughening and micro cracking, due to surface degradation in contact with body fluids, 
lowered wear resistance (Christel et al., 1989; Li, Wang and Chen, 2015). Particles of the 
material leach into the blood current causing a critical reaction of the immune system. The 
rate and dimension at which the process happens depends on how the components are 
processed, namely their sintering conditions (temperature and atmosphere). Saint Gobain 
Demarques, a french company, was considered world-leader in zirconia components for hip 
replacement until 2000, but a change in the manufacturing process, caused the femoral heads 
to fail early and in abnormal conditions, causing the removal of the product (Prozyr®) from 
the market in 2001 (Adamovic, Ristic and Zivic, 2018). Since then, zirconia is used in 
combination with alumina to improve its fracture toughness. The results showed a high 
resistance to cracking and crack propagation without premature ageing. This material evolved 
and is now commercialised under the brand Biolox® delta, by CeramTec AG. The company 
used nano-sized particles of Y-TZP for their ability to uniformly distribute within the alumina 
matrix. Addition of chromium oxide to reduce hardness and strontium oxide to prevent cracks 
during sintering, made this product a staple in the orthopaedic market. Used mostly for 
biological fixation, where the roughness of the surface or porous microstructure is key, these 
inert materials provide biocompatibility and excellent mechanical strength, and don’t degrade 
(kept until failure or until the patient’s death). A disadvantage is their fixation mechanism, 




loosening and wear of the implant resulting in failure. Adding to this, the lack of degradability 
prevents their use in temporary applications. These limitations shifted the focus to 
biodegradable and bioactive materials, i.e. CaP based ceramics, bioactive ceramics, 
biodegradable polymer and even biodegradable metals (Gao et al., 2017). 
Bioactive ceramics and CaP based ceramics are biocompatible and osteoconductive, and their 
bonding strength to the native tissue, when implanted, is 5-7 times higher than that of inert 
bioceramics. Unfortunately, these ceramics are not highly crystalline, structure wise, and their 
mechanical strength is lower than that of cortical bone, limiting their usage to low/non-
loading areas, i.e. tooth root replacements and jaw augmentation. Source wise, mineral such 
as HA can be extracted from corals or animal bones (natural sources) or made in the 
laboratory (synthetic). It is extremely appealing for its high affinity with amino acids, protein 
and organic acids in the body, however it does not degrade in vivo (Gao et al., 2017). When 
the hydroxyl groups in HA are substituted by fluorine ions, the materials become fluorapatite 
(FA), a more stable version at high temperatures and under degradation (Shareef, 2018). A 
degradable bioceramic is TCP, also known as whitlockite. It can be found in various forms 
(am-, ap-, ß – and α-), but ß-TCP is the most investigated for medical applications due to its 
crystalline structure. Applications include cements for small bone defects, acting as hardening 
agent, dental implants and filler for its surface reactivity (provider of Ca2+ ions and PO4
3-). 
When spray coated into implants that were placed in dogs femora, it did not perform as well 
as HA, however it is still implemented in metallic prostheses (Kokubo, 2008). In a study 
conducted by Yuan et al. (Yuan et al., 2007) TCP scaffolds containing bone marrow 
osteoblasts were implanted in dogs. The results showed a rapid integration with the host bone 
and full repair of the defect in 3 months. This was attributed to the fast degradation rate (10-
20 times higher than HA), that allows for a greater availability of Ca and P ions to conduct 
osteoblasts and accelerate the regeneration process. An alternative to Ca-P ceramics is 
Calcium-Silicon (Ca-Si) ceramics such as wollastonite and diopside. These have better 
mechanical properties than CaP based materials and benefit from the effect of Si in vivo. Si is 
an important element in the human body and can be found in bone and in the extracellular 
matrix (ECM). It has an important role in bone calcification and has been reported as 
beneficial for bone density improvement, and in preventing osteoporosis. It promotes the 
production of collagen and proteoglycans and activates the expression of genes related to 
osteoblasts proliferation and differentiation. These features allied to their mechanical 




As demonstrated previously, bioactive ceramics (bioglasses and glass-ceramics) allow the 
formation of an HCA layer that improves the response of osteoblasts, and more recently of 
MSCs (Kokubo, 2008; Park, 2013). They are mainly composed of silicon dioxide, phosphorus 
pentoxide and calcium oxide, with other additions possible, depending on the application and 
the desired properties. Glasses are extremely versatile, and their bioactivity and mechanical 
properties can be tuned depending on their composition and processing. Their low toughness 
and insufficient strength limit their use but improvement has been attempted through the use 
of nanoscale second phases, and dimension reinforcement with nanoparticles (Gao et al., 
2017). Another option was discovered in 1982 by Kokubo et al., a bioactive glass-ceramic 
named AW. This material presented both bioactivity and improved mechanical properties, 
close to those of human cortical bone. AW containing crystalline oxyfluoroapatite 
(Ca10(PO4)6(O,F2)) and β-wollastonite (CaO⸱SiO2) in an MgO–CaO– 
SiO2 glassy matrix . The glass is obtained via melting and quenching route, but every supplier 
could change and tune the production method. The glass frit obtained is then milled to reduce 
the particle size and create the AW powder. The initial powder is amorphous, but when 
heated, apatite and β-wollastonite form. The amount of crystallinity can be controlled by 
changing the hold times for the crystal nucleation and crystal growth (Hench, 1991; Kokubo, 
Kim and Kawashita, 2003). AW glass ceramic applications have been intensively studied 
since its discovery targeting several areas of the body (e.g. hip and spine). Fujita et al. 
produced intramedullary plugs for total hip replacement and implanted them in 22-year-old 
beagle dogs. The implant consisted of porous AW rods with an average pore size of 200 µm. 
the scaffold performance was evaluated at different times after the implantation, and 24 
months later the implant was resorbed and substituted by newly-formed bone (Fujita et al., 
2000). 
 
2.4.2 Processing of bioceramics 
In order to attain good results, a device should be designed accordingly to the application, and 
the material chosen prepared and processed in a repeatable and reliable fashion. In bone 
implants, shape and morphology are highly important for tissue integration, as explained 
previously. Porous structures are usually created using porogens, or similar additives, that are 
added to the initial mixture and then removed using a solvent, or by pyrolysis. Particle 
leaching and freeze drying are also common methods, particularly for polymer-ceramic 
combinations (Goudouri, Balasubramanian and Boccaccini, 2016). These techniques allow 




the  success of the device (Khang  Kim, Moon Suk, Less, Hai Bang and Ltd., 2007; Meyer 
Thomas et al., 2009).  
In ceramics processing, regardless of their nature, preparation of raw materials, forming of the 
green body and sintering processes are highly related, and influence each other directly. The 
chemical composition will dictate which process should be used, and the final properties of 
the part. Another approach could rely on the desired material properties according to a certain 
application, which will dictate what materials could be suitable and the best processing 
method to attain them. The same applies to the manufacturing method, because not all 
materials can be processed the same way, and not all processes give the same end results, for 
a determined material formulation (Lee, 1996). 
 
2.4.2.1 Conventional processes of crystalline ceramics 
Sintering at high temperatures is the most common route to produce a crystalline ceramic. The 
process starts with the powder processing, followed by the green body forming and finally the 
sintering to create the microstructure (Kokubo, 2008).  
 
Powder processing 
Powders can be processed using a wet or dry chemical route, according to the product being 
made. Particles obtained via dry route agglomerate due to the solid-state thermal reactions, 
which demands the use of a comminution method to decrease the particle size and 
homogenise the mixture. The wet route is more precise for the creation of crystalline 
bioceramics, controlling the process at an atomic level through the use of liquid precursors 
(Kokubo, 2008). Powders main characteristics include size, morphology, density, specific 
area, roughness, porosity, degree of agglomeration, purity and interparticular forces. 
Interaction forces during packing and sintering depend on geometry, roughness, nature of the 
surface and interparticle distance (Fatah, 2009). In a mixture, the size distribution of particles 
combined with shape, roughness, density, hardness and moisture content, have a great impact 
on the structure, the tap density and its flow properties. The tendency has moved towards fine 
powders, but the use of particles below 1 µm often comes associated with agglomerate 
formation, leading to heterogeneity of the mixture. Small particles have high surface area to 
volume ratio making them more reactive in a mixture and prompt to agglomerate. 
Agglomerates can be soft or hard depending on the type of bonding between the particles. 




mechanical methods such as milling and pressing. Hard agglomerates are bond chemically 
therefore must be avoided. The presence of agglomerates in the powder lead to variation in 
the packing density during forming and an heterogeneous microstructure after sintering (De 
Campos and Ferreira, 2013). A monodisperse powder allows a greater control of the 
microstructure whilst a polydisperse powder doesn’t. Larger grains coarsen rapidly at the 
expense of smaller grains, hindering densification process and promoting irregular grain size. 
A polydisperse mixture can increase mechanical resistance, provided the ratio between small 
and big particles is carefully calculated and narrow (monodisperse-like mixture) (Ganguli and 
Chatterjee, 1997). The particle shape can also dictate the ability of the powder to pack. 
Equiaxial shapes are preferred, with preference for spheres, to promote flowability, 
homogeneous packing and high matter diffusion. Irregular shapes may cause particle 
interlocking hindering the packing and therefore the sintering ability of the precursor. 
Differential sintering due to agglomerates or irregular particle shape, leads to different 
shrinking rates across the green body and development of large pores and cracks in the final 
part, causing its failure upon mechanical testing (Ganguli and Chatterjee, 1997).  
Powders are commonly produced via wet methods, e.g. spray drying and freeze drying. Spray 
drying consists mainly on the breakdown of a fluid feedstock into droplets (solution, slurry, 
emulsion, or sol), by spraying it into a heated chamber where the droplets dry and deposit into 
a vessel (figure 9). The nozzle system is under pressure, promoted by a pump, which controls 
the droplet size. For big droplets, nozzle diameter, viscosity and surface tension of the 
solution, are increased. Smaller droplets are generated by decreasing the nozzle diameter and 
the viscosity, whilst increasing the pressure. The main steps of the spray drying process are: 
1. Preparation of feedstock by proper dispersion of the agglomerates using pre-milling 
and dispersants;  
2. Atomization of the feedstock. The solid content should be at least 75% with a 
particle size suitable for the nozzle (high particle size leads to nozzle clogging and 
too small provokes agglomeration); 
3. Drying of droplets into solid agglomerates; 
4. Calcination and, if necessary, sintering of the products. 
This method is a large-scale, low-cost alternative to dry routes, where the solid substances are 
thermally bonded, and the product milled to obtain a smaller particle size. Breakage of the 
agglomerates is caused by the high thermal energy used to melt the raw materials. It is 
extremely effective for the production of fine powders, ideal for moulding (Lee, 1996; 
Kokubo, 2008). Similarly, freeze drying uses a wet precipitated powder that is frozen due to 




chamber, via sublimation, and removed from the dried object, leaving only the particles. The 
powders deriving from freeze drying have high surface areas, promote high packing density 




Figure 9 – Illustration of a common spray drying system, divided by components (numbered 
1-6). 
 
Powder consolidation and forming 
The green body production can be achieved using either dry or wet powders with viscous 
fluids, via two routes: melt casting and firing of compacted powders.  On melt cast, the raw 
powders are molten together and then formed using casting, rolling, pressing, blowing and 
spinning. This route is not appropriate for ceramics with high melting points or that 
decompose after melting, therefore is mainly used for glasses. For crystalline ceramics, firing 
of compacted powders is the ideal route. This method consists on the consolidation of dry 
powders followed by their shaping using a mould to produce the green body. The green body 
is then fired to densify. Polymers such as polyvinyl alcohol and paraffin are added as glues to 
increase the plasticity of the green body, to form it into the desired shape (Kokubo, 2008). A 
mould is created, and the mixture poured in, followed by cold isostatic pressing in Argon 
atmosphere, preventing the accumulation of internal stresses caused by air bubbles or excess 
of water in the part. Common forming methods are uniaxial compaction, slip casting and 
injection moulding. The process used dictates the additives that will be present in the mixture, 
e.g. uniaxial compaction uses water-soluble resins such as poly vinyl alcohol (PVA) in a 3-
5wt%. Slip casting applies sodium alginates in a 0.5-3 wt%, whilst injection moulding relies 
on thermoplastic resins and paraffin, in a 10-25 wt%, or plasticizers such as phthalate esters in 




after water evaporation and densification, but to prevent problems upon part removal, olive oil 
or silicone are added as lubricants (Kokubo, 2008). 
Sintering and densification 
Sintering is the stage where the microstructure is created, a main step to attain the desired 
final properties. The part is heated to 50-75% of the melting temperatures to promote matter 
diffusion between particles, joining them and reducing porosity. In the solid state the matter 
exchange occurs via atomic diffusion, denominated solid state sintering (Lee, 1996). The 
main goal of sintering is to reduce surface energy for particles to bond. This physical bonding 
can happen via diffusion, where the matter is transported from inside the grains into the pores, 
or via coarsening, the rearrangement of matter between different parts of the pore surface. 
Both methods lead to densification and depend highly on particle size and shape (figure 10). 
The result is a defined microstructure composed by grains that are separated by a grain 
boundary. Depending on the predominant mechanism the part density varies, being diffusion 
the best route to attain full densification. Coarsening tends to promote the formation of highly 
porous parts, with weak mechanical properties (Lee, 1996). 
 
 
Figure 10 - Sintering mechanism and matter transport systems. When temperature increases, 
matter starts diffusing binding particles and decreasing porosity, necking and densification, 
e.g. sintered silicon and alumina (Lee, 1996). 
 
To control densification, several factors must be kept stable: temperature, particle size, 




particles for the reasons discussed on the powder processing section. Hering (Lee, 1996) 








   𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (2) 
In equation 2, n varies according to the diffusion type, 3 for lattice diffusion and 4 for grain 
boundary diffusion. This applies to a constant temperature and spherical particles with radius 
r, with a hexagonal or cubic close packing. The required amount of time needed to sinter the 
part is represented by t. This relation predicts that a decrease on particle size from 1 µm to 
0.01 µm will accelerate the sintering from 106 to 108 factors. Another valid point to be 
accounted for is that smaller particles are more reactive therefore tend to agglomerate if not 






    𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (3) 
 
In this equation N is the number of particles in the mixture, a is the radius and Vm the molar 




    𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (4) 
The specific surface energy per surface area (γs) is multiplied by the molar volume and the 
result divided by the particle radius. This represents the decrease in surface free energy of the 
system when densification occurs. Since the particles surface area is also smaller due to their 
bonding to other particles, the driving force for sintering is the reduction of the surface energy 
via consolidation of the mass of particles (Lee, 1996).  
The problem of coarsening prevails on solid state sintering, but it is reduced on liquid phase 
sintering (figure 11). In this process, an additive with lower melting point is used to create a 
liquid phase that infiltrates between grains, prompting diffusion mechanisms. Consequently, 
an increased transport of matter to the pores occurs. Liquid phase sintering is very effective 
on ceramics with high degree of covalent bonding because they are harder to densify using 
solid state. It is also used to reduce costs of solid-state sintering, when temperatures for 
melting are too high, causing a high expenditure of energy. The amount of liquid phase 




additives are silicates that remain as a glassy phase after cooling, providing the material with 
a glassy appearance which is the base of their designation as vitrified ceramics (Lee, 1996).  
 
 
Figure 11 - Liquid sintering mechanism and example of resulting microstructure using over 
5vol% of liquid phase (Lee, 1996). 
 
In theory, liquid sintering’s driving force is based on Young Laplace equation (equation 5) 
which assumes that the pressure in the liquid is lower than in the pore, generating capillary 




    𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (5) 
In this equation, r represents the radius of the pore in a liquid and γlv the specific surface 
energy of the liquid-vapour interface. When dividing that energy for the pore radius, the 
pressure difference (Δp) across the curved surface is given. That stress is equivalent to 
submitting the system to hydrostatic pressure. The increased compressive capillary stress, 
generated by the liquid infiltrating the pores, reduces friction and aids particle rearrangement. 
This results in enhanced densification, faster grain growth and occasionally the production of 
a specific grain boundary (Lee, 1996). In most cases the liquid phase remains in a glassy state 
as mentioned before. In some specific cases this phase might be incorporated in the solid 
solution, crystallize or evaporate, commonly known as a transient liquid phase. For 
evaporation, the liquid phase disappears during sintering. Despite the aid in densification of 
the part, by itself this measure is not enough to attain full density. Parameters that were 
previously mentioned such as powder particle size and morphology and presence of pressure 





2.4.2.2 Conventional processes: glasses and glass-ceramics 
Bioactive glasses commonly arise from melting metal oxides, carbonates and fluorides 
together, resulting in a composition based on silicates (SiO2), phosphate pentoxide (P2O5), 
alkaline (Na2O, K2O) and non-alkaline earth oxides (CaO, MgO). Structurally, the silicates 
and phosphates form a network that composes the skeleton of the glass and strengthens it. The 
alkaline and non-alkaline earth oxides break it, allowing the formation of spaces where the 
oxides can bond. The addition of oxides, also called modifiers, lowers the melting point, 
changes the refractive index, the viscosity of the melt, the density of the material and the glass 
transition temperature (Tg). Nonetheless, these oxides are essential for bioactivity (Kokubo, 
2008). Glasses are amorphous solids obtained by the melt cast route, also known as melting 
and quenching. The melt is cooled from a liquid state becoming rigid, without specific 
volume changes. According to the American Society for Testing and Materials (ASTM) glass 
is “an inorganic product of fusion, which has been cooled to a rigid condition without 
crystallization”. Another 2 common routes are water evaporation from a solution containing 
the glass elements, and the use of organic materials as precursors (e.g. Pexiglas®). If enough 
energy is provided for a long period of time, the glass state changes into crystalline state, with 
a rate of crystallization determined by equation 6, where Hf is the heat of fusion at the melting 




    𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (6) 
This equation states the influence of viscosity in the speed of crystallization, high viscosity at 
Tm promotes the formation of glass and slows down the crystallization rate (Park, 2013). This 
relation is presented in figure 12, where the result is dependent on the temperature influence 
on the volume and cooling rates. According to this, if the melt is cooled rapidly, then 
crystallisation is avoided, however if temperature is kept at the melting point, the high energy 
in the system allows the ions to rearrange and form small crystals. The glass must also be 
annealed at a temperature lower than the Tg to eliminate the residual stresses originated 
through the fast cooling and contraction of the structure.  Crystalline glasses present a 
crystallisation temperature (Tc), which is located between the Tg and the Tm. By lowering the 






Figure 12 - Volume changes depending on the melt transitions (Kokubo, 2008). 
Glass-ceramics are primarily formed by annealing the glass at a temperature above the Tc, 
generating a fine microstructure where each grain has an average diameter of approximately1 
µm, the key to their improved mechanical properties (Kokubo, 2008).  To estimate the 
crystallisation tendency of the glass, several parameters can be calculated based on the 
thermal transitions: crystallisation tendency (δ), glass forming ability (Kgl), and sinterability 
(Sc), represented on equation 7, 8 and 9 (Hrubý, 1972; Lara et al., 2004). According to Hruby, 
the smaller the δ, the highest is the probability of the glass having structural units with high 
crystallisation tendency, i.e. with high liquidus temperature of the melt which is unfavourable 
for glass formation. For glass forming ability, if values are below 0.1, the glass formation is 
difficult and extreme control of conditions must be applied. For values equal to or close to 
0.5, glass is easily prepared by free cooling of the melt in air. Sc in the context presented by 
Lara et al., refers to the competition between sintering and crystallisation kinetics during 
heating. The higher is the sinterability, more independent are the processes. High Sc values are 
related to better sintering behaviour and higher densification of the final sample (Hrubý, 
1972; Lara et al., 2004).  




     𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (8) 




In the represented equations, Tc refers to the temperature at which crystallisation is initiated, 
Tg the glass transition temperature, Tm the melting temperature and TMS the temperature of 
maximum shrinkage. 
In the medical field, the first glass-ceramic developed was AW where apatite grains 
crystallized in a strong wollastonite matrix, via surface crystallization, the reason why it must 
be processed using sintering. AW processing is based on the melting of metal oxides, 
carbonates and fluorides with the addition of modifiers to produce specific changes (Kokubo, 
2008). Tuning of the glass-ceramic properties allows for higher freedom regarding the 
application. The smallest of changes (below 2 wt% in glass composition) can affect 
parameters such as the bioactivity and degradation rate (Abou Neel et al., 2009; Murphy et 
al., 2009; Miola et al., 2014). Within the medical field, such changes can dictate whether the 
material will be used for a temporary or permanent solution. Researchers such as Filho et al. 
(Filho, La Torre and Hench, 1996; Massera et al., 2015) demonstrated how the increase in 
crystallization can retard the development of the carbonated apatite layer. Introduction of 
oxides is often done on purpose to easy the processing of the material. In some cases, they 
result from the processing of the material itself, being a common one alumina, originating 
from the glass frit milling. This oxide acts as stabilizer and has been used in many 
applications to control the microstructure during the sintering process of glasses and other 
polycrystalline ceramics (Baino et al., 2016). AW can resist failure by fatigue under a 
constant loading of 65 MPa, stronger compared to sintered HA which sustained the same 
loading for only 1 minute. In the study developed by Kokubo et al. was estimated that AW 
can prevail for 10 years when submitted to those loading conditions, immersed in SBF 
(Duminis, Shahid and Hill, 2017). Bioactive materials are also in study as reinforcement of 
polymer and metallic matrices of biocomposites once they can induce the precipitation of an 
HCA layer and improve the fixation of biodegradable polymeric implants, whilst enhancing 
osteoconductivity (Navarro et al., 2008). 
 
2.5 Biocomposites in orthopaedics 
A composite consists of two or more different materials, separated by an interface, at the 
micro or macro scale. Briefly, a composite consists of a continuous phase (matrix), reinforced 
by one or more discontinuous phases (filler). The composite is usually designed according to 
the final properties of the device, demanding a fine balance between material ratio/weight 
percentage (wt%). The choosing of the appropriate processing technique is also key to obtain 




classified as a particulate, fibre or laminate composite. Particle can be spherical, cubic, 
tetragonal or with random shape, e.g. crushed glass. Fibres can be long or short in terms of 
size, unidirectional or random in terms of orientation. Laminates are produced by stacking 
oriented fibre composite laminae to form a structural element (Ratner et al., 2004). An 
important aspect is the relationship between matrix and reinforcement/s, whether they work 
separately or synergistically. A common goal is achievement of high mechanical properties 
such as stiffness, strength, toughness and fatigue resistance. Fibres are a preferred 
reinforcement for these applications because their strength can be tuned by changing fibre 
orientation and wt%. Some of these composites reach stiffness and strength values similar, or 
higher, than those of metals (Ratner et al., 2004). Particulates are isotropic therefore not as 
useful for improvement of mechanical properties. They can be used to induce a chemical 
reaction, increase degradation or even to attract a certain type of organism/cells (Navarro et 
al., 2008; Ahmed et al., 2011).  
 
2.5.1 Types of biocomposites 
Composites have been introduced for clinical application for their ability to mimic the 
hierarchical structure of human tissues. The combination of two different materials with 
desired properties is a main advantage, namely for load bearing applications, eliminating 
problems such as stress shielding and post-implantation fractures, common in metals. The use 
of degradable matrices reinforced by stronger materials is seen as a viable solution for the 
problem. Balancing the materials ratios allows the control of the degradation rate and 
consequently of the mechanical strength (Shikinami and Okuno, 1999; Agarwal, Broutman 
and Chandrashekhara, 2006; Ahmed et al., 2011). In medicine, most matrices are made of 
biodegradable polymers due to their physicochemical properties, and successful use in clinical 
applications. Materials such as PLA, Poly (glycolic acid) (PGA), polycaprolactone (PCL) and 
Polyhydroxybutyrate are considered perfect candidates to process biocomposites for bone and 
ligament repair. They have also been combined with bioactive molecules and particles to 
promote cell guidance and/or stimulation towards a response (Navarro et al., 2008). Studies 
on their ability to improve osteoconductivity had positive results. Composite scaffolds made 
of PLLA and HA, or poly(lactic-co-glycolic acid) (PLGA) and HA, demonstrated improved 
mechanical properties, osteoconductivity and bone formation (Zhang and Ma, 1998). Another 
study performed by Ma et al. showed the positive effects of adding HA, on the osteoblastic 
cell seeding uniformity, and a significantly enhanced expression of mature bone marker genes 





2.5.1.1 Biocomposites for bone regeneration 
Biocompatibility and biodegradability are important when processing a scaffold for tissue 
regeneration. A wide range of materials can be used to attain these properties, however the 
technique to process them must be adequate. Several processing techniques have been used to 
produce 3-D scaffolds, from particle-leaching to solvent casting. New techniques such as fibre 
bonding, membrane lamination and gas saturation are amongst the most common, and 
recently, 3D- braiding to make scaffolds for ligament replacement (Laurencin and Freeman, 
2005; Navarro et al., 2008). The production of biocomposites can be challenging and should 
mirror the target tissue. Bone is a composite by nature, apatite reinforced with collagen, with 
different types of structures at the micro and macro-scale. A bioactive ceramic-polymer 
composite has potential to mimic this. Using a polymer with mechanical properties within the 
range of bone, e.g. PLLA, guarantees the device will withstand the loads, be ductile, and by 
being biodegradable, to disappear once the bone tissue is fully regenerated. The addition of a 
bioactive material such as HA and AW, promotes the tissue growth adjacent to the implant, 
whilst enhancing the proliferation of osteoblasts, and the differentiation of MSCs (Wang, 
Kukobo and Bonfield, 1996; Wang, 2003). 
 
2.5.1.2 Biocomposites for fracture fixation 
In fracture fixation, Ti plates are the gold standard device but problems such as stress 
shielding, and re-fracturing are highly associated with these devices. Other disadvantages 
include plate migration and, in the case of maxillofacial fractures, a potential interference with 
facial growth and thermal sensitivity (Suuronen, 1993; Giannoudis, Psarakis and Kontakis, 
2007). To counter these problems, research on biodegradable devices as taken place, with the 
most common being associated to PLLA due to its low cost and suitable mechanical 
properties. PLLA plates and screws are broadly studied, with interesting works developed by 
Bos et al. for zygomatic fractures and Suuronen et al. on PLA and PGA, for mandible and 
orbital fractures (Bos et al., 1987; Suuronen, 1993). Commercially, products such as the 
OSTEOTRANSMX (Takiron CO, Ltd, Osaka, Japan) are in the market. This device is 
composed of PLLA and HA which makes it bioactive and completely resorbable (Sukegawa 
et al., 2016). Fibre reinforced composites made of a PLA matrix and iron doped phosphate 
glass fibres (PGF) are reported in literature for internal fixation purposes. These had varying 




unidirectional-oriented (Ahmed et al., 2011). At 5 wt%, PLLA/Ca-doped short phosphate 
glass fibres composites proved to stimulate biomineralization of hMSCs (Melo et al., 2019).  
 
2.5.2 Processing of biocomposites 
The processing of non-porous bioactive polymer-ceramic composites for tissue replacement is 
well known. Avoiding contamination is imperative since it can lead to leaching of toxic 
substances upon implantation and/or when the device starts degrading (biodegradable 
biocomposites) (Wang, 2003). Two routes currently exist either based on physicochemical 
methods or on thermo-mechanical methods. The first route includes precipitation of mineral 
crystals in situ in the polymer matrix (CaP reinforced with collagen) (Clarke et al., 1993) and, 
dispersion of bioceramic particles/fibres in the polymer solution (HA/Chitin) composites 
(Wang, Weng and Poret, 2001), with subsequent consolidation. The second route, based on 
thermal and mechanical mechanisms, allows the impregnation of porous bioceramic matrix 
with a polymer. This method is useful for the manufacturing of biodegradable composites 
and/or incorporation of bioceramic particles/fibres into a polymer matrix, via conventional 
plastic processing technologies, including hydrostatic extrusion (Ladizesky, Ward and 
Bonfield, 1997; Wang, 2003). In industry it allows the process of composites with enhanced 
mechanical performance, via compounding, milling, compression and injection moulding. 
Different geometries and homogeneous distribution of the reinforcement can be obtained by 
using a compounding extruder, internal mixer or a two-roll mill (Wang, Porter and Bonfield, 
1994; Wang, L Hench and Bonfield, 1999).  
 
2.6 Additive manufacturing                                                                                                                                                                                         
To overcome the problems of traditional manufacturing, new processing techniques, such as 
AM, with the ability to generate complex shapes with high porosity, at various scales, have 
been developed (Yasa and Ersoy, 2018). Personalisation attracted the attention of 
professionals in the bone RM area, and has been the hype of orthopaedic research (Butscher et 
al., 2012; Morris et al., 2016). Another advantage of AM is its growing market, already 
published on Wohlers report of 2018, which states an industry continuous growth of 21%, 
lower than in 2015 (25.9%) (Caffrey, Campbell and Wholers, 2016; Wohlers et al., 2018) 
which is still translated into USD$ 7 billion. A rise is predicted for 2025 due to the demand 
from industries such as automotive, dental, manufacturing and healthcare (Caffrey, Campbell 




In AM, the parts are produced in a layer by layer fashion, using a computer aided design 
(CAD) model that is converted into an STL file. The information can come from a scanning 
method, such as CT and magnetic resonance imaging (MRI), designed by the researcher, or a 
combination of both. Depending on the material and application, different AM processes can 
be applied. Both liquid or solid-state materials are accepted, i.e. thermoplastic polymers that 
are molten to a viscous state, resins that are cured using light, solid bulks that are deformed 
using mechanical energy, and powders that are shaped using binders or laser. A general 
overview of the techniques is demonstrated in table 8, according to ASTM F42 (Gibson, 



























































Table 8 - AM processes according to ASTM F42, and some examples of used techniques 
(Wong and Hernandez, 2012). 




A liquid photopolymer is contained un a vat 
and processed by selectively delivering energy to 
cure specific regions of a part cross-section 
Powder bed fusion 
SLS and SLM 
A container filled with powder that is 
processed selectively using an energy source, 




Processes that deposit a material by extruding 
it through a nozzle, typically while scanning the 




Droplets of material are selectively deposit 
onto a platform and cured using an energy source 
Binder jetting 
3DP 
A binder is printed into a powder bed in order 
to form part cross-sections 
Sheet lamination 
LOM 
Processes that deposit a layer of material at a 




Processes that simultaneously deposit a 
material (usually powder or wire) and provide 





Liquid-based processes include Fused Deposition Modelling (FDM) or Fused Filament 
Fabrication (FFF), where the materials used are generally thermoplastic polymers such as 
acrylonitrile butadiene styrene (ABS) and PLA. The second process is Stereolithography 
(SLA) which uses acrylate or epoxy resins that contain monomers and photoinitators that are 
activated by ultra-violet (UV) light. They act as catalysts for the polymerization reaction, 
allowing the material to solidify. A third process, is ink jetting, similar to SLA, except that 
liquid inks are created using either polymers (urethane acrylates and methacrylate resins), 
metals (bismuth, led and thin alloys),  or ceramics (zirconia and alumina), with a viscosity 
range between 20-40 cP, at printing temperature (Gibson, Rosen and Stucker, 2010; Wong 
and Hernandez, 2012).  
Solid-based material processes can use either bulk forms or powder, depending on the 
material and the application. On Laminated Object Manufacturing (LOM) sheets of metal, 
plastic, ceramics or paper, are joined through the application of heat and pressure. Powder 
based processes provide better resolutions and do not require the application of supports, or 
post processing in most cases, once the powder bed acts as the support itself, and the high 
resolutions permit a higher level of accuracy and surface smoothness. In powder bed methods, 
the material can be molten, sintered or bound using a liquid binder. Processes using melting 
include Selective Laser Melting (SLM) and Selective Laser Sintering (SLS). SLM is used 
only for metals and metal-ceramic composites, commonly aluminium (Al) and Ti alloys, 
stainless steel and other tool steels, nickel-based alloys and cobalt-chrome. Some companies 
provide precious metals such as silver and gold. SLS materials range from thermoplastic 
polymers, usually polyamide 12, PLA or even PCL, to ceramics such as HA and AW 
(Lorrison, Dalgarno and Wood, 2005; Williams et al., 2005; Lee et al., 2015). Finally, Binder 
Jetting uses polymers such as PMMA, gypsum, and starch-based materials. For ceramics 
sintering must be used to finish the part. The binder varies but is commonly water based. 
Ceramics aside, most parts are infiltrated with glues and other types of adhesives provided by 
material and equipment suppliers, to attain structural integrity. Special cases such as Electron 
Beam Manufacturing (EBM) and Laser Engineered Net Shaping (LENS) can process both 
metals and ceramics, using wire or powder forms as feedstock. In this case a melt pool is 
created, and powder is deposited onto it, solidifying once the laser moves away from the melt. 
The wire form is used mainly for simple geometries, coatings or when thin to thick transitions 
are required (Lorrison, Dalgarno and Wood, 2005; Williams et al., 2005; Gibson, Rosen and 
Stucker, 2010; Wong and Hernandez, 2012; Butscher et al., 2013; Lee et al., 2015; Mancuso 




Within the medical area, AM has been widely studied for production of devices targeting 
tissue regeneration. Printing of biocompatible and biodegradable materials, both natural and 
synthetic, is evolving, with study numbers growing by the year (Sachlos and Czernuszka, 
2003). Binder Jetting is a frequently used technique as previously assessed. Early on 1998, 
Kim et al. had printed chloroform onto a PLGA powder bed to create 3D scaffolds for liver 
TE. These comprised channels with a diameter of 800 µm with microporosity created by 
sodium chloride leaching from the PLGA powder. Despite the desirable microstructural 
features, the use of organic binders demanded an exhaustive procedure for solvent cleanse and 
evaporation (Kim et al., 1998). Lam et al. used water as binder for starch base scaffolds. The 
scaffolds were free of toxins, but hadn’t the mechanical stability needed, leading to their 
infiltration with PLLA and PCL solutions in methylene chloride (Lam et al., 2002).  
  
2.6.1 AM of ceramics for bone repair devices 
AM of ceramics in literature consist mainly of a multi-step process involving the use of 
sacrificial binders and powder particles, e.g. binder jetting where the binder is removed inside 
the furnace during a “de-binding” stage. SLM and Direct Energy deposition (DED) are the 
only routes reported with the ability to process ceramics in a single step. The AM processes 
used to obtain ceramic parts are presented on table 9 alongside the feedstock form, advantages 
and disadvantages of each route (Deckers, Vleugels and Kruth, 2014). 
Single-step methods are also limited in terms of materials used since these cannot include 
cells and the nozzle limits the features size. Some geometries might need supports in the case 
of DED, and for SLM and SLS, trapped powder can be a problem as in SLS. SLA provides 
high resolutions and accuracy as well as repeatability but is limited in terms of materials that 
can be used. HA suspended in photocurable monomers was processed by SLA to produce 
orbital floors and other craniofacial devices (Sachlos and Czernuszka, 2003).  Despite the 
success it is known that the use of cells with the resins is also limited once most of the resins 
are toxic. SLS allows for the use of cells once the materials can be biocompatible, however 
the range is limited to some bioceramics such as CaPs. For load bearing applications in bone 
tissue, HA and CaPs are not suitable. Lee et al. used SLS to produce personalized AW 
scaffolds which incorporated a cylindrical central channel. This design was chosen to increase 
cell penetration and medium flow, guaranteeing nutrient delivery to the cells in the centre of 
the structure. The in vivo results report osteoid formation and tissue in-growth. Also AW 
scaffolds do not require osteogenic pre-induction, highlighting their aptitude for custom-















Do not require 
binder removal step 
 
Limited options of 
processes 
Not able to process 
many ceramics at 
the moment 
 
Thermal cracks arise 
from the rapid 






Deposit of dry 
powder 
agglomerates of 10 
– 100µm generally 













Able to produce 












produce crack and 






might form if the 
process steps is not 
well controlled 
(especially the 
binder burnout step) 
 
Deposit of dry 
powder 
agglomerates of 10 
– 100µm generally 
leads to low-density 
ceramics 
 
Poor surface quality 
in some processes 























dispersed into a 
thermoplastic or 
wax filament 
Table 9 - Processing of ceramics using AM (Deckers, Vleugels and Kruth, 2014). 
 
Binder jetting theoretically allows the use of any powder and corresponding binder. The 
powder bed acts as a reagent and support simultaneously, resulting in decreasing of material 
costs and increasing of design possibilities. When applied to ceramics (figure 13) it can 
include a sacrificial solid binder, added to the powder bed, to increases interparticular contact, 
enhancing green part density. Later, during sintering, it promotes material diffusion resulting 




binder removal, avoiding part distortion via swelling or excessive shrinkage (Lee, 1996; 
Dyson et al., 2007; Rodrigues, 2018). Despite the lower resolutions, compared to other 
powder bed methods, and the lack of control over porosity, binder jetting is material versatile, 
if it is post-processed accordingly. Trapped materials are easily removed once the particles 
aren’t strongly bound prior to sintering.  
 
 
Figure 13 – Left: Binder jetting printing process. A roller spreads a layer of powder onto the 
powder bed and an inkjet head selectively deposits the binder. The platform lowers down, and 
another layer is spread. The process continues until the part is finished. The part is then 
cleaned and sintered to attain structural integrity (Gibson, Rosen and Stucker, 2010). Right: 
Sintering furnace. 
 
2.6.1.1 Binder jetting of bioactive glasses and glass-ceramics 
Bone is heterogeneously porous, which suggests use of a technique that could create this type 
of microstructure, ideally without the use of any additives. Binder jetting offers such a 
technique and could be ideal to fabricate personalised bone implants. As mentioned in section 
2.4, the most commonly processed bioceramics are HA and TCP. These materials have been 
used under powder form as feedstock for binder jetting, alone and in combination with 
polymers or other ceramics (Lv et al., 2019). HA in both nanoscale and microsphere form 
(Suwanprateeb et al., 2009; Lv et al., 2019) has proved its suitability to create bone scaffolds 
using binder jetting, however with lower mechanical properties, compared to cortical bone. 
NanoHA scaffold, sintered at 1250 ˚C and a porosity of 58%, reached a compressive strength 
of 84 MPa. In this study it was also observed that higher binder saturation allowed for better 
mechanical properties. This relation between binder and mechanical performance was also 










Cycles repeats until end of process
• Piston fully raises
• Parts are removed 
from powder bed
• Cleaning and post-




Here the binder acted as a ligand and wet chemical reagent, promoting the reaction between 
dicalcium phosphate anhydrous and calcium hydroxide to obtain TCP. An alternative to a 
reaction process, using resins as binders can improve both flexural strength and modulus 
whilst improving strain at break (Suwanprateeb, Sanngam and Suwanpreuk, 2008). The 
morphology of the powder bed is important, meaning the powder preparation must be 
adequate. Studies comparing milling with spray drying of HA powders showed that milling is 
more advantageous since it leads to better mechanical properties (Suwanprateeb, Sanngam 
and Panyathanmaporn, 2010). Spray dried powders benefited tap density however milling 
promotes packing and therefore increases green density. This leads to a higher level of 
interaction during sintering, through inter and intra particle forces, consequently to a stronger 
part. Another strategy to improve the mechanical properties involves doping the powders, to 
induce a reaction during sintering. TCP powders doped with SiO2 and ZnO produced 
scaffolds with better mechanical properties and enhanced cell proliferation, compared to TCP 
only (Fielding, Bandyopadhyay and Bose, 2012). 
The versatility of the binder jetting process is not limited to the raw materials (binder and 
powders) but also to the printing parameters. HA parts produced with a layer thickness of 
0.10 mm proved to yield better flexural strength and modulus, compared to those printed with 
layers of 0.08 mm  and 0.20 mm (Suwanprateeb et al., 2012). In considering load bearing 
applications, the processing technique can be applied to glass-ceramics such as AW (Vlasea et 
al., 2010; Alharbi, 2016; Mancuso et al., 2017). Binder jetting of bioactive ceramics, 
specifically Bioglass formulations and AW, both blended with MD, was extensively studied 
and experimented by Mancuso et al. (Mancuso et al., 2017) with values obtained for the 
printed implants matching previous studies, with minimum variation. The use of binder jetting 
permitted the production of strong accurate structures, at lower cost. Examples of printed AW 
implants and their microstructure, compared to bone, can be seen in figure 14. This work 
aimed to test the printing of different shapes using different powder blends to assess the 






Figure 14 – a) AW implants processed via 3DP. b) Microstructure of the printed parts 
obtained via µCT, c) compared to bone (Mancuso et al., 2017). 
 
2.6.1.2 Important parameters binder jetting 
Binder jetting uses powders as feedstock and sintering as post processing. When using 
powders, it is key to control the particle size, shape and size distribution, in order to obtain 
uniform layers, a faster sintering, and stronger part. The powder size and morphology directly 
affect the flowability and wettability of the material. This influences the layers homogeneity, 
binder concentration and distribution. When establishing printing parameters, it is also 
important to define the values for the binder to volume ratio of the inner core and shell. These 
relate to the amount of binder deposited on the outer edges and surfaces of the part (shell) and 
in its interior (inner core) (Alharbi, 2016). The parameters and respective effects are described 
below: 
1. Powder packing: spherical particles, or equiaxial shapes, benefit packing uniformity. 
An increase in surface roughness, shape irregularity and aspect ratio, promotes 
packing density. In a powder mixture, packing density can be improved by upgrading 
the size ratio between the 2 powders, according to their composition (fraction of large 
to small particles). A polydisperse powder blend benefits packing density leading to 
an increment on green body strength (Ganguli and Chatterjee, 1997). 
 
2. Flowability (described as the powder deformation, in movement, when submitted to 
external forces): an alteration in the powders state of balance occurs causing the 




top of the other. This is considered a “free flow” (like a viscous liquid). Cohesive 
powders might have the appearance of conventional powders but once the flow starts, 
it is possible to see the slip between agglomerates (Fatah, 2009). Flowability in AM 
dictates  the powder bed homogeneity and content uniformity (De Campos and 
Ferreira, 2013). It is measured by the flowability factor (ffc - ratio between 
consolidation stress and compression strength) and by both size and particle shape. 
Rough surfaces have a significant effect on the adhesion force and changing the 
roughness can change the Van der Waals interaction by up to several orders of 
magnitude. Mohammed et al. observed that irregularities in particle shape cause 
considerable interlocking amongst the particles and increases their resistance to flow. 
Their roundness reduces the interparticle forces and improves their flow properties 
(De Campos and Ferreira, 2013). Fine powders usually have poor flowability due 
interparticular forces that overcome gravitational forces, causing the powder to 
agglomerate. At this point, the ratio of Van der Waals forces to the particle’s weight 
increases with size reduction. As a result, the particle’s surface area per unit of mass 
decreases, generating a platform for cohesive forces to interact (De Campos and 
Ferreira, 2013). The poor flowability leads to heterogeneities in the powder layers and 
powder entrapment inside the part, even after de-powdering (Butscher et al., 2012). 
This theory was proved by Geledar et al. in 2008, when comparing the angle of repose 
(AOR) of alumina powders with 6.59 µm and 63.1 µm. AOR increases when particle 
size decreases, implying a high degree of cohesion and low flowability (Geldart, 
Abdullah and Verlinden, 2009). 
 
3. Wetting (the ability of the powder to absorb a binder): excessive wetting will cause 
binder spreading whilst lower leads to poor layer building. This is dependent on the 
powder hydrophilicity and can be determined by the contact angle between binder and 
powder. Higher binder viscosity hinders coverage whilst low viscosity promotes 
overspreading. Topography of the powder bed surface dictates absorbed binder 
quantities, specifically powder particle size and shape, e.g. round smaller particles 
have higher surface areas therefore a higher capacity for adhesion. Chemical reactions 
between powder and binder can lead to particle swelling when the amount applied is 
excessive. Particle dissolution occurs when the binder is not correctly chosen 





4. Interaction with fluids/binding: the interaction of the liquid binder with the powder 
bed involves the dissipation of kinetic energy of the droplet, surrounding of droplets 
by powder, infiltration of the liquid and rearrangement of the powder particles under 
the capillary forces (Lanzetta and Sachs, 2003). Binder concentration must be 
minimized because too high reactivity prevents binder spreading whilst too low 
favours it. Binder concentration should be adjusted to provide the part mechanical 
stability. Binding can happen via two mechanisms: powder dissolution by the binder 
with subsequent recrystallization, or by gluing of the powder particles with polymer-
based binder (Butscher et al., 2011). The 2 essential binding steps are binder 
absorption and mechanical interlocking. Binder absorption may happen via a chemical 
reaction and subsequent inter particle crystallization, or by particle adhesion. Either 
way the part needs to be post-processed to attain mechanical interlocking (Butscher et 
al., 2011). 
 
5. Sintering: the sintering step is very important for the successful processing of a 
ceramic part and has been described in detail on section 2.4.2. The protocol should 
encompass a de-binding step before the sintering step to allow the binder to evaporate 
without causing part distortion. For a glass-ceramic, the protocol includes a nucleation 
step and a crystal growth step that allows those crystals to grow. These steps are 
crucial once they provide the material enough crystallization to improve the 
mechanical properties (Butscher et al., 2012; Alharbi, 2016; Mancuso et al., 2017). 
 
2.6.2 AM of biocomposites 
AM as proven to be a powerful tool, especially in the medical area. The freedom of design 
and wide range of techniques available to produce lightweight complex geometries makes it 
an attractive approach to produce medical devices. Unfortunately, current AM is filled with 
proprietary materials which limits the range of physicochemical properties attainable. To 
overcome these problems, researchers are focusing on developing their own materials, 
especially composites, to enhance variety and improve properties of printed parts (Gao et al., 
2015; Yasa and Ersoy, 2018; Melo et al., 2019). Although multi-material printers already 
provide a method of making composites layer by layer, a growing interest grew towards pre-
blending materials (matrix and reinforcement) prior to the printing. The resultant composites 
exhibit unique characteristics and capabilities, and since they are tuneable, the possibilities are 




composites involve the use of thermoplastic matrices (PLA, Polyether ether ketone, ABS) 
reinforced with either carbon fibre or glass fibre, to improve the tensile properties of the 
material. Short and continuous fibres have been printed for application in automotive and 
aerospace sectors using FDM, SLS and other adapted/developed techniques. Using FDM for 
such applications is limitative in terms of material choice because it needs to have an ideal 
viscosity to be extruded and still provide structure rigidity to the final part. Thermoplastics are 
the first choice for this technique, but their mechanical properties are often lower than metals 
and ceramics. This is counteracted by using reinforcements made of a stronger material. 
When mechanical properties are in focus, fibres are the first choice. Long and oriented fibres 
loaded in high percentages (< 40%) contribute positively towards tensile properties, but with 
their introduction appears porosity. The voids created by the introduction of the reinforcement 
must be controlled since they deteriorate the fibre-matrix interface, hindering the mechanical 
performance of the device (Yasa and Ersoy, 2018). Short-fibres tend to be less used but 
authors such as Zhong et al. observed that by reinforcing ABS with short-glass fibres, tensile 
strength was favoured but flexibility and handling were reduced. Shofner et al. used vapour 
grown short carbon nanofibers and observed an increase in brittleness low interlayer and 
intralayer fusion above 10% loading. Despite this, tensile properties were still enhanced and 
high enough for the chosen application (Zhong et al., 2001; Shofner et al., 2003). In terms of 
content, Ning et al. concluded that the best percentage of loading was 5%, and anything above 
40% wasn’t printable due to nozzle clogging. The use of carbon fibres generally improved the 
tensile properties but decrease toughness, ductility and yield strength. Higher lengths favoured 
tensile properties but did not affect the yield strength value. Just like Shofner et al., the results 
showed an increase in porosity for 10% fibre loading (Ning et al., 2015).  
In the medical area, biocomposites are widely studied for musculoskeletal applications, 
commonly under the form of fixation devices or as scaffolds for bone regeneration (Wang, 
2003). Using AM to produce such devices attracted both scientific and industrial community. 
Commonly printed with binder jetting, these include mixtures of glass powders with CaPs, 
but don’t comprise the needed bioactivity for stimulation of a biological response. An 
example was Winkel et al. with the addition of HA to control shrinkage and improve stability 
of the structure during sintering. Polymer-ceramic biocomposites consisting of a 
thermoplastic polymer and a bioactive ceramic, are in focus once both ductility and strength 
can be obtained, from polymer and ceramic respectively. Work developed by Baino et al. 
reported the processing of a scaffolds containing β-TCP and collagen. The scaffolds could not 




casted onto it. Nonetheless, these structures presented fully interconnected pores and 
supported cell adhesion and proliferation up to 7 days (Zhang et al., 2012). On a later work 
the author used CAD/Computer aided manufacturing (CAM) technology to study the cartilage 
bone transition area to create a biomimetic structure. The author observed defects on the 
subchondral bone plate which aimed the passage of blood vessels and nutrient into the bone 
tissue. This enlightened and improved the vision around bone scaffolds design of 
osteochondral interfaces (Bian et al., 2016). Similar work based on the use of two techniques 
to produce different parts of the device, and joining them together, is available and reported, 
however on composites the knowledge remains scarce (Costa et al., 2018).  
Composite formulations comprising polymer and bioceramics proved to deliver bioactivity, 
osteoconductivity and mineralization of bone marrow-derived hMSCs (Kalsoom, Nesterenko 
and Paull, 2016; Melo et al., 2019). Researchers such as Xiong et al., produced PLLA-TCP 
biocomposites using Low-Temperature Deposition Manufacturing (LDM) (figure 15). In their 
work, a slurry made of 15% PLLA, 15% TCP and 70% dioxane was prepared. Room 
temperature was kept stable to ensure no disturbance of the bioactive properties occurred. The 
slurry was fed into to the material supply, connected to a screw pump nozzle (0.3 mm 
diameter). The scaffolds were built in a layer by layer fashion, 0.15 mm layer thickness, under 
0 ˚C to freeze the scaffold upon building. The scaffolds were freeze-dried to remove the 
solvent and to attain solid state at room temperature without losing shape and mechanical 
integrity (Xiong et al., 2002). 
 
Figure 15 - Schematic of LDM process (left) and geometry of produced scaffolds (right) 
(Xiong et al., 2002). 
 
The low temperature was attained by refrigerating the vat containing the slurry as 
demonstrated on figure 15. Woodpile geometry was applied once it encompasses controlled 




applications commonly within the range of 400-600 µm. This allows for cell migration, and 
multiple layer formation without clogging the pore. In this study the average pore size 
reported was 400 µm for macro-porosity and 5 µm for micro-porosity, with an overall 
porosity of 89.6%. These values can be tailored by changing layer dimension and distance 
between each rod of the pile. The scaffolds were implanted in canine radiuses where both new 
bone and marrow grew. Mechanical properties were low but within the range of spongy bone, 
12 MPa and 60 MPa for bend strength and compressive modulus respectively (Xiong et al., 
2002). 
Another interesting study on AM of biocomposites, consisted on the processing of PLLA and 
10 wt% carbonated HA nanospheres using SLS (Zhou et al., 2008).  The nanospheres were 
produced using an emulsion technique and fed into a modified SLS machine. Tetragonal 
porous scaffolds were produced, using a layer thickness of 0.10 mm and laser power of 11-19 
W. The results report an average macro-pore size of 0.6 mm, 0.2 mm smaller than the 
designed scaffold. On figure 16 fully fused PLLA particles are shown, however, for the 
composite the fusion level was lower. The author suggest that the particles at the surface 
prevented the fusion (Zhou et al., 2008). On the same fashion of this technique, Du et al. 
fabricated graded composites using PCL/HA microspheres. The spheres were fed onto an SLS 
machine and used to produce multi-layered cylinder-shaped scaffolds. These struts showed 
excellent results in both in vitro and in vivo studies, inducing cartilage formation and 
regeneration of bone in the subchondral area (Du et al., 2017). PCL/HA scaffolds have also 
been produced using FFF technology with the aim of osteogenic differentiation of hMSCs 
derived from adipose cells. The cells differentiated in both PCL and composite scaffolds, but 






Figure 16 –SEM of microspheres: a) PLLA and b) PLLA/CHA. c) Printed part; f) and e) SEM 
of printed parts: d) PLLA and e) PLLA/CHA (Zhou et al., 2008). 
2.7 Summary of the literature review 
The knowledge collected up to date allows to define some key conclusions that work as 
guidelines for the development of the current experimental work: 
• AW bioactive glass-ceramics are a potential solution for load bearing applications 
in RM. Several in vivo and in vitro studies show that AW stimulates and promotes 
bone in-growth into the implant; 
• AM techniques allow the fabrication of complex bespoke geometries and offer a 
variety of materials, getting the research closer to personalisation; 
• Binder jetting is a versatile and low-cost process that permits the production of AW 
bone implants with porous microstructures, without the use of additives; 
• Mechanical properties of printed AW implants mimicked the ones in human bone; 
• Powder properties are essential for a successful fabrication once they influence 
manufacturing process, which relies on layer homogeneity and binder absorption; 
• Sintering protocols must be defined accordingly to the material and include a de-
binding process to allow the safe evaporation of the binder without shape 
distortion; 
• Glass-ceramic crystallization process is important during material processing and is 
divided in 2 stages, nucleation and crystal growth. Changes in crystallization affect 
the material sintering and can change the processing properties, namely sintering 
temperature and dwelling time; 




• Processing of biocomposites using AM is already under study with promising 
results, however the knowledge on polymer-ceramic printing is still scarce and 
needs further development; 
• PLLA and other known thermoplastics are the focus materials for matrices while 
and bioactive materials such as HA, TCP and AW have been the chosen ones for 
reinforcement; 
• The addition of bioactive ceramics to polymer matrices can enhance the material 
osteoconductivity and osteoinductivity. Biocomposites can provide degradability 
and bioactivity, whilst stimulating osteoconductivity and MSCs mineralization; 
• The shape of reinforcement affects the material final properties and its processing 
route; 
• Fibre-reinforced biocomposites are highly studied and show promising results for 
processing devices with enhanced mechanical properties; 
• Fibre orientation and size influence the final tensile properties and ductility. Fibre 


















 Chapter 3. Materials and Methods 
 
This chapter introduces the materials and methods used in this research project. These are 
divided in 2 sections: section 3.1 reports on materials and methods with protocols gained from 
previous work, and section 3.2 reports on protocols which have been developed or further 
optimised during this project.  
 
3.1 Standard Materials and Methods 
3.1.1 AW-based materials 
AW was introduced in chapter 2 and was the chosen bioceramic for this project. The AW 
glass-ceramic precursor was produced via a melting route by Glass Technology Services 
(Sheffield, UK) and supplied under the form of frit with a density of 3.078 g/cm3  (Kokubo et 
al., 1985; Alharbi, 2016). The base batch composition of the glass-ceramic precursor provided 
in literature consists of 4.6MgO∙44.7CaO∙34SiO2∙16.2P2O5∙0.5CaF2 (in wt%).  
The use of this material on this research group is common, being this project a continuation of 
the works developed by Alharbi. N. and Mancuso, E and Rodrigues, N. throughout their PhD 
studies, where this AW was used as powder feedstock for binder jetting printing of load 
bearing devices (Alharbi, 2016; Mancuso, 2016; Rodrigues, 2018). Highlighting this fact is 
important since the studies developed in the current project allowed to understand why the 
material changed its thermal behaviour, once passed from Mancuso, E. to Rodrigues, N. In 
this project it is demonstrated (chapter 4) that this is derived from an Al2O3 contamination of 
the powders.  
To better understand the study, the materials were nominated from M1 to M6, being M1 the 
powder acquired for the studies of Alharbi, N. and Mancuso, E. M2 was later provided to 
Rodrigues, N. and was the powder used in chapter 5 for the binder jetting process. According 
to an elemental analysis performed on the materials, the M1 was contaminated with 0.68 wt% 
Al2O3 and M2 with 0.14 wt%. This contamination is thought to be acquired during the milling 
process, therefore, to be present at the surface of the particles. To be able to understand how 
the Al2O3 affects the material, 3 new AW glasses were created by adding the percentages of 
Al2O3 detected in M1 and M2, to the AW base formulation. A pure AW powder was also 




The new powders developed consisted of M3, a pure AW with a final percentage of 0.04 wt% 
Al2O3, M5 and M6 with 0.13 wt% and 0.61 wt%. The formulations in detail are demonstrated 
on table 10, prior to normalisation.   
3.1.1.1 Alumina doped AW 
The glass making process was performed at Glass Technology Services (Sheffield, UK) and 
will described in detail. The raw materials were weighted using a pan top balance (KERN 
3000-2) and mixed for 5 minutes using a turbular mixer (TURBULA System Schatz T2C), 
amounting to a total of 500 g for each batch. Once mixed, half the powder was transferred 
into a silica crucible and placed inside a furnace (Lenton EAF 17/12) at 1400 ˚C for 30 
minutes. When molten, the other half was added and left to melt and mix for a further 60 
minutes. Finally, the crucible was carefully removed from the furnace and the molten glass 
poured into a steel mould and left to cool down. This was considered the first melting step and 
aimed to mix the ingredients and allow the evaporation of CO2. The cool glass was cracked 
with a hammer and the resulting pieces placed inside 2 platinum crucibles, with spare pieces 
used to perform XRF analysis as described in 3.1.3.2. The platinum crucibles were placed in a 
different furnace (Lenton UAF 17/12) at 1400 ˚C for 1 hour. This was considered the re-
melting stage which allowed the glass mixture to become homogeneous. Once fully molten, 
the glass was poured into a metal vase filled with cold water to create the glass frit. M1 
powder batch was obtained as frit and milled with a planetary mill equipped with alumina 
balls (Pulverisette 6 grinder, Fritsch, Germany) at 400 rpm in two stages of 2 minutes each. 
Later, it was milled at 410 rpm for 3 minutes to homogenize and attain a smaller particle size. 
The M2 powder batch was milled with a ball mill (CAPCO 12VS, USA) equipped with 
porcelain balls for 10 hours. Later, using the previously referred planetary mill, it was 
processed at 410 rpm for 2 minutes. For M3, M4 and M5 powders, the glass frit was initially 
milled using the mentioned ball mill, and porcelain balls, for 8 hours. The powder was then 
sieved through a 200 µm sieve mesh using a sieve shaker (Podmore’s Engineering, Stoke-on-
Trent, UK), to obtain a particle size below 200µm. At this stage the particle size was not 
confirmed by mastersizer. Further milling, using the planetary mill at 410 rpm for 3 minutes, 
allowed the decrease of the particle size to the desired range, 122 µm ± 8.5 µm (mean ± SD). 
Sieving was performed with an Auto Sieve Shaker SV001 (Impact, UK), with 90 µm, 53 µm 
and 20 µm sieve meshes for a minimum of 1 week. Finally, the blend was created by mixing 
the powder from each size range, in is designated percentage, inside a roller mixer (Stuart, 













4.6MgO∙44.7CaO∙34SiO2∙16.2P2O5∙0.5CaF2 + 0.68Al2O3 
M2 4.6MgO∙44.7CaO∙34SiO2∙16.2P2O5∙0.5CaF2 + 0.14Al2O3 





Table 10 - Batch composition of all developed glasses, doped with alumina and control 
(without alumina). 
 
3.1.1.2 Sample preparation for SEM and XRD analysis– uniaxial compression 
The powder was processed into a blend with particle size ranging from 20-90 µm, using the 
method described in 3.1.1.1. Each powder batch was processed into discs with 10 mm 
diameter and 2 mm thickness, using a uniaxial manual press (Specac IST, Specac Ltd, USA). 
In order to mould the powder into discs, a paste was prepared containing AW and isopropanol 
on a 3:1 (w/w) ratio, which translated in 0.35 g of AW and 0.1g of isopropanol per sample. 
The material was weighted using an analytical balance (Sartorius UC152) and mixed until it 
attained a paste-like texture and most isopropanol evaporated. The paste was left to dry for 40 
s at room temperature and poured into the mould to be pressed at 1 ton for 1 minute. The 
green parts were sintered (SNOL 1300, TMS Europe, UK) using a 2-step protocol, consisting 
of a nucleation step and crystal growth phase (Alharbi, 2016; Mancuso et al., 2017). The 
nucleation step was kept common for all batch types, 779 °C with 1-hour dwell. The crystal 
growth step dwell time was maintained as 1 hour however, for the sintering temperature, 
different values were applied. M1 was kept at 1150 ˚C as previously established (Mancuso et 
al., 2017), and M2 and doped batches sintered at 1250 °C. 
 
3.1.1.3 Preparation of M1 and M2 AW powder 
Prior to processing the samples, the AW frit was converted into a powder blend with desired 
particle size ranges, via milling, sieving and mixing.  
Milling and sieving 
The AW frit was primary milled for 10 hours using a ball mill containing porcelain/alumina 




using a sieve shaker (Podmore’s Engineering, Stoke-on-Trent, UK), to obtain a particle size 
below 200 µm. At this stage the particle size was not confirmed. Further milling, using a 
planetary mill containing zirconia balls (Pulverisette 6 grinder, Fritsch, Germany) at 410 rpm 
for 3 minutes, allowed the decrease of the particle size to the desired range, 122 µm ± 8.5 µm 
(mean ± SD). The sieving was done using an Auto Sieve Shaker SV001 (Impact, UK), with 
90 µm, 53 µm and 20 µm sieve meshes for a minimum period of 1 week.  
Mixing of powders 
The AW powder obtained from different sieve meshes (single or combined with a solid 
binder), was placed inside a roller mixer (Stuart, SRT6, UK) for 3h.  
 
3.1.2 Binders 
3.1.2.1 Maltodextrin – solid binder 
Maltodextrin (MD) is a product from starch hydrolysis, and is considered an amorphous 
thermoplastic polymer with a Tg ranging from 100 °C to 200 °C (Raja et al., 1989). Following 
previous studies, described in chapter 2, MD (MyProtein, UK) was chosen as the solid binder 
to create the final powder blend for binder jetting printing. In this study, MD is also used as a 
solid binder, introduced in the binder jetting blend to act as glue for the AW particles. As part 
of the blend creation process, the MD was sieved to attain the desired particle size range of 20-
53 µm, using the method described on 3.1.1.3. 
 
3.1.2.2 Zb®60 – liquid binder 
This product consists of a liquid binder, which will interact with the MD to create a glue that 
keeps the glass-particles together allowing for the creation of a green part. The clear water-
based binder was purchased from EMCO Education Ltd (UK) with a composition of 18% 
humectant, 4% polymer and 78% water (in wt%). 
 
3.1.3 Base polymer - PLLA 
PLLA is an aliphatic polyester, approved by the US Food and Drug Administration (FDA), and 
commercialized under the medical grade standard. For this project, PLLA (Purasorb PL 38, 
Corbion - Purac Biomaterials), with a density of 1.24 g/cm3, was selected and used as a matrix 
for PLLA/AW biocomposites processed via FFF printing.  The material properties are shown 






Tm (ºC) 170 
Tg (ºC) 56 
Shape Fibre, Sponge, Film 
Tensile strength (MPa) 900 (fibre) 
Young’s Modulus (GPa) 8.5 (fibre) 
Elongation at break εB (%) 25 (fibre) 
Pdwo (37ºC – period until becomes water 
in saline water) 
3-5 years 
Pet50 (37ºC – period until tensile strenght 
becomes 50% in saline water) 
6-12 months 
Table 11 - PLLA physicochemical properties (Melo, 2014). 
 
3.1.4 Binder Jetting printing and sintering – production of AW scaffolds 
The overall printing process of an AW scaffold is demonstrated in figure 17 and consists of 3 
phases: powder preparation, printing and post processing. The first step is the formulation of 
the powder blend. The powder blend used in this work aimed a faster sintering, and  completed 
the current AW/MD powder blend catalogue (Alharbi, 2016; Rodrigues, 2018). 
 
 
Figure 17 - Overview of printing process using binder jetting and sintering, from raw material 
preparation to the part characterisation. Process is initiated with powder blend preparation 




drying. The printing is performed, and the result is a green part. The green part is sintered 
using a defined protocol to allow the material to crystallise and attain structural integrity.  
 
For a successful printing, a minimum of 500 g of powder must be used. For this, AW was mixed 
with MD on a 70% to 30% ratio, respectively. The final blend morphology consisted of:  
• MD (20µm-53µm): 30%, 150 g; 
• AW (53µm -90µm): 30%, 150 g; 
• AW (20µm -53µm): 25%, 125 g; 
• AW (< 20 µm): 15%, 75 g. 
The powder blend preparation was performed according to the protocol described in 3.1.1.3. 
 
3.1.4.1 Powder bed properties 
The characterisation was based on 3 parameters: powder bed density, powder flowability and 
packing ability. For the powder bed density and degree of compaction, a tap density test was 
applied (figure 18a). A cylinder was filled with 100 ml, the initial volume (Vi) of the powder 
blend and tapped every second for 3 minutes. The tapping time was estimated by performing 
a pilot assay. Here the time needed for the powder to stop descending inside the cylinder was 
measured with a timer (Samsung Galaxy S5). Once no descendent movement was detected 
the final volume (Vf) was recorded. The powder blend mass was also recorded before and 
after the tapping test to calculate the powder bed density and estimate the amount of air within 
the mixture. With the obtained values, the Carr index (compressibility of powder), Hausner 
ratio (flowability) and powder bed density were calculated (equation 10, 11 and 12, 
respectively). 
𝐶. 𝑖𝑛𝑑𝑒𝑥(%) = (
𝑉𝑖−𝑉𝑓
𝑉𝑖
) × 100     𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (10)  
𝐻.  𝑟𝑎𝑡𝑖𝑜 =  
𝑉𝑖
𝑉𝑓




      𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (12)  
The powder flowability was also measured using the funnel test (figure 18b). The procedure 
consisted on passing the powder blend through a funnel to investigate how powder settled 
once deposited. The funnel was slowly dislocated upwards to keep a safe distance from the tip 







the funnel, measurements of the cone height (h) and base diameter (d) were taken and used to 
calculate the angle of repose (θ) (equation 13).  
 
 
Figure 18 - Powder bed properties. a) Measurement of tap density, before and after 3 minutes 
tapping. b) Schematics of the funnel test for the flowability of the powder. 
 
3.1.4.2 Binder Jetting printing and sintering 
The printing was done on a commercial ZPrinter® 310 Plus (ZCorporation, Rock Hill, SC, 
USA). The printing process started with the design of the implant. Two types of samples were 
created using this method, discs (12 x 2 mm) and bars (2 x 30 x 2 mm), as presented in figure 
19. Samples were sketched using a CAD software (Autodesk Inventor, Professional 2015, 
Autodesk Inc.) and converted to an STL file. The file was uploaded into the printing software, 
and the following printing parameters were defined: 
• Layer thickness: 0.1 mm. 
• Binder to volume ratio of inner core: 0.1. 
• Binder to volume ratio of the shell: 0.21.  
The printing process was explained on chapter 2, section 2.5.1. Briefly, a liquid binder is 
selectively deposited onto a powder bed on a layer by layer fashion. The final part is left to dry 
for a minimum of 12 hours. The powder surrounding the printing area, which did not get in 
contact with the liquid binder, was immediately removed to avoid moisture absorption. Once 
θ = tan−1 (
2ℎ
𝑑




the parts dried, unbound powder was carefully brushed away and the green body taken for 
sintering. The sintering process was performed in a state of the art furnace (SNOL 1300, TMS 
Europe, UK) and the heating protocol divided in 3 steps: de-binding (350 °C, at 2.5 °C/min), 
crystal nucleation (779 °C, at 5 °C, hold 1 hour) and crystal growth (1250 °C, at 5 °C, hold 1 
hour).  
 
Figure 19 - Design of binder jetting samples using CAD software. Disc samples used for 
physiochemical and biological characterisation. Bars samples aiming mechanical testing via 
3-point bend test. 
 
3.1.4.3 Part density and porosity measurements 
The density of samples was measured using an Archimedes kit, mounted onto a precision 
balance (KERN ABT 220-5DM, ± 0.1 mg, a maximum weight capacity of 220 g, Germany). 
Firstly, the sample dimensions were taken using a calliper, and used to calculate the bulk 
volume, as per equation 13, where h is the height of the sample and r the radius. Firstly, the 
samples were weighed to obtain the dry mass (m1). Then, each sample was immersed in di-
ionized water (DI) to obtain the immersed mass (m2), and finally gently dried with a paper 
towel and reweighted to obtain the wet mass (m3).  
The values were applied to equation 14, equation 15 and equation 16, to calculate the bulk 
density, total porosity and open porosity, respectively.  AW density was defined as 3.078 g/cm3   
(Alharbi, 2016). 







) =  
𝑚1
𝑉𝑜𝑙𝑢𝑚𝑒
    𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (14) 
𝑇𝑜𝑡𝑎𝑙 𝑝𝑜𝑟𝑜𝑠𝑖𝑡𝑦 (%) = (1 −  
𝑚1
𝐴𝑊𝑑𝑒𝑛𝑠𝑖𝑡𝑦 × 𝑠𝑎𝑚𝑝𝑙𝑒 𝑣𝑜𝑙𝑢𝑚𝑒






The estimation of pore size and size distribution was based on image analysis, using the .tiff 
files obtained from the XRCT (analysis to be described in 3.1.3.5). To better understand the 
distribution of the porosity within the samples, 3 samples were scanned, and 3 areas of the 
sample used for the analysis: top, middle and bottom. From each area, 5 scans were considered, 
to increase the accuracy of the measurement. Briefly, images were opened on imageJ (NIH) 
and submitted to a thresholding treatment to isolate the pores (figure 20). Since the pores have 
irregular shapes, the Feret diameter function was applied and the measurements taken 
considering the maximum dimension of each pore. The obtained values were statistically 
treated using the software GraphPad Prism (section 3.1.9). 
 
Figure 20 - Pore size analysis using imageJ. Thresholding to obtain pore isolation and pore 
contouring allowing the calculation of Feret diameter. 
 
3.1.4.4 Shrinkage evaluation 
The volumetric shrinkage was assessed on a total of 5-disc shaped samples. Diameter and 
height, before and after printing, were measured using a calliper then used to calculate the initial 
and final volumes of the samples. Shrinkage was calculated in volume (equation 17) and linear, 





𝑂𝑝𝑒𝑛 𝑝𝑜𝑟𝑜𝑠𝑖𝑡𝑦 (%) =  
𝑚3 − 𝑚1
𝑚3 − 𝑚2
× 100     𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (16) 
𝑆ℎ𝑟𝑖𝑛𝑘𝑎𝑔𝑒 𝑖𝑛 𝑉 (%) =  
𝑉𝑖 − 𝑉𝑓
𝑉𝑖
× 100      𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (17) 
𝑆ℎ𝑟𝑖𝑛𝑘𝑎𝑔𝑒 𝑖𝑛 (𝑥, 𝑦) (%) =  
𝑟𝑖 − 𝑟𝑓
𝑟𝑖
× 100    𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 (18) 
𝑆ℎ𝑟𝑖𝑛𝑘𝑎𝑔𝑒 𝑖𝑛 (𝑧)(%) =  
𝑧𝑖 − 𝑧𝑓
𝑧𝑖





3.1.5 Methods for physicochemical characterization 
3.1.5.1 X-ray diffraction (XRD) 
XRD analysis allows the evaluation of the material’s crystallinity and structure. The samples 
were analysed using the PANalytical X'Pert Pro MPD, powered by a Philips PW3040/60 X-
ray generator and fitted with an X'Celerator detector. Diffraction data was acquired by 
exposing the samples to Cu-Kα X-ray radiation, with a characteristic wavelength () of 1.5418 
Å.  X-rays were generated from a Cu anode supplied with 40 kV and a current of 40 mA.  The 
data was collected over 0-60 2θ range, and the scans analysed using the equipment software 
PANanalytical X’Pert HighScore Plus©. The patterns compared to the ones within the data 
bases provided by the supplier (ICDD 1999 and COD 2016). 
The AW was examined prior to processing, in raw powder form (glass-ceramic precursor), 
and post-processing, as a compressed pellet and printed scaffold. The crystallinity of the 
PLLA was also assessed in all 4 stages of the scaffold processing: 1) granule form (raw); 2) 
post-melting in hot plate; 3) as extruded filament; 4) as printed scaffold (FFF). Further details 
on the sample processing for AW and PLLA based composites are described in chapters 4, 5 
and 6. 
3.1.5.2 X-ray fluorescence (XRF) 
This technology measures the secondary X-rays emitted by a sample when excited by a primary 
X-ray source (Fishcher, 2019). It was used to confirm the elemental composition of produced 
AW powders as produced. The frit samples were milled into fine powders (< 45 µm) and mixed 
with a bonding agent (20 wt%, CEROX BM-0002-1, FluxANA, Germany). The resultant paste 
was pressed into pellets to produce homogenous samples for analysis. The analysis was 
performed using a wavelength disperser XRF S4 Pionner (BrukerAXS GmbH) with a 
collimator of 0.46˚, no filter, and in vacuum conditions. The operation was conducted using a 
fundamental oxides detection mode. 
 
3.1.5.3 Scanning electron microscopy (SEM) 
Samples from both physicochemical and biological characterization were imaged with SEM. 
The samples for physicochemical characterization were mounted on an Al stub and fixed using 
disc shaped carbon adhesives. The coating was performed with 15 nm gold particles using a 
sputter coater (Polaron SEM Coating Unit), and then dried overnight. For the imaging of 




critical point drying were performed.  Dehydration was carried out using, 25%, 50%, and 75% 
ethanol (30 minutes each) followed by 100% ethanol (2 x 1 hour). A final dehydration step was 
performed with CO2 in a Baltec Critical Point Dryer (Leica Geosystems Ltd). Fixed specimens 
were mounted on an Al stub with Achesons Silver Dag (Agar Scientific) and then dried 
overnight. The observation of all samples was performed by the TESCAN VEGA LMU SEM, 
housed within EM Research Services, Newcastle University. The images were collected using 
the software supplied by TESCAN. 
 
3.1.5.4 Powder morphology analysis 
The particle size and size distribution were measured using a laser particle size analyser 
Mastersizer 3000 (Malvern Instruments Ltd), in dry cell mode. For each sample type, 5 readings 
were accounted to allow the statistical analysis. The collected data was treated with the 
equipment’s software, which allows for the calculation of particle size and size distribution, per 
percentage of volume. The size distribution was estimated using the Dx values, Dx10, Dx50 
and Dx90 which indicate the amount of sample under a certain size (µm) (Malvern Ltd, 2019).  
 
3.1.5.5 X-ray computer tomography (XRCT) 
The microstructure of processed devices was investigated with an XRadia/Zeiss VersaXRM 
410 XRCT (Carl Zeiss Vision Inc.), providing 1 µm resolution. AW samples were analysed 
using a scanning voltage of 140 kV, a current of 71 µA, with a voxel size of 2.6 micro voxels. 
Approximately 600 slices were obtained, covering the full sample height. The scanned 2D slices 
were used for the reconstruction of the 3D model using Avizo Fire software (Durham 
University, UK). For the biocomposite samples, all parameters were maintained except the 
applied voltage which was 60 kV. 
 
3.1.5.6 Differential Scanning Calorimetry/Thermogravimetric Analysis (DSC/TGA) 
The DSC and TGA analysis aimed to detect the temperature at which the main thermal 
transitions occur, glass-transition (Tg), crystallization (Tc) and melting (Tm). Both Tg and Tm 
were represented as endotherm transitions while Tc was shown as exothermic (Bottom, 2008; 
Pooria Moghadam, Tohidi and Ranjbar, 2010).  Mass loss from thermal degradation was 
recorded simultaneously. The DSC/TGA measurement of AW powders was done using a 
DSC Q600 (TA instruments, USA) and the results treated using TA Universal Analysis 




at a rate of 10 °C/min. An empty crucible with the same weight was used as reference. Due to 
equipment restrictions, the DSC analysis of the PLLA was performed on a Mettler Toledo 
DSC 3 (Mettler-Toledo Ltd, U.K.). The polymer was placed inside an Al pan (12.5 mg) and 
an empty pan was used as reference. Each sample was heated from room temperature up to 
250 °C at a rate of 10 °C/min. The data was collected using the supplier’s software, STARe 
Evolution. The results obtained from both machines were exported into Microsoft Office 
Excel and plotted as Heat Flow (mW) vs Temperature (°C). 
 
3.1.5.7 Hot Stage Microscopy (HSM) 
HSM is highly used for ceramics and glasses to determine their temperatures of softening, 
melting, flowing and sintering. The result of the data treatment is a plot where several 
variables can be analysed as a function of temperature (Panna, Wyszomirski and Kohut, 
2016).  The AW powder (particle size < 20 µm) was mixed with deionised water to form a 
paste and inserted into a moulding device with cylindrical shape (2 x 3 mm). The AW 
samples were analysed on a Misura® equipment (Expert System Solutions, Italy), with an 
isothermal protocol ranging from 25 °C to 1300 °C, at a rate of 10 °C/min. A video camera, 
placed inside the instrument, allowed the monitoring of changes in the sample silhouette with 
temperature. These were later processed into images and videos. The data acquired was also 
converted into graphs using Microsoft® Office Excel.  
 
3.1.5.8 Mechanical testing 
The mechanical properties (n=5 per material) were assessed through 3-point bend test and 
compression, using 1 mm/min crosshead speed, on a standard testing machine (Shimadzu, 
United Kingdom), with a 5 kN load cell. The effective modulus was calculated from the 
stress-strain curve, as the slope of the linear part of the curve. The yield point for both flexural 
and compressive strength was determined at the point where strain occurs without the increase 
in loading. The data was exported from the equipment software (Trapezium X, Shimadzu, 
United Kingdom) as a .csv file and treated with Microsoft® Office Excel to obtain the stress-
strain curves. The statistical analysis was performed on Graph Pad Prism 7, as described 
below in 3.1.7. The samples types analysed consisted of: 
• AW bars processed using binder jetting (2 x 30 x 2 mm, as in section 3.1.4.2), span 




• PLLA and PLLA/AW bars processed using FFF (10 x 40 x 3 mm, as in 3.2.2.2), span 
length of 32 mm; 
• PLLA and PLLA/AW squares processed using FFF (10 x 10 x 3 mm, as in 3.2.2.2). 
For the AW pellets (8 mm diameter, 2 mm thickness) created with uniaxial compression, 
the compression test was performed on the same type of testing machine (Shimadzu, 
United Kingdom), using a 10 kN loading cell, with a crosshead speed of 1 mm/min. For 
the sample analysis (n=5), a 30 N pre-load was applied, and the strain normalised 
accordingly. 
 
3.1.6 In vitro degradation assay 
3.1.6.1 Mass loss and pH variations  
Samples were weighed (n=3 per material) using a precision balance (precision of ≥ 0.001 g, 
Sartorius, Sartorius AG), placed into individual plastic vials containing Phosphate Buffered 
Solution (PBS) with an average pH 7.4 (Sigma Aldrich, UK), and incubated at 37 °C. Squared 
and bar shaped samples were immersed in 5 ml and 25 ml of PBS, respectively.  The solution 
was refreshed weekly and measurements were taken at week 1, 2, 4, 6 and 8. To assess the 
mass loss, samples were incubated at 37 ˚C for 48h, and re-weighed to obtain the dry weight. 
Flexural strength was assessed according to the method described in section 3.1.3.8. The pH 
of the solution was measured using a portable FG2-Kit Five Go™ pH meter (Mettler Toledo 
Ltd, UK), with a calibration at pH 2 and pH 7, lower and higher range respectively.  
 
3.1.6.2 Ion leaching via inductively coupled plasma mass spectrometry (ICP-MS) 
The collected PBS solution was analysed by ICP-MS on a Thermo X-series2 instrument 
operating in collision cell mode (using 3 mL/min 8% H2 in He as collision gas) for elemental 
detection. The samples were diluted 5-fold in 2.5% (w/v) high-purity HNO3 (Merck) 
containing 20 µg/L indium (In) and platinum (Pt) as internal elemental standards. For each 
sample, magnesium (24Mg), calcium (40Ca), indium (115In), and platinum (195Pt) isotopes 
were monitored sequentially using the peak-jump method (100 individual reads of 20-30 ms 
on each isotope). This was performed across 3 channels of 0.02 atomic mass unit separation, 
each analysed in technical triplicates. Elemental concentrations were determined by 
comparison with matrix-matched standard solutions (Merck) of known elemental composition 




the analysis performed by Dr. Kevin Waldron at the Institute for Cell and Molecular 
Biosciences, Faculty of Medical Sciences, Newcastle University. 
 
3.1.6.3 Diffusion Ordered Nuclear Magnetic Resonance Spectroscopy (DOSY) 
Diffusion NMR 1H proton measurements were used to determine polymer chains 
hydrodynamic radii. These were carried out using a Bruker Avance III 400 MHz nuclear 
magnetic resonance (NMR) spectrometer, equipped with a 5 mm SMART probe. All 
measurements were carried out at 298 K using Bruker ICON automation software and 
processing carried out using Bruker Topspin software (V3.6.1). Samples were analysed using 
a bipolar gradient pulse and calculations are made using the Stokes Einstein equation 
(equation 20). 
𝐷 =  
𝐾𝐵𝑇
6𝜋𝜂𝑅𝐻
    𝐸𝑞. (20) 
Here D is the diffusion, KB the Boltzmann constant, T the temperature, 𝜂 the dynamic 
viscosity and RH the molecules hydrodynamic radii. Samples were dissolved in deuterated 
chloroform (CDCL3) (1 mg ml
-1 concentration) and analysed across 64 magnetic gradient 
intervals to determine polymer and solvent diffusion (Swift et al., 2017). The relative sample 
viscosity of the sample was determined via comparison to a CDCL3 blank (D = 2.59 x 10-9 
m2 S-1) with a known solvent viscosity (5.28 x 10-4 kg m-1 s-1) (Rabinovich, Labashov and 
Kucheryavyi, 1960). Sample viscosity was determined via changes in solvent diffusion and 
thus a corrected polymer material hydrodynamic was determined from PLLA 1H proton 
diffusional shift. The analysis was performed by Bradford University.  
 
3.1.7 Assessment of bioactivity – immersion in SBF 
To evaluate the deposition of an HCA layer on top of the prepared scaffolds, a bioactivity assay 
was performed as demonstrated on figure 21. The SBF was prepared according to the 
instructions provided by  Kokubo and Takadama (Kokubo and Takadama, 2006), with a final 




(in mM), with pH 7.42, at 36.5 °C. The samples were immersed in 5 ml of SBF (n=3 per 
material), incubated at 37 °C and the solution refreshed weekly. At each time point, samples 
were removed from the SBF solution and immersed in di-ionised water for 30 s, to remove the 








Figure 21 - Overview of bioactivity assessment assay for both bioceramic and biocomposite 
samples. Process begins with the preparation of SBF solution, where samples are immersed in 
for a determined amount of time. Analysis of results consisted on the observation of 
precipitated minerals and reading of the pH solution.  
 
3.1.8 Cell studies  
3.1.8.1 Cell culture  
TERT hMSCs (hTERT-MSCs) Y201 , an immortalized cell line (James et al., 2015), were 
cultured up to passage 87 before being used in this study. Cell culture consisted on seeding 
the Y201 cells into T175 culture flask containing Dulbecco’s modified eagle medium, 
(DMEM) with high glucose, sodium pyruvate, L-glutamine and phenol red (Gibco; Thermo 
Fisher Scientific). Cell were then incubated at 37 °C in a humidified atmosphere of 5% CO2. 
Media change was performed every 2 days until the desired cell density for the assay was 
attained.  
 
3.1.8.2 Cell seeding method 
The scaffolds were firstly sterilised and washed with Dulbecco’s PBS (DPBS; Sigma Aldrich, 
UK) before being placed in 12 well plates. The hTERT MSCs were seeded in triplicate on top 
of the scaffolds at a density of 50 000 cells/scaffold and then incubated at 37 °C in a 
humidified atmosphere of 5% CO2. Cell number was previously defined on a pilot study. 




days. Tissue culture plastic was used as a positive control. Cells were cultured for a total of 21 
days with defined time points varying according to the analysis being performed. 
 
3.1.8.3 MTT (3-dimethylthiazol-2,5-diphenyltetrazolium bromide) colorimetric assay 
The metabolic activity of cells was measured in triplicated using an MTT kit (Thiazolyl Blue 
Tetrazolium Bromide; Sigma Aldrich) after 1, 3, 7, 14 and 21 days. The MTT solution was 
prepared according to supplier instructions to reach a final concentration of 0.5 mg/mL. The 
solution was mixed with serum-free DMEM, deprived of phenol red (Gibco; Thermo Fisher, 
UK) and incubated for 4 hours, at room temperature and away from light. The media was 
removed, replaced with 400 µL of isopropanol and the plates agitated for 30 minutes. The 
absorbance was read with a spectrometer (ELx800; BioTek Instruments, UK) at 570nm. To 
estimate the cell number, a standard curve was created by seeding hTERT-MSCs in different 
densities (0, 10 000, 30 000, and from there onwards up to 450 000 with a 50 000 increment). 
 
3.1.8.4 Live and dead staining 
Cytotoxicity was assessed at day 1 and day 3, using a live/dead kit (Thermo Fisher, UK). The 
stock solutions were prepared in accordance to the manufacturer’s recommendations, meaning 
a final concentration of 4 µM of ethidium homodimer-1 and 2 µM of calcein. Briefly, the 
media was removed from the wells and the samples were washed twice with PBS. The 
prepared solution was pipetted into the wells, followed by incubation for 30 minutes at room 
temperature, protected from light. Imaging was done through an inverted confocal microscope 
(LSM 800; Carl Zeiss Ltd) which required the placement of each sample in a supplied plastic 
dish (seeding surface facing the lens), and the addition of DPBS to avoid sample drying. For 
the imaging, predefined laser wavelengths were applied, AF488 (410-546nm) for green (live) 
and AF546 (576-700nm) for red (dead).  
 
3.1.8.5 Cell fixation and base staining for confocal microscopy 
Samples were collected at day 1, 7 and 21 for morphological observation via confocal 
microscopy. The cellular media was aspirated, and samples were washed with DPBS. A 
solution of 4% paraformaldehyde (Sigma Aldrich) was added to the wells and incubated for 
15 minutes at room temperature. Cells were washed 3 times with a DPBS/0.1%Tween 20 
solution, immersed in 3% w/v Goat’s serum/DPBS/0.1%Tween 20 and incubated for 30 




Goat’s serum/DPBS/0.1%Tween 20 and Vinculin (ABfinity rabbit; Thermo Fisher), on a ratio 
of 1:200. Samples were then incubated for 1 hour at room temperature, light protected. 
Further washing with DPBS/0.1%Tween 20 preceded the addition of the secondary antibody 
(Alexa Fluor 488, donkey anti-mouse antibody; Life Technologies) which was prepared and 
incubated under the conditions described for the primary antibody. The washing process was 
repeated and a solution containing phalloidin-tetramethylrhodamine B isothiocyanate peptide 
(Sigma Aldrich) and DPBS/0.1%Tween 20 (1:1000 ratio) was applied for 30 minutes, at room 
temperature and light protected. After a washing cycle, the 4′,6-diamidino-2-phenylindole 
(DAPI; Sigma Aldrich) was added and incubated at room temperature, light-protected, for 1 
hour. Finally, samples were washed with DPBS/0.1%Tween 20 once, followed by DPBS 
wash step.  
A second set of samples was stained to detect collagen type 1, the actin filaments and the 
nucleus.  After fixation and washes as in the previous staining, samples immersed in 2%v/v 
bovine serum albumine/DPBS/0.1%Tween 20 and incubated for 30 minutes at 4°C. A 
primary antibody solution was added, consisting of DPBS/0.1%Tween 20/anti-collagen 1 
antibody (ab34710, Abcam plc) on a ratio of 1:1000. Samples were then incubated for 3 hours 
at 4°C. Further washing with DPBS/0.1%Tween 20 preceded the addition of the secondary 
antibody Goat Anti Rabbit IgG H&L Alexa Fluor®488 (ab150077, Abcam plc). Samples 
were incubated at room temperature protected from light for 1 hour.  The washing process 
was repeated, and the staining of the actin filament and the nucleus proceeded as previously 
explained. Samples were imaged using confocal microscope (Nikon A1+; Nikon Instruments) 
with an immersion lens with 40x magnification. Images were acquired using the NIS software 
and utilising predefined channels, DAPI, Alexa 488 and Alx568 for DAPI, vinculin and 
collagen type 1, and phalloidin respectively. 
 
3.1.8.6 Cell fixation for SEM 
The SEM analysis was performed at day 1, 7 and 21. The cell media was aspirated, specimens 
washed with DPBS and fixed with a solution of 2% Glutaraldehyde (TAAB Laboratory and 
Microscopy) for 10 minutes followed by two immersions of 15 minutes in Sorensen’s 
Phosphate Buffer (TAAB Laboratory and Microscopy). Samples were then rinsed in DPBS 





3.1.8.7 Osteogenic differentiation assessment  
Osteogenic differentiation was assessed through the production of Alkaline Phosphatase 
(ALP). Culture media was removed, samples washed with DPBS and fixed as demonstrated 
in 3.1.6.5. A double washing step with DPBS was performed followed by alkalinisation with 
Water/0.1MTris solution (Sigma Aldrich). The alkaline solution was removed and replaced 
with 1ml of liquid yellow ALP solution (Sigma Life Science). The solution was incubated for 
30 minutes at room temperature and light–protected, then 100 µL were taken from each well 
and pipetted into a 96-well plate (in duplicate) to quantify the ALP activity. The reading was 
performed at 405 nm, with a standard curve created for calibration by placing different 
concentrations of 0.1MTris/ALP into a 96-well plate. 
 
3.1.8.8 Alizarin red staining 
Samples used for ALP measurement were washed in DPBS twice and stained with 1mL of 
Alizarin Red (AR) solution (Sigma Aldrich) and incubated at room temperature for 15 
minutes. Samples were washed with deionised (DI) water multiple times and dried overnight. 
Imaging of the samples was performed on a stereomicroscope equipped with a digital colour 
camera (Leica Microsystems). The images were acquired using the supplier software (LAS; 
Leica Microsystems). Quantification of Ca deposition at the surface of samples was 
performed with X-ray Photoelectron Spectroscopy (XPS) (Thermo Scientific K-Alpha XPS 
spectrometer). The samples were mounted on a clean stainless-steel plate and immobilised 
using copper clips. The survey scans were acquired with 0.4 eV steps, Pass Energy 150 eV, a 
dwell time of 10 ms and averaged over 20 scans. The spectra were repeated at three analysis 
positions on each sample (diameter of 400 µm) with non-overlapping analysis areas. Data 
analysis was performed with the CasaXPS software.   
 
3.1.8.9 Alcian Blue staining and sulphated glycosaminoglycan quantification (sGAGs) 
The alcian blue stock solution was prepared according to standard protocols. First, acetic acid 
(Sigma Aldrich) was added to DI to attain a concentration of 3% v/v and an acidic pH of 2. 
Alcian blue powder (Sigma Aldrich) was mixed in it to obtain a final concentration of 1% 
w/v.  Samples were washed in DPBS twice, stained with 1 mL of the prepared alcian blue 
solution and incubated at room temperature for 20 minutes. Samples were then washed with 
deionised water multiple times and dried overnight. Imaging was performed as described in 




guanidine -Hydrochloric acid (HCl) solution (Thermo Fisher), prepared according to supplier 
instructions. Samples were incubated at room temperature for 3h, and manually shaken every 
hour for a period of 10 minutes. From each well, 200 µL were pipetted in duplicate onto a 96-
well plate, and the reading performed at 630 nm, using the protocol defined in 3.1.6.7. A 
calibration curve was created to allow the estimation of sGAGs per cell number. The 
procedure was based on the protocol provided Biocolor Ltd, for the staining using Blyscan 
Blue.  Chondroitin sulphate (Sigma Aldrich) was added to water on a 100 µg/ml to create a 
stock solution that was then diluted to obtain different concentrations of sGAGs. Briefly,   
100 µL of chondroitin sulphate solution from each concentration were pipetted into a 1.5 ml 
eppendorf and 1 ml of alcian blue (prepared as described above) added. The mixture was 
manually shaken for 30 minutes and spun in a microcentrifuge (accuSpin Micro 17, Fisher 
Scientific) for 10 minutes at 1200 rpm. Next, the alcian blue solution was gently poured out, 
and the excess of alcian blue in the walls removed to avoid overestimation of values. To dilute 
the alcian blue bound to the sGAGs, 0.5 ml of 6 M guanidine solution were added, incubated 
for 10 min at room temperature and then centrifuged at 1200 rpm for 5 minutes. For the 
absorbance reading, 200 µL of the supernatant were pipetted in duplicate into a 96-well. The 
equipment and protocol for the reading were the same as described above. 
 
3.1.9 Statistical analysis 
The collected data was analysed with the software Graph Pad Prism 7 and expressed as a 
mean with a deviation taken as measure of group variability. Mean values and standard 
deviations were calculated from 3 samples per time point, including the positive control, with 
exception of the mechanical properties as printed where n=5. The results analysed using 2-
way ANOVA with Tukey post-hoc multiple comparison, for levels of statistical significance 
of p< 0.05 (*), p< 0.01 (**), p< 0.001 (***) and p< 0.0001 (****). 
 
3.2 Developed materials and methods - PLLA/AW biocomposite filament for FFF 
printing – particle and fibre reinforced 
The AW precursor described in 3.1. was used as a filler on a 5 wt%, under particle and fibre 
form (supplied by GTS under proprietary intellectual property terms). The average ± SD 
values for powder particle size was14 µm ± 1 µm and the average fibre length was 560 µm ± 
236 µm and fibre diameter 87 µm ± 5 µm. As matrix, medical graded PLLA introduced in 3.1 





3.2.1 Material blending and filament fabrication 
The material processing is shown in figure 22 (Melo et al., 2019). The PLLA granules and 
AW were mixed inside an Al mould to form rods measuring 200 x 3 x 4 mm. The rods were 
then pelletized to created granules that were fed into a twin-screw extruder (Rondol 
Technology Ltd, United Kingdom) to produce a homogeneous filament. For the extrusion 
process, a maximum temperature of 190 °C was applied, then reduce to 160 °C at the die.  
The extruded material was inserted in a haul-off machine at 0.7 mm/s, at a feeding speed of 
20 ± 5 rpm and an extrusion speed of 60 ± 10 rpm. The resultant filament diameter was 1.6 
mm ± 0.2 mm.  
 
 
Figure 22 – PLLA and biocomposite filament preparation. Raw materials are blended inside a 
mould to produce biocomposite rods. The rods are pelletized and used as feedstock of a twin-
screw extruder to process the final biocomposite filament. Material is pulled by a haul-off 
machine to tailor the filament diameter. 
 
3.2.2 Sample preparation: FFF 
As previously explained on chapter 2, section 2.6, the AM process starts with the drawing of 




printer software where it can be read by the 3D printer. The FFF process is represented on 
figure 23 alongside the scaffolds design and dimensions. Briefly, the scaffolds were designed 
as woodpile structures using Autodesk Inventor (©Autodesk Inc.), using a 0/90 laydown 
pattern. Two types of samples were created, squared for structural, chemical and biological 
characterisation, and bar shaped for 3-point bend, before and after degradation. Both sample 
types contained a pore size of 1 mm, the same for the beam size. Squared samples 
measurements were 10 x 10 x 2 mm (correspondent to width, length, height). Bar shaped 
samples measured 10 x 40 x 3 mm.  The .stl file of the scaffolds was then exported into the 
printer’s slicing software (CraftWare, CraftUnique Ltd) and the printing parameters defined 
as 0.7 ±0.1 mm extrusion width, 0.2 mm layer height and 30 mm/s of draw speed. The 
filament prepared in 3.2.2.1 was fed into the printer (Craftbot 2, CraftUnique, Hungary) and 
pushed into a nozzle heated to 230 ˚C. The molten filament was selectively deposited onto a 
building platform, heated at 60 ˚C, on a layer by layer fashion. Each part was printed 
individually to avoid failure from filament discrepancies and no post processing or supports 
were needed.  
 
 
Figure 23  - Scaffold design and processing via FFF printing. Biocomposite filament is 
selectively deposited onto a heated building platform on a layer –by-layer fashion. Two types 
of samples were created, with a design consisting of on 1 mm pores and 1 mm beams. Beams 




Chapter 4. Design of alumina doped apatite-wollastonite powders: effects in 
processing, microstructure and mechanical properties of pellets 
 
The aim of this work was to evaluate the effects of alumina (Al2O3) on the crystallization 
process of AW, and its implications on the sintering of green parts. To study the effects of 
alumina in the crystallization, five types of AW formulation have been investigated, two 
surface doped AW powders with 0.68% (M1) and 0.14% (M2) alumina respectively, a pure 




4.1.1 Elemental analysis of AW batches 
The XRF analysis is represented on table 12. All main components of AW powder are 
present, with some minor contaminants such as potassium oxide (K2O), ferric oxide (Fe2O3), 
strontium oxide (SrO), and zirconia oxide (ZrO2). Alumina was also detected for both M1 and 
M2 batches, however with an amount 5 times higher for M1 batch, compared to M2. As 
expected for the doped batches, the percentage of alumina was within the target range planned 
for the initial composition. Fluorine (F) was not detected in this analysis despite its inclusion 











Table 12 - XRF results for AW powder batches. All values represented as wt%. 
Compound M1 M2 M3 M4 M5 
MgO 3.72 3.68 4.09 5.23 4.24 
Al2O3 0.68 0.14 0.04 0.20 0.61 
SiO2 33.12 35.49 41.02 46.71 40.78 
P2O5 13.79 15.47 12.57 9.93 12.99 
K2O 0.03 - - - - 
CaO 48.42 44.81 42.21 37.86 41.29 
Fe2O3 0.09 0.10 0.06 0.06 0.07 
SrO 0.02 0.02 0.01 0.01 0.02 
ZrO2 0.01 - - - - 




4.1.2 Powder morphology – particle size, shape and size distribution 
The particle size of a representative AW sample was assessed by mastersizer (table 13) and 
SEM (figure 24), following the protocol described in chapter 3.1. Since samples were 
processed using the same methods, the powder morphology was similar: particles with sharp 
edges and irregular shape, typical of a glass powder. 
  
Figure 24 - SEM micrograph of AW powders as received. 
 
According to the results of particle size and size distribution (table 13), obtained for the M1 
powder used in HSM, 90% of the particles are below 74 µm, a value higher than the sieve 
mesh aperture (20 µm). This was attributed to defects on the mesh and to the elongated shape 
of glass particles. These can be smaller than 20 µm in width but bigger in length. This variety 
in sizes and shapes for each sieve mesh, is observable in figure 25, where some particles 
collected from the 20 µm sieve appear to be ≈ 50 µm in width. The long “blade-like” shaped 
particles are also visible and are pointed by arrows on the represented micrograph. Remaining 
powders were sieved using the same procedure. 
 
Analysis Dx10 Dx50 Dx90 
M1 3.14±0.5 24.7±3.36 74±8.65 
Table 13 - Representative analysis of particle size of M1 powder used for HSM analysis 
(n=5). Values as mean ± SD. 
 
A powder blend with a maximum particle size of 90 µm was used for the uniaxial 
compression process (figure 25). Irregular size and shapes were observed on the SEM 






Figure 25 - Representative analysis of powder morphology evaluated with SEM. Micrographs 
demonstrate the variety of sizes and shapes obtained from each sieve mesh (20 µm, 53 µm 
and 90 µm). Red arrows pointing the elongated particles capable of passing through sieves 
with smaller aperture than their major dimension. 
 
4.1.3 Thermal properties 
The DSC-TGA graphs are demonstrated in figure 26, with all thermal transitions highlighted, 
and an example of how the temperatures were taken. Two crystallization peaks were 
identified for M1 and M2, however for the remaining materials only the second peak was 
seen. The first peak is related to apatite and the second to wollastonite (A and W), since 
apatite crystallizes prior do wollastonite (Kokubo et al., 1985; Emad and Van Noort, 2011). 
Two peaks were also observed for melting in all samples. The temperature corresponding to 
each thermal transition is shown on table 14. The Tc was present in the form of two peaks 
therefore the highest temperature was chosen as the centre of each peak for this transition, in 
the case of M1 and M2, of the second peak (Figure 26e). According to the collected values, 
similar transition temperatures were obtained for all batches, with Tg, ranging from 748 ˚C to 
758 ˚C, Tc from 927 ˚C to 949 ˚C, and Tm from 1258 ˚C to 1270˚C (irrespective of their 





Figure 26 - DSC-TGA analysis of analysed AW powders. a) M1; b) M2; c) M3; d) M4; e) 
M5; f) method to register transition values on equipment’s’ software. Tg: glass transition 
temperature; Tc: crystallisation temperature; Tm: melting temperature. 
Batch Tg (°C) Tc (°C) Tm (°C) 
M1 756 936 1267 
M2 758 927 1270 
M3 748 928 1258 
M4 752 945 1270 
M5 754 949 1262 




Two approaches are taken for the results interpretation, based on the values registered in table 
15: 1) when alumina is at the surface of the particle (M1 is compared M2); 2) influence of 
alumina as a dopant in the glass formulation (M3 is compared to M4 and M5). As the 
sample’s mass was different the analysis was directed towards the H value alone, for a better 
understanding of these variations.  When M1 is compared to M2, the influence on the Tg is not 
significant, with samples reporting the same value, 0.1 J. The reverse happens for the doped 
batches where, between M3 and the doped batches (M4 and M5), it increases 3 times with 
alumina content, going from 0.1 J (M3) to 0.3 J (M4). No difference was seen between M4 
and M5. Regarding the Tc, M1 reported an H ≈ 2-fold higher (5.5 J) than M2 (3 J). This 
tendency was seen for M5, 2 times higher than M3 and M4 (which did not diverge between 
each other). The energy associated with the melting follows the same trend in both types of 
comparison: H increases with alumina content, but with a smaller effect than for the Tc.  
 
 




















Tg 1.655 0.061 3.628 0.12 6.32 0.11 13.32 0.32 9.105 0.31 
Tc 147.5 5.46 94.79 3.03 178.5 3.03 150 3.6 192.2 6.5 
Tm 134.4 4.97 101.59 3.25 58.5 0.99 171.4 4.11 139.9 4.76 
*Sample mass: M1: 0.037 g; M2: 0.033 g; M3: 0.017 g; M4: 0.024 g; M5: 0.034 g. 
Table 15 - Enthalpy of each thermal transition for studied AW batches H meaning enthalpy. 
 
4.1.4 Sintering behaviour of AW powders 
The HSM analysis is represented in figure 27 and highlights the first shrinkage (FS) and 
maximum shrinkage (MS) points, alongside the thermal transitions obtained from figure 26. 
The melting temperature was placed at the end of the graph as a representative point because 
due to equipment restrictions, attaining this temperature range leads to sample spreading and 
possible damage of the sensors. All batches behave differently (figure 27a), with the 
minimum and maximum values of sintering percentage attained for M2 (~ 5%) and M1 (~ 
20%), respectively. An expansion of 12% is also detected on M1, starting around 1250 °C, 
within the melting temperature range, absent for M2. M3 reported ~ 17%, similar to M4 and 




27b), M1 shows an area reduction of ~ 60%, but M2 only ~ 12%. Both M4 and M5 registered 
~ 40%, and M3 ~ 60%, higher than the alumina doped batches.  The shrinkage mechanism 
was also studied through the detection and placement of FS and MS points. These 
transformations happened at the same temperature range for all powders, however the 
percentage of sintering achieved at that point varied. On figure 27a, all powder batches attain 
MS prior to a second crystallization, with exception of M2 that later experiences a smaller 
contraction. This is replicated on figure 27b, where all batches attain their maximum area 
contraction after the second crystallization, but M2 shows no area reduction past this point.  
 
Figure 27 - Sintering analysis of AW batches with particle size range < 20 µm. a) Sintering 
percentage for each batch and representation of their densification mechanism. Detection of 
first shrinkage (FS) and maximum shrinkage (MS). b) Variation in area of the sample during 
sintering. Thermal transitions relatively positioned according to DSC analysis (Tg, Tc1 and Tc2 




Gathering the data collected on the DSC analysis and the HSM, several important parameters 
(described in section 2.4.2.2) were studied. Crystallisation tendency (δ), glass forming ability 
(Kgl), and sinterability (Sc) were calculated using equation 7, 8 and 9 (Hrubý, 1972; Lara et 
al., 2004) (table 16). Briefly: 
• the smaller the δ, the higher the ability to crystallise; 
• for values below 0.1 the glass forming ability (Kgl) decreases, meaning the material is 
less stable in glassy state; 
• higher sinterability, implies that crystallisation is less dependent from sintering. 
The values presented in table 16 show that M1, compared to M2, has lower crystallization 
ability (113.7), higher stability in the glassy state (0.29), and its crystallization kinetics is 
highly dependent on the sintering process (-45.56). In contrast, M2 has a higher crystallization 
ability (71.61), being less stable in the glassy state (0.17), with crystallization kinetics highly 
independent from the sintering (97.69). M3, M4 and M5 did not differ significantly from each 
other. Most parameters were similar, with exception of sinterability that was -31.52 for M3, -
11.68 for M4 and -4 for M5.   
 
 
𝜹 Kgl Sc 
M1 113.70 0.29 -45.56 
M2 71.60 0.17 -97.69 
M3 134.60 0.37 -31.52 
M4 161.30 0.45 -11.68 
M5 160.30 0.46 -4.00 
Bioglass 45S5* 64.00 0.25 <0.00 
Table 16 - Calculated values for crystallisation tendency, glass stability and sinterability. 
*(Lara et al., 2004) 
 
 4.1.5 Crystallinity of powder and sintered samples 
The XRD analysis was used to identify the presence of any crystalline phases on the raw 
material and sintered pellets. According to results showed on figure 28a, all powders, except 
M1, are amorphous prior to sintering, and no evident crystalline phases can be found. M1 
possesses a residual phase which could be associated with its making process. A broad peak 
centred at 30 ° was observable for all powders (Rodrigues, 2018). For the sintered pellets 




(▲), whitlockite (*) and diopside (●). M1 presented the weak diffraction of peaks for all 
phases, and absence of others related to whitlockite (10° and 21°, 2θ), and wollastonite (14°, 
2θ).  Higher intensities were obtained for the remaining samples with a predominant phase 
being whitlockite, followed by wollastonite. M2 comprised the highest intensity peaks for the 
wollastonite, whilst M4 showed the best development of diopside. All phases were collected 
ICDD Powder Diffraction File 2 Database (2004), ICDD44 Powder Diffraction File 4 - 




   
Figure 28 - XRD analysis of AW batches. a) powders; b) sintered pellets. Crystalline phases 
identified represented with symbols: * for whitlockite, ▲ wollastonite and ● for diopside. 
 



































































































































































4.1.6 Microstructure of sintered parts 
The microstructure developed for each material after sintering was analysed with SEM (figure 
29). With exception of M1, all materials produced a crystalline microstructure, consisting of 
randomly oriented crystals. The crystal size and shape varied, with most crystals presenting 
either a cubic or pillar shape. The crystal size was not possible to measure due to the 
uncertainty created by their random orientation, but most appear to be smaller than 10 µm. 
M2, like M3 presents a crystalline structure, with presence of gaps between crystals. Glassy 
phase was detected for M5 samples, distributed amongst the crystals and bound to them. A 
higher degree of necking is observable for M4, compared to M3. 
  
Figure 29 - Micrographs of sintered pellets produced via uniaxial compression. Scale bar on 





The density and total porosity of the parts were also calculated and displayed in table 17. 
According to the results sample bulk density (equation 14) was identical, between 0.57 g/cm3 
and 0.68 g/cm3. These values are 5 times lower than the ones registered for AW, without 
accounting for porosity. Total porosity was also similar, with values ranging the 78-81%. 
From this data it is possible to see that the densest pellet was made with M4, and the least 





Total porosity (%) 
M1 0.67 ± 0.02 78.12 ± 0.57 
M2 0.65 ± 0.01 78.95 ± 0.32 
M3 0.65 ± 0.02 78.81 ± 0.52 
M4 0.68 ± 0.02 78.00 ± 0.53 
M5 0.57 ± 0.05 81.32 ± 1.75 
AW (Alharbi 
et al., 2015) 
3.078 N/A 
Table 17 - Calculated density and total porosity of produced pellets. 
 
4.1.7 Mechanical properties 
All batches were tested under compression, with for 5 samples of each. The results (figure 
30b) show a similar effective modulus between M1 (~ 0.9 GPa) and M2 (~ 1.1 GPa), but a 
higher compressive strength (figure 30a) for M2 (~ 354 MPa) compared to M1 (~ 145 MPa). 
M3 and M4 did not differ in modulus but M4 presented a higher strength, ~ 234 MPa versus ~ 
96 MPa for M3. Compared to M5 (~ 61 MPa), M3 has a higher value for maximum stress 
point but the same effective modulus. M4 and M5 were similar in terms of modulus, with M4 





Figure 30 - Mechanical behaviour of samples under compression. a) Maximum stress point in 
MPa. b) Effective modulus in GPa. Analysis performed for n=5. *denotes significance p < 
0.05, ** p< 0.01, *** P< 0.001 and **** p< 0.0001. 
 
4.2 Discussion 
The AW powder batches were characterised in terms of thermal, structural and chemical 
properties. In the raw state, all powders are amorphous (figure 28a) therefore, present no 
crystalline phases. The particles shape was similar, irregular with sharp edges, typical of glass 
powders (Lee, 1996; Ganguli and Chatterjee, 1997; Juhasz et al., 2004).  The particle size and 
size distribution were defined prior to analysis to ensure consistency was present, as particle 
size has proven to influence the sintering process of materials (Butscher et al., 2012; Gomes 
et al., 2014; Alharbi, 2016; Rodrigues, 2018). According to table 14, the thermal transitions 
for all powders are within the same temperature range but the enthalpy associated with these 
differed. To facilitate the discussion, the analysis will be firstly performed separately: i) 
powders containing alumina at the particle’s surface (M1 vs M2); ii) powders containing 
alumina in their base composition (M4 vs M5) compared to pure AW (M3). 
 
4.2.1 Influence of alumina at the particle’s surface  
The crystallization process is an exothermic transition where energy is being released from 
the material and provided to the surroundings. This permits the diffusion of matter and 
consequently the  reorganization of the material’s microstructure (Pooria Moghadam, Tohidi 
and Ranjbar, 2010). As observed in table 15, twice the amount of energy is needed to 
crystallize M1, when compared to M2. It can be stated that the crystallization process can 
occur within the same temperature range, but the degree of crystallization attained can differ. 




analysis (figure 28b). Both batches presented peaks referring to the respective crystalline 
phases, but with higher diffraction for M2. The crystalline character of M1 was confirmed 
with XRD, but unlike M2, these were not observable with SEM. The absence of a visible 
crystalline microstructure can infer that these crystals are possibly at the nanoscale. This 
means that the nucleation happened (perhaps at a smaller level) but the crystal’s growth was 
lower, comparatively to M2. Another factor influencing the disparities in crystal formation is 
associated with the sintering temperature. J. Park et al. (Park et al., 2010) studied the 
influence of the sintering temperature in the crystallisation of AW doped with Al2O3, and 
noticed the conversion of apatite crystals into whitlockite above 1000 ˚C. It was also observed 
that the amount of precipitated β-wollastonite was directly proportional to the sintering 
temperature. Both phenomena are clearly seen from the XRD spectra of the analysed powders 
(figure 28b), where apatite was never detected, only whitlockite, also reported for samples 
sintered at 1200 ˚C. (Chang, Mao and Wu, 2000b). Moreover, the peaks relating to 
whitlockite and β-wollastonite on M1, sintered at 1150 ˚C, are smaller than for the remaining 
batches, sintered at 1250 ˚C. 
Focusing on the results in table 16, M1 has lower crystallization ability, higher stability in the 
glassy state, and its crystallization kinetics is more dependent on the sintering. In contrast, M2 
has a higher crystallization ability, therefore is less stable in the glassy state, and its 
crystallization kinetics is independent of the sintering, permitting a faster and abundant 
crystallisation, before this temperature is reached. This data is in accordance to the DSC 
analysis where a lower energy is needed to crystallize M2, and to melt it, indicating is less 
stable in glassy state, searching a natural state of organization. 
A study by Baino et al. (Baino et al., 2016) highlights the role of Al2O3 and boron oxide on 
the densification of different bioactive glasses. According to the results, Al2O3 doped glasses 
show a 1-step densification mechanism whilst boron doped glasses present a multi-step 
densification. The densification of Al2O3 doped glasses occurred prior to crystallization, 
causing a slight increase in the sintering temperature, compared to the one registered in the 
plateau for MS. The multi-step densification process prevented a maximum densification 
prior to sintering, leading to an increase in temperature of 100 ˚C, significantly higher than the 
previously analysed. Based on the HSM data (figure 27a), M2 is crystallizing prior to MS, 
characteristic of the multi-step densification, whilst M1 seems to follow the 1-step 
densification route. Al2O3 is a glass stabilizer widely used to enhance densification and 
improving glass stability. In this study, it is assumed that the Al2O3 particles derived from ball 
milling adhere to the surface of the AW particles via impact. Being the crystallization of AW 




limiting the crystallization process. As a result, the material’s ability to crystallize decreases, 
and it becomes more stable in the glassy state, consequently easier to sinter at lower 
temperatures. The amount of Al2O3 is reduced by a factor of 5 on M2, compared to M1. This 
translates into a high crystallization ability, and as a result an enhanced crystallinity. During 
sintering, the early crystallization decreases the number of necking sites available, hindering 
the densification process, i.e. contraction of the structure. This phenomenon is commonly 
observed in the clusters model where impurities at the surface of the powder particles can 
crystallize and decrease overall densification (Oscar, Bellini and Dutra, 2012; Duminis, 
Shahid and Hill, 2017). The results plotted in 27b show that effect, with M1 reporting an area 
reduction of 60% and M2 of 20%. Throughout sintering, crystallization induces a stabilisation 
of the structure, resulting in a more viscous flow. This prevents matter diffusion at the 
initially determined sintering temperature, demanding a higher input of energy to excite the 
atoms and lower the viscosity to promote matter diffusion (Baino et al., 2016). This 
culminates in the increase of sintering temperature, which in this work was translated by a 
change in the protocol from 1150 ˚C (M1) to 1250 ˚C (M2) (100 ˚C adjustment). The 
processing route of the material affects the crystallinity, which is important for stress 
distribution within the structure, principally the presence of defects. The amount, size and 
orientation of crystals dictates the quantity of stress points, and how cracks spread and grow, 
known as fracture toughness. The microstructure also relies on the manufacturing methods 
and post-treatment of the part, therefore several parameters must be accounted for the analysis 
(Freiman and Hench, 1972; El-Kheshen et al., 2008). Glass-ceramics are brittle materials, and 
their main strength relies on the quality of their surface. When subjected to loading 
conditions,  micro cracks spread, weakening the part and leading to failure (Emad and Van 
Noort, 2011). Here, the influence of Al2O3 at the surface wasn’t crucial for the effective 
modulus of the created discs, instead its effects manifested on the maximum stress point 
attained. Despite the similar effective modulus, the compressive strength was higher for M2 
compared to M1. Previous studies on Li2Si2O5 glass-ceramics reported that the flexural 
strength of material is dependent of the nucleation time and amount of crystallization attained, 
whilst the elastic modulus depended only on the crystallization degree (Freiman and Hench, 
1972). The increase of the flexural strength was directly proportional to the amount of crystal 
fraction, provided the proper nucleation time was applied. For insufficient time, the opposite 
was observed. The nucleation time was identical, but both size and amount of crystals was 
lower, resulting in a higher amount of glassy phase. The flaws occurred in the glassy phase of 
the material rather than in the crystalline phases, since cracks propagate freely through the 




limited the amount of free ways for the cracks to propagate. This allowed the material to 
withstand higher loads before failing (Freiman and Hench, 1972).  The type of crystallised 
phase is also crucial. Previously, the effects of the sintering temperature in the development of 
crystalline phases on Al2O3 doped AW were evaluated (Park et al., 2010). Below 900 ˚C, only 
apatite developed whilst at that given temperature and above, β-wollastonite was present. 
Wollastonite is the phase responsible for the improved mechanical properties, which is 
attributed to the crystal growth and shape. Column shaped crystals appear at the surface and 
grow inwards, acting as filler to the glass matrix, reinforcing it. At 1100 ˚C, another 
phenomenon was detected, the presence of whitlockite and increase of β-wollastonite, derived 
from the conversion process of apatite into whitlockite, which start at 1000 ˚C. Above 1100 
˚C the conversion is considered to continue, and the amount of β-wollastonite is assumed to 
increase. Here, M1 sintered at 1150 ˚C presented already whitlockite, different from previous 
studies, where it was sintered at lower temperatures, developing only apatite and β-
wollastonite (Kokubo et al., 1982; Alharbi, 2016; Mancuso, 2016; Mancuso et al., 2017; 
Rodrigues, 2018). M2, sintered at 1250 ˚C presented also both phases, but in higher intesity, 
reflecting the effects of temperature already described above. This improvement in 
wollastonite content derived from the higher temperature adopted reflected on the strength 
values attained, which were significantly higher for M2 (p< 0.01). The effective modulus of 
both materials was similar, even though the materials microstructure was different. This is 
associated with the high porosity measured (~ 76% to 80%). Here, low densities were 
attained, (< 0.6 g/cm3) compared to the one of pure AW, ~ 3.078 g/cm3 which is 5 times 
higher. The values obtained are comparable to others in literature (Ahmetoglu et al., 2009; 
Mancuso, 2016). 
 
4.2.2. Influence of alumina within batch composition 
When assessing the thermal properties of the doped AW powders, a direct relation was 
observed between the amount of Al2O3 and the crystallization enthalpy. High content of 
Al2O3 leads to an increase of the crystallization enthalpy, meaning this material is more stable 
in the glassy phase, therefore needs more energy to promote rearrangement of its structure. 
The amount of energy involved in the crystallization of M5 is noticeably higher, compared to 
M3 and M4.  
The HSM analysis of the powders (figure 27a) confirmed that the amount of Al2O3 did not 
influence the material sintering ability. Identical sintering percentages were obtained for all 
doped batches, and M3. For the area reduction the 20% difference was seen between doped 




differently from  the crystalline phases, resulting in a different densification of the structure 
(Freiman and Hench, 1972). Focusing on the sinterability, the doped powders present the 
highest degree of dependence when relating the crystallization and sintering, supporting the 
stabilization effect. This stabilization effect did not suppress the crystallization but altered the 
microstructure of the material. According to the XRD analysis (figure 28b) and the SEM 
micrographs of the sintered parts of M3, M4 and M5 (figure 29), the microstructure observed 
relates to a crystalline material, with all phases present in similar amounts. A higher level of 
necking was observable for M4 when compared to M3, indicating a higher level of matter 
diffusion, possibly promoted by the Al2O3. The presence of Al2O3 promotes the formation of 
liquid phase, which enhances sintering and contributes for the development of crystals (Lee, 
1996; Oscar, Bellini and Dutra, 2012).  Above 0.14 wt%, Al2O3 doesn’t promote 
crystallization but also doesn’t hinder it, instead it allows for a higher degree of melting, 
visible by the presence of glassy phase (figure 29, dashed circle). The effect in the 
microstructure and part crystallinity directly influenced the mechanical properties, showing a 
benefit when added on 0.14 wt%, where the MSP was significantly higher than for M4 
compared to M3. For M5, the effect was the opposite, and the modulus decreased. This 
tendency was already observed on 4.2.1, where the amount of glassy phase influences the 
part’s strength, due to its lower density compared to the crystalline phase. Since M3, M4 and 
M5 were processed using the same temperature, the effects of it on the development of 
crystalline phases were neglected. The modulus was attributed to the high porosity of the 
pellets, mimicking the discussion performed in 4.2.1. The values were not statistically 
different between M3 and M4, however, the values obtained for M4 were higher than M5. 
This could be associated with the existence of higher among of glassy phase in M5, which 
leads to a lower density of the material, translating into a lower modulus. 
According to the results presented, M4 was the batch with best mechanical properties (p< 
0.01 for M5 and p< 0.05 for M3), whilst keeping the crystallinity of the material.  From an 
industrial point of view, doping AW with alumina could be an advantage compared to 
inducing a surface contamination. The doping process of glass is repeatable and can be 
monitored easily, ensuring the quality standards demanded by industry. This type of process 
is also upscalable, meaning the production can be increased. This would reflect in higher 
productivity, and wider range of supply, lowering operation costs. Changes in the protocol 






The kinetics and formation processes of glasses and glass-ceramics are complex. It can be 
influenced by multiple factors such as impurities, temperature, pressure, particle size, shape 
and size distribution. All these are key to establish the processing parameters and final 
properties of the manufactured part, influencing its application range (Butscher et al., 2011, 
2013). The study of initial batch composition and its sintering behaviour is imperative when 
making glass, especially when attempting to dope or change their properties. For glass-
ceramics, factors such as the crystallisation temperature and dwell times, are crucial to allow 
crystal growth (Jones and Hench, 2006; Gerhardt and Boccaccini, 2010; Oscar, Bellini and 
Dutra, 2012), which then reflect in the final microstructure, and consequently in the 
mechanical properties of the device. When present at the surfaces of the particles, the alumina 
acted has a crystallisation suppressor by occupying the nucleation sites of the AW precursor 
particles. When included in the initial batch composition, Al2O3 decelerated the material 
contraction whilst allowing for crystallisation. The knowledge acquired in this study led to the 
conclusion that Al2O3 can influence the sintering behaviour in different ways, depending on 
how it is inserted in the process, altering the mechanical performance of parts. When at the 
surfaces of the particle it benefits the sintering process, allowing the process to happen at 
lower temperature, leading to less energy expenditure and accelerating the production time. 
Based on the results, Al2O3 could be used as dopant for the AW glass, to promote a higher 
degree of crystallisation whilst maintaining the mechanical properties. Such effects could be 
explored further to evaluate how the dopant could contribute for the control of crystal growth, 
and its influence on the material mechanical properties and bioactivity. Furthermore, 
processing parameters could be investigated in higher depth for doped powder to assess the 












Chapter 5. Binder Jetting of AW implants for bone repair 
 
Based on previous studies, in this chapter it is investigated the influence of crystallization on 
the physicochemical and biological properties of AW parts, produced with binder jetting 
printing, and sintering. A powder blend consisting of 70% AW precursor particles and 30% 
MD was created, focusing on smaller particle size ranges, to promote matter diffusion during 
sintering. Here we evaluate the influence of the powder blend properties in the printing 
process, and the resulting green parts. Post-sintering, sample’s microstructure and mechanical 
properties were characterized, alongside the bioactive character. Finally, a biological assay 
was performed to evaluate the osteoinductive and osteoconductive character of the implants 
and their influence on of hTERT-MSCs behavior. 
 
5.1 Results 
5.1.1 Elemental analysis of AW powder 
The initial composition of the AW used matched the one developed for M3, however, after 
XRF analysis (Table 18) it could be seen it suffered changes. Table 18 and shows all elements 
present in the AW powder provided for the binder jetting process. The result showed that this 
powder is similar to M2, studied in the previous chapter, and therefore is expected to behave 
in the same way. The elements found match the ones in the initial formulation, with exception 
of alumina with 0.13 wt%. Minor contaminants such as potassium oxide (K2O), ferric oxide 



























Table 18 - XRF analysis of AW used to print binder jetting implants. Values presented as 
wt%. 
 
5.1.2 Thermal properties and weight loss 
The thermal transitions of the AW powder were obtained by DSC analysis (figure 31a) and 
their values shown in table 19, alongside the calculated ∆H and H. The values obtained were: 
754 ˚C for the Tg, 928 ˚C for the highest Tc, and 1266 ˚C for the Tm.  The enthalpy associated 
to the described thermal transitions demonstrates that crystallisation is the process involving 
more energy, with a total of 3.65 J (both peaks summed). For the Tg and the Tm, the values 
calculated were lower, 0.27 J and 2.32 J, respectively. The values obtained for the thermal 
transitions replicate the ones obtained in chapter 4.  Concurrently the weight loss was 
analysed and recorded as less than 1% (figure 31b).  
 





 Tg Tc Tm 
Temperature (˚C) 754.00 857.00 928.00 1266.00 
H (J/g) 8.85 25.02 92.26 75.36 
H (J) 0.27 0.78 2.87 2.34 
Table 19 - Thermal transition and energy associated with them based on the DSC analysis. 
Enthalpy (H) calculated using sample mass (J x g): 0.031g. 
 
5.1.3 Powder blend morphology – particle size, shape and size distribution 
The analysis of the powder blend morphology was assessed using mastersizer and SEM. 
Particle shape, size, and size distribution were evaluated for both AW and MD powders, in 
order to ensure the final blend contained the desired morphology. According to figure 32, and 
as previously investigated in chapter 4, AW particles have sharp edges, and display an overall 
irregular shape. MD particles are also irregular in shape but with rounder edges.  The particle 
size of each interval defined for the blend was recorded in table 20.   
The analysis shows that most particles are within the desired size range, with only 10% being 
above ~ 100 µm (Dx90), and 10% below ~ 1.10 µm (Dx10). This could derive from the 
particles elongated shape and potential sieve mesh defects (also seen in chapter 4). 
 
 
Figure 32 - Representative analysis of AW and MD powder morphology evaluated with SEM. 













> 20 µm 1.10±0.98 14.30±0.96 53.80±1.75 
20 µm - 53 µm 12.90±0.13 47.60±0.21 103.00±0.34 
53 µm - 90 µm 48.20±0.72 87.50±0.80 144.00±0.83 
MD 20 µm - 53 µm 21.50±0.84 49.80±1.73 100.00±5.11 
Table 20 - Particle size analysis of raw materials composing the powder blend. Particle size 
intervals for AW and MD analysed individually (n=5). The size distribution was estimated 
using the Dx values, Dx10, Dx50 and Dx90 which indicate the amount of sample under a 
certain size (µm) (Malvern Ltd, 2019).  
 
5.1.4 Powder blend sinterability and volumetric changes 
The sintering ability of the powder blend was evaluated for each size interval separately. Also 
known as softening analysis, both sintering percentage and area variation were collected to 
assess how the material expands and contract with heating. The maximum sintering 
percentage and area reduction percentage (figure 33) were achieved for particles within the 
20-53 µm size range, ~ 20% and ~ 40%, respectively. The lowest value for both sintering and 
area reduction was recorded for particles within the 50- 90 µm, ~ 5 % and ~ 10% 
respectively. From both figures it is also observable that first shrinkage happens at similar 
temperatures for < 20 µm and 20-53 µm intervals, and later for 53-90 µm. The same is 
translated for the maximum shrinkage, which was associated with Tc1 for the lower size 





Figure 33 - Sintering analysis of powder blend by size range. Left: sintering percentage. 
Right: area variation. Thermal transitions collected from DSC analysis indicated in graph. 
 
5.1.5 Powder bed properties – density, packing and flowability 
The powder blend printability was evaluated using 4 parameters: Carr index, Hausner ratio, 
angle of repose and bed density (table 21). The Carr index obtained for this powder blend was 
27%. This is corroborated by the Hausner ratio value of 1.37, which reflects a fair flowability. 
The AOR is also within the fair flow range, which was expected from the previous parameters 
(Huang et al., 2013).  The bed density was determined as 1.31 g/cm3, closely one third of the 







Carr index (%) Hausner ratio Angle of repose (˚) 
Bed density 
(g/cm³) 
27.00±2.00 1.37±0.04 35.40±5.60 1.31±0.07 
Table 21 - Powder bed properties determined for a total of 5 samples. Results displayed as 
mean ±SD. 
 
5.1.6 Printing quality and part dimension accuracy 
The printed structures presented a rough surface and were mechanically weak (figure 34a). 
This made them difficult to handle, and take measurements using callipers. Instead, samples 
were placed on a flat surface and a ruler used as reference. Sintered discs (figure 34b) were 
easy to handle, with parts presenting a good structural integrity and firm when manually 
pressed. To allow a degree of comparison, these samples were also placed on a flat surface, 
and measured with a ruler. According to the CAD file (previously shown in section 3.1.2.2), 
the discs diameter was 12 mm, which after printing appears to be ~ 10 mm. After sintering, 
the parts shrank to ~ 8 mm.  
 
Figure 34 - Printed and sintered AW discs. a) Green parts. b) Sintered parts. Ruler spacing: 1 
mm. 
 
On figure 35, are presented examples of failed green parts (prior to sintering). The bars were 
broken during handling, a result of weak structure integrity (figure 35a). The discs are an 
example of layer dragging, which caused the top layer to slide towards the end of the building 





Figure 35 - Representative failed prints. a) Broken bar showing poor structural integrity. b) 
Discs reporting the results of layer dragging.  
 
5.1.7 Structural properties of printed parts 
The printed parts were firstly evaluated in terms of shrinkage, density and porosity (table 22). 
The mean bulk density of the discs was 2.1 g/cm3, nearly double the powder bed density and 
1.5 lower than AW’s density (3.078 g/cm3). Volumetric and linear shrinkage were also 
evaluated, (x,y) for the diameter and (z) for the height. Volumetric shrinkage was ~ 59%, 
which is within the value registered for the < 20 µm and 20-53 µm particle size ranges (figure 
33, right). It is realised that samples shrink more in (x,y) than in (z), ~ 28 % and ~ 21 %, 
respectively. The part mean total porosity was ~ 32%, and the open porosity ~ 4.6% 
(Archimedes). Pore size was and size distribution were studied and plotted in figure 36. The 
sample was divided in 3 areas (figure 36a) to ensure an even distribution of the pore size 
calculation throughout the samples. The values obtained (figure 36b) show a mean pore size 
of ~ 84 µm, ~ 89 µm, ~ 77 µm, for top, middle and bottom, respectively. Statistically, no 
significant differences were found. 
 
Figure 36 - Pore size measurement schematics and results obtained, for sintered AW discs. No 
statistical difference found. a) Illustration of measurement areas classified as Top, Middle and 





















2.1±0.1 59.2±3.0 27.9±3.9 21.4±4.2 4.6±1.5 32.3±4.0 
Table 22 - Properties of the parts after printing and sintering. Results expressed as mean ±SD 
for n=5. 
 
To visualize the sample microstructure, including the porosity, SEM micrographs were taken 
(figure 37). The first evaluation compares the part microstructure in the green state and after 
sintering. The top of the samples is identical, which corroborates the values obtained for the 
open porosity (table 22). The part cross-section shows that internally, the green part is more 
porous, but the sintered part shows a higher degree of interconnection. Large holes can also be 
spotted prior to sintering.  Most pores observed for the sintered part appear to be smaller than 
200 µm, which agrees with the information obtained from the image treatment (figure 36b). 
Developed crystals with different sizes are observed on the sintered part, most of them with a 





Figure 37 - Micrograph of printed bar on green state (prior to sintering) and sintered. Images 
of top and part cross-section show an overview of the open porosity and total porosity. 
Zoomed micrographs report the absence of crystals on the green part, and their presence on 
the sintered part. 
 
5.1.8 Mechanical properties of sintered AW bars 
The mechanical properties of the printed parts were evaluated using 3-point bend test using 
the bar shaped samples demonstrated in figure 38a. The resultant plot displays the stress vs 
strain relationship (figure 38b), where different failure points can be seen for all tested 
samples. The calculated values were collected and reported in figure 38c. The mean value for 




are lower compared to  cortical bone (50 MPa) (Hench, 1991). The elastic modulus reported 
for the bars was ~ 1.4 GPa, which is within the range for cancellous bone (< 0.8 GPa), but 
significantly lower than cortical bone (> 7 GPa).   
 
   
Figure 38 - Mechanical behaviour of samples under bending. a) Successfully printed and 
sintered bars used for 3-point bend test. Ruler displaying the dimensions in (x,y). Ruler 
spacing: 1 mm. b) Stress-strain evaluation containing all 5 samples tested. c) Table of values 
obtained for maximum strength and effective modulus of measured samples. 
 
5.1.9 Bioactivity and CaP ratio determination 
The bioactive character of the AW samples was studied via immersion in SBF. The data was 
retrieved at day 1, 7, 14 and 21 and the results displayed in figure 39. The pH significantly 
increases at day 7, and then decreases by day 14 (figure 39a). No further alterations were 
recorded up to day 21. The change in pH can be related to the difference in mineral nucleation 
between day 1 and day 7 (figure 39b). At day one, residual nucleation is observed, whilst at 
day 7, a fully developed layer of apatite globes is shown. Past day 7, up to day 21, full 
coverage of the sample is attained, with typical cracking of the layer noticeable at day 14. The 























apatite coating evolves from Ca deposits to an amorphous layer, with a CaP decreasing from 5 
to 2.5, the latter typical of Ca deficient apatite (Mekmene et al., 2009). By day 14 the CaP 
was 1.9, closer to bone apatite (1.67) (Mekmene et al., 2009), unchanged by day 21. The 
shape of the mineral progresses, becoming more defined with time and mainly presenting the 
flake-like morphology, typically found in bone apatite. The apatite clusters diameter appears 
to be within the 2 µm range at day 7, increasing to ~ 5 µm by day 21. 
 
 
Figure 39- Study of the bioactive character of samples using immersion in SBF. a) pH 
variation of the SBF solution throughout the study. b) Micrographs of sample surface at each 
time point. ****denotes significance at p< 0.001, and *p< 0.05 for pH values only. 
 
5.1.10 Study of hTERT MSCs behaviour when seeded onto AW discs  
5.1.10.1 Cell viability, growth and proliferation 
The metabolic activity of cells on the AW scaffolds and TCP control was measured using the 
absorbance of diluted formazan crystals, produced by cells during MTT assay (figure 40a). 
According to the results, cell metabolic activity was not significantly different between the 
AW samples and the TCP controls, with exception of day 21 where it was significantly higher 
for AW scaffolds in comparison to the TCP control. The cell viability was demonstrated via 
live/dead staining, but only for the scaffolds (figure 40b). At day 1 cells appear attached, with 
most of them stained green, meaning they were alive. Some dead cells can be observed 
(stained red), but at much lower number. By day 3 the number of dead cells was negligible, 





Figure 40 - Cell metabolic activity and vitality measured using MTT and Live/Dead assays. a) 
Cell metabolic activity based on MTT absorbance values and pre-made calibration curve. 
****denotes significance p<0.0001. b) Cell viability and attachment measured at day 1 and 
day 3, after seeding. Green staining applied for live cells, and red for dead.   
 
Cell shape and morphology were observed with SEM and confocal microscopy (figure 41). 
From the SEM micrographs, an increase in cell density is noticeable. Cell number 
progressively increased to form a consistent tissue-like layer, visible at day 21. It is also 
possible to see that cells colonized the pores of the samples and migrated through them. The 
successful migration was reported on the cross-section image, showing a cell in the centre of 
the sample, translated into 1 mm of cell travel. In terms of shape, cells appear fibroblastic at 
day 1, which is common for the hMSCs, evolving into spindle-like by day 7, commonly seen 
for pre-osteoblasts (Krishnan et al., 2010). At day 21 a shape could not be distinguished due 
to the dense tissue formation. The confocal microscopy shows the evolution on both cell 
shape and adherence. At day 1 cells appear fibroblastic and stained green for the vinculin, 
meaning they started the focal adhesion process, based on the actin filament nucleation. This 
continues at day 7, where cell appear prolonged, with spindle-like shape, and grouped. By day 
21, a dense tissue structure (Stein, Lian and Owen, 1990; Marion and Mao, 2006) can be seen, 





Figure 41 - Cell morphology and attachment on AW scaffolds along the 21 days of study. 
SEM micrographs taken from the top of the sample, and the cross section (CS) indicate the 
presence of cell in these areas. Confocal images presenting cell shape evolution, from 
fibroblastic to spindle-like between day 1 and day 7, culminating in tissue formation at day 
21. For confocal, blue staining for targeted the nucleus (DAPI), red the cell body (Phalloidin) 
and green the actin filaments representing adherence (Vinculin). 
 
5.1.10.2 Osteogenesis and biomineralisation 
The ALP levels were significantly different between the AW scaffolds and the TCP at day 7 
and day 21 (figure 42a). At day 1 the TCP showed no production of ALP whilst the AW 
scaffolds did, ~ 3.21 x 107 nM/n.cells. One-week post-seeding, the TCP showed significantly 
higher levels of ALP, with ~ 2.6 x 106 nM/n.cells, which then stabilised up to day 21. For the 
AW scaffolds, no ALP was detected further on, until day 21. The micrographs on figure 42b 
display the presence of mineral deposits on top of the cells from day 1. The amount of 




shape resembling the apatite of figure 39b. The CaP ratio (figure 42c) at day 1 was ~ 2, but by 
day 21 it decreased to ~ 1.5.  There is a progressive change from day 1 to day 21, from the Ca 
deficient apatite range to the bone apatite (1.67). 
 
Figure 42 - Evolution of cell differentiation and assessment of biomineralization. a) 
Evaluation of Alkaline Phosphatase activity as a marker for osteogenesis * denotes p < 0.05. 
b) SEM images of cell containing mineral deposits taken at day 1, 7 and 21. The detected 
deposits (red arrows) evolved into a more defined structure, presenting a crystal shape like 
bone apatite by day 21. c) CaP ratio estimation obtained from the EDS analysis. 
 
5.2 Discussion 
5.2.1 Powder blend formulation influence and printability 
Here, a polydisperse blend of irregularly shaped particles was created, maximum size of1 µm 
to 144 µm (table 20). These were added in different percentages, aiming to improve the 
sintering process, and to evaluate the influence of the blend morphology in the printing. When 
manufacturing the AW scaffolds, the layer spreading was the first parameter evaluated. The 




particles. According to literature, the limit value for free flow is 21% (Ganesan, Rosentrater 
and Muthukumarappan, 2008), which is lower than the one obtained for the powder blend, 
27%. Other studies consider this value within the fair flowing range (Huang et al., 2013), and 
this is corroborated by the Hausner ratio value of 1.37, which reflects a fair flowability. The 
bed density was within the range needed for a good layer deposition using a binder jetting 
machine (Zocca et al., 2014). Altogether, these values should translate into a successful 
printing with a defect-free layer deposition (Hausner, 1981; Zocca et al., 2014). In this case, 
problems with layer dragging were reported, initially associated with the small particle size of 
the blend. However, it was noted that the dragging effect occurred merely towards the end of 
the batch, where insufficient material in the feeding platform led to a poor layer spreading. 
The lack of material in defective layers caused a soaking effect when the binder was 
deposited. This instigated the particles from the subsequent layer to adhere to the roller, and 
consequently to lateral layer dragging. Due to limited amount of raw material, a maximum of 
500 g was produced each time, limiting the number of experiments that could be performed. 
Another hindrance was the irregular shape of the powder, which caused particle anchoring, 
also contributing for the failure of the print at that point (Hausner, 1981; Ganesan, Rosentrater 
and Muthukumarappan, 2008). It was concluded that below 200 g, printing was no longer 
possible without major defects in the layers. Despite the poor flowability, caused mainly by 
lack of material, all initial prints were successful. Parts were easily manufactured but were 
very weak in green state, impeding the measurement using callipers.  
 
5.2.2 Powder blend influence in the final part structure 
 After sintering, the sample microstructure slightly changed from a porous bulk of AW 
particles and dissolved MD, into structure with an interconnected pore network. The total 
porosity did not exceed 30%, with the open porosity accounting for only ~ 5%. The amount 
of porosity was low compared to scaffolds targeting cancellous bone (~ 80%) (Hutmacher, 
2000; Zeng et al., 2018) but is within the acceptable range of values for implantable materials 
(Sobieszczyk, 2010).  The pore size was smaller than the desired for bone repair applications, 
being the biggest pores ~ 89 µm (figure 36b). According to literature, the ideal pore size for 
cell migration and nutrient infiltration is within the range of 200-400 µm (Hutmacher, 2000; 
Lee, Kim and Knowles, 2014). Although the microporosity is important for scaffolds 
osteoconductivity, previous studies have reported bone ingrowth in pores smaller than 10 µm 
(Chan et al., 2012). According to Bignon et al. (Bignon et al., 2003), the macroporosity is 




the adherence of the cytoplasmic microextensions. The successful migration of cells was 
reported by SEM (figure 41), where their presence in the centre of the sample by day 7 is 
observable and maintained up to day 21. This suggests that the low open porosity did not 
hinder their migration into the implant, but it could have contributed for the low number of 
cells that succeeded to do so. 
 
5.2.3 Factors affecting the mechanical properties 
The results for the 3-point bend test indicated that samples maximum strength was identical to 
the previously studied ones, for similar density values (Ahmetoglu et al., 2009). The values 
are also within the range attained in chapter 4, expected from the material similarities with 
M2, and in previously processed AW pellets, using traditional manufacturing (Mancuso, 
2016). Compared to dense AW (~ 200 MPa) (Kokubo, 1991), since the samples are ~ 30% 
porous, values of ~ 70 MPa would be expected, instead of the registered ~ 20 MPa. This is not 
uncommon, and similar values were reported, with changes relating to the tested device or 
manufacturing process (Fujita et al., 2000; Xiao et al., 2008). For the effective modulus, 
samples processed via binder jetting and other manufacturing techniques (Kokubo et al., 
1982; Fujita et al., 2000; Alharbi, 2016; Mancuso et al., 2017), presented results up to 10 
times higher for the elastic modulus. Differences in powder material processing, sample 
manufacturing and material composition, don’t allow for a direct comparison, but rather serve 
as references of the versatility and wide range of properties that are attainable with AW.  An 
example is the flexural strength obtained previously with M1 bars (produced also with binder 
jetting) (Alharbi, 2016; Mancuso et al., 2017), ~ 35 MPa, matching the values obtained here, 
but with significantly higher modulus. Several reasons can lead to these disparities in results, 
such as processing and microstructure of the part (Zhang et al., 2007; Ahmetoglu et al., 2009; 
Park et al., 2010; Willie et al., 2010; Alharbi, 2016; Mancuso et al., 2017). 
5.2.3.1 Influence of part processing 
 Part structural defects, derived from poor spreading of the layers, lead to an heterogenous 
distribution of the loads, causing the part to fail prematurely (Butscher et al., 2011, 2012; 
Gomes et al., 2014). Here, several defects were detected with relation to the powder blend 
flowability and high tendency to compact. Layer dragging caused powder dislocation at each 
passage of the roller causing a heterogeneity in the final part integrity. Another factor is the 
sample size and accuracy of the dimensional measurements. Sample warping during sintering, 
can cause the measurements to be overestimated, leading to a drop on the mechanical 




different degrees of interconnection within the structure. The amount of necking is essential 
not only for the homogeneity of the part, but for the distribution of the loads. Highly 
crystalline structures do not allow for the same amount of matter diffusion, leading to lower 
necking between particles and to a higher degree of anisotropy. This is directly reflected on 
the mechanical properties of the parts, which are weaker and contain a higher amount of stress 
points (Lee, 1996; Ahmetoglu et al., 2009; Park et al., 2010). 
 
5.2.3.2. Influence of microstructure 
Variances in microstructure are also a common cause. Briefly, crystalline materials tend to 
have superior mechanical performance under loading due to their organized atomic structure 
(Freiman and Hench, 1972), however, these concepts cannot be fully translated into all 
material classes. Glass-ceramics mainly consist of a crystal phase trapped within an 
amorphous glass matrix. These two components have different properties and therefore 
influence the final part in various ways (Emad and Van Noort, 2011). When organized and 
homogenous, crystallisation promotes the mechanical strength. When the structure is 
composed of disoriented and irregularly sized crystals, stress points are generated, hindering 
the mechanical performance of the part (Freiman and Hench, 1972; Li, Wang and Chen, 
2015). Ceramics are naturally stronger under compression, but under bending their 
performance is highly dependent on a consistent microstructure with fine grain boundaries 
and no defects (pores inclusive) (Lee, 1996). Samples produced previously with M1 powder 
were deprived of such developed crystals (present possibly at the nanoscale). This was 
connected to the presence of alumina at the surface of the particle. The printed structures 
made with this M2 equivalent, possess crystals visible at the microscale, oriented randomly. 
Such complex microstructure could translate into more stress points in the microstructure, 
hindering the flexural properties. Another factor associated with the crystallisation of the part, 
is the difference between the created crystalline phases, with emphasis on their thermal 
expansions coefficient (TEC). Different phases have different TEC, meaning they will not 
contract and dilate identically (Freiman and Hench, 1972). The results discussed in chapter 4 
indicate that the AW powders sinter through different mechanisms, and therefore area 
reduction also changes. This is supported by the amount of crystalline phase present for the 
M1 and M2 sintered samples (figure 28b). M2 samples, possessed higher intensity peaks for 
both whitlockite and wollastonite, and diopside, compared to M1. This means that the 
crystallinity is further developed, enhancing the effect of TEC in the final properties. This 




removed either by doping the material with a stabiliser, by introducing an annealing step, or 
both (Freiman and Hench, 1972).  
 
5.2.4 Impact of crystallisation in bioactivity 
The concept of bioactivity and the mechanism by which it occurs were introduced in chapter 
2. Several studies have shown that, changes smaller than 2 wt% in a glass composition can 
affect both bioactivity and degradation rate (Abou Neel et al., 2009; Murphy et al., 2009; 
Miola et al., 2014). Filho et al. as shown how the increase in crystallisation can retard the 
development of the HCA layer (Filho, La Torre and Hench, 1996; Massera et al., 2015).  The 
AW used in this work has a high tendency for crystallisation (chapter 4), therefore concerns 
regarding the loss of bioactivity were raised. As the results show (figure 39b), the material 
remained bioactive even after crystallising, with apatite nucleation starting after 1 day of 
immersion in SBF. The CaP evolved with time, resulting on a mean CaP of 1.96 at day 21, 
close to bone apatite, reported as 1.67 (Mekmene et al., 2009). These results ensured the 
bioactive character of the material, therefore its potential use in implantable devices. 
 
5.2.5 MSCs growth, differentiation and biomineralisation 
AW is a biocompatible material, and this translated into the cell viability shown on figure 40. 
Cells were alive and adhered by day 1 and proliferated along the 21 days. At day 21, the 
number of cells estimated for the AW scaffold was significantly higher than for the TCP 
which could be associated to the higher surface area of the scaffolds, promoted by the 
porosity (Hutmacher, 2000; Joshi et al., 2013). Another possibility is the limited area of the 
TCP well that can lead over confluency, causing cell death. Silicate-based bioactive glasses 
and glass-ceramics have proved to enhance the bond between implant and tissue, which 
provides a more stable environment for bone healing. Another advantage of these materials is 
the ion leaching profile. Some ions can induce a specific response, e.g. osteogenic 
differentiation, up-regulation and activation of genes related to osteoprogenitor cells, and 
angiogenesis (Baino et al., 2016). The addition of stabilizers such as alumina can reduce the 
glass solubility, inhibiting its bonding to bone (El-Kheshen et al., 2008). The AW used had a 
minor contamination of alumina at its surface, however, the effects reflected only in the 
crystallisation behaviour of the material (chapter 4). The bioactivity was maintained implying 
that the ion release remained unchanged, therefore the cell response should also be positive. 




ALP measurement for the AW scaffolds (figure 42) showed a common behaviour for these 
cells, a higher peak at day 1 followed by a decrease, and later absence of ALP (James et al., 
2015). The abrupt decrease in ALP is commonly associate with the transition between 
differentiation and mineralisation stages (Stein, Lian and Owen, 1990; Loty et al., 2000). ALP 
is produced when differentiated cells need phosphorus to make apatite (Štefková, 
Procházková and Pacherník, 2015). When the P is available, and the mineral is present, the 
ALP levels naturally decrease (Endres et al., 2003; Marion and Mao, 2006). The transition 
between differentiation and mineralisation appears to take place between day 1 and day 7, but 
in between these ALP values were not monitored impeding the quantification. The 
biomineralisation was assessed with SEM and EDS (figure 42b), by observing the Ca deposits 
on top of the cells and estimating their CaP ratio with EDS (figure 42c). Visibly developed 
crystals arranged in clusters are shown (figure 42b), smaller than 5 µm each. The EDS 
analysis confirmed the CaP ratio as ~ 1.5 by day 21, meaning the cell started to mineralise. 
The ALP values on TCP increased and remained stable after day 7, implying that 
differentiation occurred. SEM and EDS analysis were not performed for TCP due to 
equipment restrictions.  
 
5.3 Conclusion 
A polydisperse blend consisting of 70% AW and 30% MD was successfully formulated and 
characterised in terms of printability. In terms of part processing, it was observed that a 
successful manufacturing of the AW scaffolds depends on both powder blend properties, and 
machine set-up/limitations. Despite the labelling of the blend as “fair flowing”, it was 
concluded that a minimum amount of powder must be available to avoid layer dragging and 
excessive binder saturation. For the part characterisation, the main observation relied on the 
relation between porosity and mechanical properties. It was determined that, for glass-
ceramics, the mechanical properties depend on both structural and crystalline properties of the 
material. For the same amount of porosity, and the same material base composition, the 
difference in crystallinity, namely crystal size and orientation, proved to play a crucial part in 
the overall TEC. Allied to the layer defects, this led to the appearance and random distribution 
of stress-points in the sintered microstructure, causing it to fail prematurely. With this, it is 
concluded that the material processing must be finely controlled for the application in view. 
Bioactivity of the material remained unchanged as well as the response to hMSCs, proving 
that the addition of crystallisation only influences the mechanical performance of the device, 




the scaffolds could be used in areas with lower loading, in small defects or as tissue 
regeneration platforms. For load bearing application, optimisation of the process and blend 
must be done, alongside the addition of stabilisers and changing of the sintering process to 
include an annealing step. The work developed on chapter 4 contributes for these findings, 
where it is suggested the intentional doping of the AW powder with alumina, to control and 
suppress the crystallisation, could lead to the improvement of mechanical properties, obtained 























Chapter 6. Fused Filament Fabrication of biocomposite scaffolds for bone 
repair 
 
The work reported in this chapter considers the use of AW as a bioactive filler within a 
medical grade PLLA matrix. A composite filament was created to allow the manufacturing of 
scaffolds using FFF. Three types of porous woodpile samples were created, PLLA, PLLA 
reinforced with AW particles and PLLA with AW fibres. These aimed to assess the influence 
of both AW fillers on mechanical properties, degradation profile and impact on hMSC 
differentiation and mineralisation.  
 
6.1 Results 
6.1.1 Characterisation of raw materials: PLLA, AW fibres and AW particles 
The material chosen for the matrix of the composite consisted of medical graded PLLA. Since 
the polymer must undergo several melting processes, an initial assessment of the thermal 
transitions was performed and used for process optimisation. The DSC analysis (figure 43a 
and 50c) demonstrated only a Tg and Tm, located at 76 °c and 195 °C, respectively. For the 
AW precursor particles, the analysis has been performed on chapter 5, figure 37. The AW 
fibres DSC (figure 49b and 49c) showed 2 Tc peaks (905 °C and 922 °C) and a Tm (1256 °C), 





Figure 43 - DSC analysis of PLLA and AW fibres with thermal transitions. Tg and Tm 
meaning glass transition and melting temperatures, respectively. a) PLLA; b) AW fibre; c) 
thermal transitions collected from software analysis. 
 
XRD of PLLA granules shows the presence of peaks typical from semi-crystalline PLLA 
alongside both structural phases, α and α’ (Cocca et al., 2011) (figure 44a). The AW fibres as 
produced, presented a spectrum typical of an amorphous material (figure 44b), mimicking the 
one obtained for AW powder (figure 28a).The spectrum of the printed part is typical of an 
amorphous structure, with only a residual peak of α phase (figure 44c). For the composite 





Figure 44 - XRD pattern of PLLA granules (a), AW fibres as produced (b), printed PLLA 
scaffold (c) PLLA/AWp scaffold (d).  
 
6.1.2 Primary analysis of printed parts 
Photographs of the parts were taken, using a ruler as mean of measurement. According to the 
images (figure 45a), the parts dimensions in (x,y) and (z) planes were identical to the CAD 
file (chapter 3, section 3.2). The woodpile design was also fully replicated, with no 
incongruences in the print. The printed structures presented a smooth surface and were easy to 
handle. The SEM (figure 45b) report a part with consistently adhered layers, but a few 





Figure 45 - Structure of parts as printed and illustrative dimensions. a) Photograph of printed 
PLLA parts, with dimensions illustrated by a ruler. From left to right: parts top view, square 
and bar from front view (z), and pore (distance between ruler lines is 1 mm). b) SEM of 
scaffolds after printed. From left to right: Overview of the scaffold, side view of the part to 
observe layer deposition and, zoomed set of layers exemplifying the adherence and dimension 
of deposited beams.  
 
6.1.3 Structural characterisation of printed parts 
SEM studies, shown in figure 46, display clearly the presence of AW particles and AW fibres 
in each of the composites (PLLA/AWp and PLLA/AWf) while PLLA parts were smooth and 
absent of inclusions. The SEM micrographs show the lack of bond between filler and matrix 
on biocomposite filaments, demonstrated by the clear separation between filler edges and 
matrix (pointed by arrows). After 8 weeks of immersion in PBS no changes in the structure 
were detected. The µCT micrographs of printed parts show how the filler is homogeneously 






Figure 46 - SEM and µCT images corresponding toboth filament and printed samples, before 
and after 8 weeks of degradation in PBS. SEM of printed parts, supported by µCT, showing a 
homogenous distribution of filler. Circled area displaying a particle and a fibre of AW inside 






The polymer size and hydrodynamic radii were assessed with 1H NMR DOSY, but no 
differences were found amidst all processed polymer materials (figure 47). A decrease on 
polymer size, compared the raw unprocessed material (RH CDCL3 2.2 nm), was found for 
samples in dilute solutions (figure 47a). Throughout the degradation period, the results for 
processed PLLA RH CDCL3 1.45 ± 0.10 nm, indicate that the polymer material is stable and 
















































































































Figure 47 - Diffusion analysis of polymer samples in dilute CDCl3 solution. a) Measured 
diffusion (m2 S-1) of PLLA and solvent proton peaks. b) Calculated average polymer 
hydrodynamic radii. 
 
The mechanical properties as printed were obtained from 3-point bend test and were noted in 
table 23. As printed, the flexural strength of the composites differed, with PLLA/AWf 
attaining a significantly higher effective modulus, ~ 1.5 GPa, compared to PLLA and 




3-point bend test 
Yield point (MPa) 
Effective modulus 
(GPa) 
PLLA 16.6 ±10.4 0.9±0.3 
PLLA/AWp 22.8 ±4.5 1 ±0.1 
PLLA/AWf 29.4 ±5.3 1.5±0.2 





6.1.4 Physicochemical changes and Ion leaching 
Samples were immersed in PBS for 8 weeks and their weight, mechanical properties and ion 
leaching profile were studied. No changes were found for the flexural strength and modulus 
throughout the study (figure 48a and 48b, respectively), and no mass loss was detected 
(omitted for brevity). The PBS solution pH was different at determined time points, varying 
between 7.2 and 7.6. No trend was found for the changes (figure 48c), but values are similar 
to the ones of physiological conditions (~ 7.4) (Cüneyt Tas, 2000a). The ion leaching analysis 
(figure 48d and 48e) showed major observations for week 1 and week 2. An increase in Ca 
(figure 48d) and Mg (figure 48e) was readily detected at week 1 for PLLA/AWf, with Ca and 
Mg concentrations of 86 and 23 µM, respectively. This value was significantly higher 
compared to the PLLA sample (11 µM Ca and 4.5 µM Mg) but identical to that of the 
PLLA/AWp sample (78 µM Ca and 12 µM Mg). At week 2 the same trend was observed, 
with PLLA/AWf showing the highest values (51 µM Ca and 12 µM Mg), PLLA/AWp 
showing lesser concentrations (23 µM Ca and 4.3 µM Mg), followed by PLLA (5.7 µM Ca 
and 1.7 µM Mg). Past week 2, all values remained basal and stable and no significant 





Figure 48 - Flexural properties of scaffolds and ion leaching into PBS (week 1, 2, 4, 6 and 8 
after degradation in PBS). a) Yield point; b) Effective modulus; c) pH variation of PBS 
solution; d) e) content of Ca and Mg, respectively. p<0.05 (*), p<0.01 (**), p<0.001 (***) and 
p<0.0001 (****). 
6.1.5 Bioactivity assessment - apatite deposition, morphology and CaP ratio 
Bioactivity (figure 49) was only observed for composite samples, whereas PLLA reported a 
clean surface at all time points. Mineralised deposits at the surface from day 1 to day 21 are 
visible, and their elemental composition was estimated with EDS (table 24). The Ca and P 
ratio of the precipitates increases during the first week for both samples, with PLLA/AWp 
evolving from 0 to ≈ 1.6, and PLLA/AWf from 1.5 to 2. The pH of the solution was similar 
for all samples with exception of day 7 when the PLLA/AWp had a higher pH than the PLLA. 
This was not considered significant therefore results were not added. The mineral shape 












Table 24 - CaP ratio of deposits detected at the surface of biocomposite samples. No deposits 
found for PLLA, with values registered as 0. 
 
 
Figure 49 - SEM analysis of samples and SBF solution after immersion for 21 days. 




PLLA PLLA/AWp PLLA/AWf 
Day 1 0.0±0.0 0.0±0.0 1.5±0.5 
Day 7 0.0±0.0 1.6±0.1 2.0±0.1 
Day 14 0.0±0.0 1.0±0.7 0.8±1.1 




6.1.6 Biological assay – Cell viability, osteogenesis and mineralisation 
The production of formazan by the cells increased up to day 14 for all samples, followed by a 
stabilisation (figure 50a). The same trend was observed for the cell number for all samples 
(figure 50b). PLLA/AWf and TCP samples showed significantly higher values for day 7, 14 
and 21 (p< 0.0001) compared to PLLA/AWp and PLLA (ns). Cell viability was similar for all 
scaffolds at day 1 and day 3, as observed on figure 50c. Live cells seem attached from day 1 
and back to normal morphology by day 3.   
 
Figure 50 - Proliferation of cells seeded on PLLA and PLLA/AW scaffolds compared to 
tissue culture plastic via MTT assay, and cell viability using Live/dead. a) Absorbance 
reading of dissolved formazan crystals. b) Estimation of cell number using MTT absorbance 
values and a pre-made standard curve (chapter 3). ***denotes significance at p< 0.001, and 
****p< 0.0001. c) Cell attachment and viability at day 1 and day 3. Green indicating living 




The micrographs in figure 51 report the cell behaviour along the 21 days. Cell adherence after 
24h, and tissue formation after 21 days were reported, with PLLA/AWf demonstrating a 
multilayer formation and an apparent higher cell density, supported by figure 50b and 50c. In 
terms of morphology, at day 1 cells are grouped and have a fibroblastic shape (James et al., 
2015). The morphology evolved to spindle-shape at day 7, a finalised as cobblestone-like, at 
day 21 (Hatakeyma et al., 2013). Dense tissue formation at day 1 prevented a finer 
observation.  
 
Figure 51 - Evolution in cell morphology and attachment on the studied samples. SEM 
images in grey scale, on the right for each type of sample.  
 
6.1.7 Osteogenic differentiation and cell mineralisation 
The ALP activity (figure 52a) did not differ between samples aside from day 1 where PLLA 
and PLLA/AWp had significantly higher production than PLLA/AWf and TCP. From day 7 
onwards samples did not diverge between each other. When analysed individually, the ALP 
values for each sample did not change with time, with exception of PLLA which experiences 
a significant drop between day 7 and day 14. Figure 52b shows the presence of mineralisation 
on top of the cells in both composite scaffolds, and for PLLA/AWp octacalcium phosphate 




samples surface (figure 52c) confirms the presence of Ca for composite samples only, with 
PLLA presenting a residual value due to equipment artefact. Ca content was not significantly 
different between composites at any time point. XPS and EDS analysis were not performed 
on TCP samples due to the equipment limitations.  
The visual presence of mineralisation was shown by alizarin red staining (figure 52d) at day 
21. All samples presented red staining, but not the TCP. Presence of Ca and P was confirmed 
by EDS analysis (table 25), however only for the composite samples. The measurements were 
taken at sites where deposits were found on top of the cells to separate them from what could 
be HCA layer from the samples. Mineralisation wasn’t detected on cells at day 1, inferring 
that these values are associated with the sample rather than the cells. PLLA samples presented 
an atomic % of 0 (zero), while the composites reported values within the range of Ca deficient 
apatite, close to bone apatite (CaP of ~1.6) in the case of several samples. For the TCP, 
stereomicroscope images reported the absence of staining, consequently these were not 





Figure 52 - Osteogenic differentiation of seeded cells for polymer and composite samples. A) 
Alkaline Phosphatase activity measurement as osteogenesis indicator. b) SEM images of 
samples at day 21. Presence of octacalcium phosphate indicated by OCP on PLLA/AWp 
alongside cell with mineralised bone nodules indicating mineralisation. Ca layer on 
PLLA/AWf. c) XPS analysis of Ca content. d) Alizarin red staining of cell-seeded PLLA, 
PLLA/AWp and PLLA/AWf scaffolds Micrographs of samples collected at day 21. Red stain 
indicated presence of Ca at the sample surface (bar 5mm). e) Comparison of samples 
immersed in SBF and samples seeded with cells. Statistical analysis between samples at each 





CaP (mean±SD) PLLA PLLA/AWp PLLA/AWf 
Day 1 0.0±0.0 1.7±1.6 0.7±0.8 
Day 7 0.0±0.0 0.8±1.0 0.9±0.2 
Day 14 0.0±0.0 1.2±0.6 0.4±0.3 
Day 21 0.0±0.0 1.1±0.6 0.6±0.7 
Table 25 - CaP ratio of samples per time point. Values presented as mean ±SD for n=3. 
 
The confocal analysis (figure 53) corroborates the data relating to cell differentiation, up to 
day 21 where the thick tissue does not allow a clear observation of morphology. The staining 
of collagen type 1 also acted as a marker for cell differentiation into osteoblasts. The 
increasing concentrations of collagen type 1 with time (stained green) suggest that cells are 
differentiating into osteoblasts in all tested samples (Astachov, Nevo and Vago, 2012a). This 
information is corroborated by the cell shape, already described in figure 51, where the 
evolution from fibroblastic to spindle-like can be seen between day 1 and 7. The presence of 
vinculin ensures the cell adherence, with the actin filaments allowing for their stabilisation 
and facilitating their migration. 
 
 
Figure 53 - Confocal images, using blue staining for nucleus (DAPI), red for cell body 





6.1.8 Estimation of sulphated proteoglycan production to study ECM deposition 
The presence of sulphated proteoglycans was imaged and quantified to understand the 
production of ECM by the cells throughout the 21 days of study.  The concentration of 
sGAGs was estimated using a calibration curve (figure 54a) and plotted on figure 54b. The 
results show identical values for PLLA and PLLA/AWp, however these are significantly 
higher than the ones of PLLA/AWf. Samples were not significantly different for the 
remaining time points, and all experience a significant decrease between day 1 and day 7. 
Visually, this effect is not as obvious. The alcian blue staining (figure 54c) of samples shows 
a similar amount of blue at day 1, for all samples. At day 7, the presence of sGAGs is also 
obvious in all types of scaffolds, and is enhanced at day 21, where it covers the whole 
structure. It must be clarified that the GAGs concentration plotted is an estimation as the 
calibration curve obtained was not as good as expected.  
 
Figure 54 - Production of ECM through observation and estimation of the sGAGs. a) 
Calibration curve created using different concentrations of chondroitin sulphate. b) Estimation 
of the concentration of sGAGs per cell number at day 1, 7 and 21. c) Alcian blue staining of 
sample to visually evaluate the presence of sGAGs and relative amount in each sample. 





6.2.1 Processing of composite: from filament production to printing 
In this study we demonstrate the successful optimisation of both filament and sample 
processing methods, regarding particle and short fibre reinforced composites. The 
homogenous distribution of the filler was attained from the initial blending of the material and 
its mixing inside the extruder (Wang, 2003). On the processing of PLLA/AWf, fibre 
alignment in the printing direction was observed. This was expected due to shear forces inside 
the nozzle, a well reported phenomenon for both long and short carbon and glass fibres 
(Zhong et al., 2001; Ferreira et al., 2017; Brenken et al., 2018). The printing process made the 
polymer structure amorphous (figure 44a, 44c and 44d), which could be associated to the fast 
cool down of material (Dionísio Viciosa, María Teresa, Wang, Yaming, Mano, João F., 2005; 
Cocca et al., 2011). This structural change in crystallinity could lead to higher degradation 
rate since the crystal segments are chemically more stable than the amorphous ones. In 
applications where mechanical support is not essential, but biodegradability is sought, an 
amorphous structure might be desirable.  
 
6.2.2 Mechanical properties and degradation profile 
Both the average modulus and average yield stress were broadly consistent over the 8-week 
period for all three materials. The addition of the short AW fibres slightly increased the 
flexural strength and elastic modulus of the scaffolds as printed. Angular shaped particles are 
preferred for reinforcement as they act as interlocks, decreasing the disruption between matrix 
and filler during mechanical testing. Unless used in high ratios, > 30% (Shikinami and 
Okuno, 1999; Tripathi, Choudhury and Basu, 2010), the use of bioceramic particles as 
reinforcement will not provide an improvement of mechanical properties, and are used instead 
to stimulate a response  (Tripathi, Choudhury and Basu, 2010; Ramesh, Moratti and Dias, 
2017). The slight improvement in initial mechanical properties of the fibre reinforced 
composite could be associated with factors such as fibre wetting. Fibres can retain heat which 
promotes material diffusion, resulting in improved bonding with the matrix, consequently a 
stronger material (Pipes et al., 1991; Brenken et al., 2018).  
All samples remained stable under PBS immersion, with no mass loss reported. This suggests 
the sample is not degrading in bulk. The pH oscillated but stayed within the physiological 
range, ideal for implantation (Cüneyt Tas, 2000b). The NMR data (figure 47) suggests that 
the material is not suffering chemical degradation, which is supported by previous studies 




the mechanical behaviour of the parts, and lack of defect sites and cracks that are common for 
PLLA hydrolytic degradation process (Cüneyt Tas, 2000b).  
The ion release profile changes significantly only for the composites. Since Ca and Mg are 
easy to release from the structure, their presence is noted from week 1 (Hench and Clark, 
1978a). The Ca and Mg are only present in the AW, suggesting they are being leached from 
exposed fibres and particles. Once they are consumed, the values drop, in this case by week 4, 
and are maintained relatively stable until the end. This suggests that the filler in no longer 
exposed and that the ions were consumed (Hench and Clark, 1978b). This release is gradual 
suggesting that there are multiple fibres and particles, possibly of different sizes or with 
different amounts exposed (Ahmed et al., 2011; Felfel et al., 2013). The lower leaching for 
the PLLA/AWp samples suggests that less of the AW is present at the surface of these 
composites. Smaller particles with a less rounded shape may be easier to submerge into the 
matrix as a result of the high shear stresses at the walls when the filament is extruded. 
 
6.2.3 Bioactivity study 
The bioactivity of the composite is dependent on the exposure of ceramic at the surface. A 
minimum bioceramic loading  of 20% is advised in order to attain bioactivity (Wang, 2003). 
The SEM and EDS analysis, shows deposits on top of both composites, identified as Ca 
deficient apatite, with CaP ratio varying between 0.4 and 1.7, the latter close to bone apatite 
(1.67) (Mekmene et al., 2009). This would improve osteoconductive behaviour and promote 
implant-bone bonding for both materials (Hench, 1991; Fu et al., 2011). Both cauliflower and 
flake form apatite were detected at the biocomposite’s surface. Cauliflower apatite is 
commonly observed as a product of bioactivity, but flake apatite is harder to produce once it 
demands the growth in specific crystalline planes (Lu et al., 2005; Ekmene et al., 2009).  
 
6.2.4 Influence of samples in cell behaviour 
6.2.4.1 Cells growth and morphology 
The PLLA and PLLA/AWp materials showed no significant differences in terms of cell 
viability and proliferation, nonetheless PLLA/AWf and TCP cell numbers were significantly 
higher from day 7 onwards (figure 50a).  Cells grew and proliferated in all types of samples, 
as observed in figure 51, presenting fibroblastic morphology at day 1 (typical of hMSCs), 
which evolved into pre osteoblastic at day 7. At day 21, cells evidenced a polygonal cell 




Krishnan et al., 2010; Sayin et al., 2017) and ECM production. A high proliferation rate is 
common on TCP since its surface is treated to support cell growth (Skardal et al., 2013). The 
main difference between samples was based on the proliferation rates for the PLLA/AWf 
material. Since both composites contains the same filler composition (AW precursor), 
degradability and higher ion release in PLLA/AWf (figure 48d and 48e) may stimulate cell 
growth however, further studies must be performed to assess these effects. To understand the 
ECM depositions at each time point, the concentration of sGAGS was estimated and visually 
observed using alcian blue staining (figure 54). It is known that GAGs are the major structural 
components of ECM, responsible for the maintenance of both its structure and organization 
(Robey et al., 1993).  In bone, the small sGAGS like biglycan, are present in the osteoid and 
progenitor cells, suggesting it participates in bone formation, including cell differentiation 
(Sommarin et al., 1998). Later, other like decorin are expressed. It can bind to collagen type I, 
and its influence on the mineralisation process has been suggested. Studies have shown its 
significant decrease, or disappearance just before or during the bone mineralisation process. A 
later discovery revealed another proteoglycan, osteoadherin, which is mainly produced by 
mature osteoblasts. From this information is possible to understand the increasing amount of 
sGAGs (figure 54b). No investigation was done aiming the specific identification of the 
sGAGs being produced at each point, therefore they cannot be associated to any of the 
mentioned ones. These results are a demonstration of a constant and increased ECM 
production, positive regarding the cell proliferation and possibly cell development. 
 
6.2.4.2 Cell differentiation and biomineralisation 
In terms of ALP concentration, the samples only differed between each other at day 1, where 
PLLA and PLLA/AWp present a higher level of ALP production per cell (figure 52a) 
compared to PLLA/AWf and TCP. PLLA and PLLA/AWp appear to be more osteoinductive 
at first contact. Nevertheless, all three cultures produced differentiated cells by day 21 (figure 
51, figure 52a and 52b). Osteogenesis can also be detected by increase in the production of 
collagen type I. The confocal imaging (figure 53) shows the presence of collagen type I 
increases significantly from day 7, for all types of samples. The production of collagen type I 
and type II by stem cells prior to differentiation is known (Stein, Lian and Owen, 1990; 
Marion and Mao, 2006; James et al., 2015). Depending on the cell line, collagen type I gene 
is upregulated and collagen type II is downregulated during osteogenesis, after 7 and/or 14 
days (Stein, Lian and Owen, 1990; Marion and Mao, 2006; Krishnan et al., 2010; Astachov, 




Following the  differentiation of cells into osteoblasts, mineralisation occurs, characterised by 
a drop in ALP values and production of Ca deposits that are visible around the cells, trapped 
in ECM (Stein, Lian and Owen, 1990; James et al., 2015). Although ALP is a common 
marker for MSCs differentiation, it does not predict the mineralisation stage or rate by itself 
(Štefková, Procházková and Pacherník, 2015; Abdallah et al., 2016; Marklein et al., 2016). 
Cells seeded on all samples produced ALP, but mineralisation was missing from the TCP 
control, and the mineral shape differed between the polymer and composite samples. 
PLLA/AWf showed consistent plate-like structures of CaP (figure 52b), whilst PLLA and 
PLLA/AWp evidenced small Ca deposits on top of the cells. To confirm and evaluate the 
amount of Ca and its distribution, alizarin red staining was performed and confirmed high 
levels of Ca at the surface of the samples, where a denser coating is visible for PLLA/AWf, 
compared to PLLA/AWp, which shows more mineralisation than PLLA. 
 
6.3 Conclusion 
Three types of samples were studied, PLLA and PLLA reinforced with AW particles and 
PLLA reinforced with AW fibres to assess their suitability as scaffolds for bone repair in 
critical size defects. Both polymer and biocomposites showed a good biocompatibility, and 
mechanical properties equivalent to cancellous bone, under degrading conditions, with the 
fibre reinforced composite performing better as produced. No mass loss is detected indicating 
the sample is not degrading in bulk up to 8 weeks therefore it could be used for long term 
applications. Its degradability can be tuned by increasing  the AW content (Ahmed et al., 
2011; Felfel et al., 2013). All samples promoted osteogenesis, however the biocomposites 
induced a higher degree of biomineralisation. The presence of Ca on top of the biocomposite 
samples indicated the material ability to induce apatite deposition, which was detected with 
SEM and alizarin red staining. This is an asset since once implanted there would be two 
sources of Ca, which would directly accelerate bone repair and regeneration. Overall both 
composites developed in this study could be used on critical size defects since the mechanical 
properties are within the range of cancellous bone and cells grew and proliferated in the 
scaffolds. AWf composites demonstrated higher ion leaching which rapidly stimulated cell 






Chapter 7. General discussion 
 
7.1 Summary 
The data presented in this thesis confirms the possibility to print devices for bone repair using 
different AM techniques, and materials. It highlights the importance of the material choice on 
the development of osteoinductive devices, and the influence of its quality in the 
manufacturing process. Emphasis is put on the processing methods, opting for a lean 
manufacturing model at all steps, proven to be ideal for industrial scale-up. 
The first experimental chapter (chapter 4) explores the influence of surface contaminations, 
arising from the powder processing step of glass-ceramics. It was observed that these 
contaminations can attach to the powder particle’s surface and hinder the material 
crystallisation during thermal treatment. It was also seen that the way the contaminant affects 
the process depends on the material’s innate crystallisation mechanism. A material that 
crystallises via surface will only suffer changes in the crystallisation process, if the impurity is 
at the surface. When used as dopant, it does not produce a visible effect in the crystallisation 
of the material, but it does affect the development and amount of each crystalline phase. The 
presence of the dopant allows for higher control in the development of the microstructure, 
while maintaining crystallisation and mechanical performance. 
Chapter 5 explores the printing of a powder blend with a small particle size range, 
theoretically considered out of printing range.  It was proven that these blends, qualified as 
non/poor-flowing, can be printed using binder jetting, in a reproducible way. For this, 
compliance with the minimum amount of material needed for feedstock is key. The porosity 
values obtained were lower than the ones deemed as ideal for cell migration and proliferation, 
however the biological tests revealed that both were attained successfully.  Adding to high 
cell viability, stem cell differentiation into osteoblasts, and consequent mineralisation, 
occurred. Despite the low amount of open porosity, cells were able to migrate inside the 
structure and were found in the centre of it, even after 21 days in culture. The mechanical 
properties obtained were lower than in previous work but also within the range of several 
studies reported in literature. Uncontrolled crystallisation of the structure and layer defects 
were deemed responsible for the decrease in effective modulus. These values impede the use 
of the struts for load bearing applications, emphasizing the fact that the raw material quality 
can change the outcome of the manufacturing process, and the application. In this case, the 




was also proven that the presence of crystallisation did not affect the bioactive character of the 
material, contrary to the results stated in literature.   
Chapter 6 reports the successful development of osteoinductive polymer-ceramic 
biocomposites and explores the potential of fillers with different forms. A new technique was 
developed to blend the polymer and ceramic and proved to benefit the filler homogeneous 
distribution within the matrix. Using the developed biocomposite filaments, woodpile 
scaffolds were effectively manufactured using FFF, showing the potential of this technique to 
process particle and fibre filled biocomposite filaments in a reproducible way. The 
mechanical properties of the structure were within the range of cancellous bone and can be 
tuned by changing either filler amount and/or shape, and/or the design of the part. It also 
shown that a biological response can be attained for a minimum amount of filler in the matrix 
(5 wt%), which preserves the mechanical properties and integrity of the device, for the 
average time needed for bone repair. Furthermore, it is demonstrated the importance of the 
leached ions in the cell’s response. The amount and timing of the leaching influenced both 
cell proliferation and differentiation. We proved the fillers leaching duration was different, 
and that the fibres high aspect ratio allows for higher exposure and longer leaching time, 
compared to the particulate biocomposite. This then reflected in the cell’s response, however, 
in the end both promoted cell proliferation, differentiation and mineralisation.  
 
7.2 Novelty 
In this work it is presented novelty in three levels of the manufacturing process of a medical 
device: the material development, process optimisation and biological response.  
• Firstly, the developed 2 types of AW glass-ceramic, doped with alumina, a known 
stabiliser (Lara et al., 2004; Baino et al., 2016). By comparing them to previously 
developed formulations, we attest that the influence of this dopant can be used to 
control or repress crystallisation, dependant on how it is placed in the material. This is 
of great value for the industry, since it allows for a better regulation and quality 
inspection of the raw materials (glasses and glass-ceramic precursors) prior to 
commercialisation. Also, it can aid the optimisation of the manufacturing process so 
that it is possible to produce AW bone implants with different glass formulations and 
obtain a wide range of abilities. 
• Secondly, as seen in literature (Freiman & Hench 1972b; El-Kheshen et al. 2008), 




load bearing applications. We prove that for glass-ceramics that is not applicable, and 
that uncontrolled crystallisation can indeed hinder the mechanical performance of a 
device. An element that was at first considered an impurity proved to be of value for 
the stabilisation of the material under heat treatment and can be used to tune the 
microstructure when added in different ways. It is also shown that these devices are 
osteoconductive. An accelerated cell response towards differentiation and 
mineralisation was noticed, present from the first week of cell contact with the device.  
• Finally, FFF is used to process for the first time two types of osteoinductive 
biocomposites for bone repair, using only 5 wt% of filler loading. FFF has been used 
to print different composites for other applications (Brenken et al., 2018), but none 
containing these raw materials and these filler forms (PLLA and AW particles and 
fibres). We exploit and prove the potential of this technique to fabricate osteoinductive 
devices, using its versatility, at the material and design level, as an advantage and 
opportunity to apply it in other areas.  
 
7.3 Limitations of the techniques and devices 
Throughout the execution of the project, several limitations were met regarding the techniques 
used, considering the processes should be simple and lean, to allow for an easy scale-up. 
The production of AW pure and doped powder is time consuming and does not allow for the 
making of high quantities per batch. A maximum of 0.5-1 kg of glass was produced within 1 
week, therefore decreasing the amount of experiments possible to perform. The glass was 
made within industrial context, and at the company site (GTS, Sheffield, UK) which meant 
limited time for production due the company’s ongoing activities.  
The binder jetting process relies on powder blend formulation, which is laborious and implies 
several powder processing steps. The minimum amount of powder needed to print is 0.5 kg, 
but it was stated that below 0.2 kg the prints fail due to layer dragging. Since the AW used for 
binder jetting underwent the same industrial fabrication process, a limited stock was available 
for the performance of more experiments. The resultant devices form the process have a low 
open porosity, and that influences the number of cells able to migrate inside the strut, as well 
has the number of layers formed before clogging the pore. The pore size must be bigger than 
200 µm to allow multiple cell layers to form (Sachlos and Czernuszka, 2003; Willie et al., 
2010). In this work the pore size attained was below 100 µm, but cells were still able to 




pore size ranges (Suwanprateeb et al., 2009; Alharbi et al., 2015; Mancuso et al., 2017), a 
feature that makes it appealing for bone related applications. Despite the presence of cells 
inside the device, when translated to an in vivo model, these results would most likely differ 
due to exposure to higher number of cells that could cause pore clogging faster. The sintering 
process was optimised but the lack of control over the material crystallisation could represent 
a problem for the mechanical performance, limiting the range of applications.     
Regarding the biocomposites production, the use of an extruder that does not allow matrix 
and filler to be mixed directly, implied the development of a pre-blending step, which adds a 
step to the manufacturing process. The blending process is long and has a limit for filler that 
can be added to the polymer (assuming successful physical bond). The filament was produced 
in-house and was highly dependent on human skill and manual control. This resulted in an 
uneven diameter (1.4-1.8 mm) which caused some prints to fail and originated defects in 
others, observable on the XCT analysis. Layer heterogeneity can lead to weaker parts, 
limiting the range of applications in scope. The presence of pores was also a result of poor 
layer deposition due to the filament incongruences. This reflects on the mechanical properties 
as a produced, and also during the exposure to body fluids which can accelerate the chemical 
degradation of the material (Ahmed et al., 2011; Felfel et al., 2013).  
 
7.4 Potential clinical applications 
Healing of bone fractures and reconstruction of critical-size defects is a significant challenge, 
since these do not heal spontaneously over the patient lifetime. Bone is a self-healing organ; 
however, this type of defect is highly dependent on 2 factors: 1) the surrounding tissue health, 
namely its vascularisation to allow nutrient access; 2) the MSCs present in bone marrow and 
periosteum, which are the osteoprogenitor cells. Secondary mechanisms influencing these 
cells include osteogenesis, osteoinduction and osteoconduction. At the fracture site, 
osteoinductive factors are delivered by the vascular network. In defects where vascularisation 
is limited, an external stimulus must be applied to induce the cells differentiation (Roddy et 
al., 2018). In terms of osteoconduction within the human body, the osteoconductive platform 
is created via the formation of hematoma and cartilage callus, which then supports the 
osteoblast growth at the defect site (Roddy et al., 2018).  Clinically, the most commonly used 
treatments for critical size defects are bone grafts, distraction osteogenesis (DO) and induced 
membrane technique (Masquelet), but all have their own limitations. From these 3 procedures, 
DO and Masquelet are the ones used in load bearing areas and suitable for long bone 




in combination with DO and Masquelet, to promote faster bone regeneration at the defect site 
(Roddy et al., 2018). 
None of the implants developed in this work reached the mechanical properties needed for 
load bearing areas, especially in long bone defects. The bioceramic scaffolds developed using 
binder jetting of AW, could compete with the current metal based devices (Kokubo et al., 
1982; Chang, Mao and Wu, 2000a; Mancuso et al., 2017) but processing issues reflected on a 
decrease of the flexural strength of the printed implants. Changes in the processing and 
intensive study of the material properties (chapter 4), implied that the material composition 
should be improved, and the processing further optimised, so that values can better fit the 
needs of cortical bone, and therefore allow for the device to withstand the site loads. For that 
reason, the main potential clinical application area is bone substitutes. 
 
Commercially available products used as bone substitutes are listed in table 26, and, on their 
own, all share the same issue: not suitable for loaded areas. These exist mainly under the form 
of granules, cements of injectable pastes. The presence of antibiotics also limits their use, 
especially during pregnancy and nursing, e.g. ChonOS and Palacos (R+G). There is a need for 
bone substitutes capable of supporting initial loading (minimum for cortical bone, ~ 50 MPa), 
without sourcing problems and size restrictions, and with an efficient manufacturing method. 
The production should allow for a versatile design able to be tailored to the defect site, which 













*(Lobb, DeGeorge and Chhabra, 2019); **(Gruskin et al., 2012); *** (Stryker, 2019) 
Table 26 - Current products available as bone grafts, suppliers and weaknesses associated 
their use. 
Commercial product and 
composition 
Form/Use Weaknesses 
*Osteoset (Wright Medical 
Technology, USA). 
Calcium Sulphate + 4% 
tobramycin sulphate 
Filler to be packed in 
defect Not suitable for structural support. 
Dependent of patient compliance 
regarding substance use 
(drugs/alcohol). 
Hypercalcemia. 
*ProStim (Wright Medical 
Technology, USA). 
Mixture of calcium 
sulphate, calcium 
phosphate and DBM 
Filler to be packed in 
defect or in 
injectable form 




Not suitable in the presence of 
infection, unclosed epiphyseal 
cartilage, segmental bone defects and 
areas of loading. 
**Allomatrix (Wright  
Medical Technology, 
USA). 
DBM + calcium sulphate 
powder 
Injectable gel and 
putty 
Not suitable for structural support. 




40 % TCP 
60% HA 
Type 1 collagen, purified 
(bovine) 
Filler, < 30ml 
Potential allergy to bovine collagen. 
Not suitable for children, pregnant 
women and individuals with 
osteomyelitis, and avascular sites. 
*Palacos R and Palacos 
R+G (Zimmer Biomet, 
USA). 
PMMA (R) 
PMMA + gentamycin 
(R+G) 
Cement 
Not suitable for infectious sites, 
including infectious arthritis. 
R+G can’t be applied in pregnant and 





Not suitable for structural support. 
Fast degradation. 
Bioactivity of bioglass not proven in 
clinical trials. 
.  
***Vitoss (Stryker, USA) 
TCP-based bone 
graft 










In this work we present a new process for the development and manufacturing of bespoke 
osteoinductive, and osteoconductive resorbable biocomposites without the use of additives, 
surface treatment or differentiation media.  
The biocomposite scaffolds developed here were intact after 8 weeks in degradation media, 
covering the period for initial bone repair, 35 days for low loading areas such as maxilla. The 
device mechanical performance will also depend on the bone formation throughout the 
healing period. The average bone remodelling rate is between 0.7-1 µm/day (Burr and 
Gallant, 2012), but these values are relative since the amount of remodelling depends on 
several factors such as age, site, surrounding tissue conditions and external stimulatory 
effects. Here, the biocomposite scaffolds have shown to enhancing biomineralization, 
therefore be of value for in vitro models. 
Another potential option for the developed devices would be the use as a disease model for 
both bone and joints. Previous work (Rodrigues, 2018) using AW scaffolds and PLA hybrids 
attempted to mimic the bone tissue structure, where the porous bioceramic would act as the 
cortical fraction and the polymer as the trabeculae. In vivo testing showed that the hybrid 
structure improved bone growth when compared to AW. Also, it is suggested that the 
bioactivity of the AW influenced and enhanced cell migration and proliferation on the PLA 
fraction of the device. Advances in processing techniques such as AM permitted the creation 
of osteochondral scaffolds consisting of β-TCP and PEG based hydrogel, that structurally 
mirrored the bone-cartilage interface (Zhang et al., 2015). The in vitro testing, was performed 
only for the bioceramic section of the device, showing satisfactory cell proliferation and ALP 
production by rabbit BMSCs (bone MSCs). Based on this, AW scaffolds printed with binder 
jetting could be used to create osteochondral plugs, when combined with cartilage-like 
materials such as hydrogels and other soft polymers (natural and/or synthetic).  
 
Finally, from a commercial and manufacturing point of view, both binder jetting and FFF 
allow the production of samples with complex shapes but without the use of chemicals and 
other additives, which facilitates the process scale up to industrial level. This would permit 
the production of more devices faster and at a lower cost. The uniqueness of each device, and 
the design freedom provided by these techniques introduces a new option within the bone 
regenerative medicine market, where most of the approved products are in the form of 
injectable pastes and putties, pellets, powders and cements (Oryan et al., 2014). The offer is 




results attained by the ones in the market. This creates the perfect gap to insert devices, alone, 
or in combination with hMSCs, to promote and improve bone regeneration at the defect sites, 


























Chapter 8. General conclusion and future recommendations 
 
8.1 Conclusions 
The research performed for this project allowed the understanding and development of new 
materials, from glass-doping to biocomposites comprising fillers with different shapes. The 
studied AM techniques allow the production of devices for bone repair in a controlled fashion, 
using both polymer and bioceramics, individually and combined. Overall, the aim of the 
project was fulfilled, leading to the major conclusions presented in the following sections. 
 
8.1.1 AW processing 
• Addition of alumina to the original AW glass formulation allowed the processing of 2 
new glasses with different physicochemical properties.  
• Extensive milling of powders with alumina containing balls, causes the attachment of 
alumina particles to the AW powder particles, creating a contamination with 
implications on the sintering process of parts.  
• As a contaminant, above 0.14 wt%, alumina hindered the crystal growth during the 
crystallisation process but allowed for material processing at lower sintering 
temperatures. 
• Doping AW powders with 0.14 wt% alumina improves the parts without affecting 
mechanical properties, while maintaining the crystallinity profile innate to the 
material. 
 
8.1.2 Binder jetting and sintering 
• Polydisperse blends made of irregular shaped particles with sizes < 90 µm have a 
poor printability. Binder jetting equipment should operate within a minimum 
amount of feedstock to avoid layer heterogeneity during processing. 
• Crystallisation of AW scaffolds could be tuned without affecting the bioactivity 
and osteoconductivity of the material, at the expense of application range. 
• Produced implants displayed osteoconductive properties, and allowed the 





8.1.3 PLLA/AW biocomposite processing  
• The developed method for the material blending enabled the creation of both particle 
and fibre reinforced composite filaments for FFF printing. 
• Printing process of structures was repeatable and accurate without nozzle clogging or 
other mechanical issues. 
• Defects arising from oscillation on filament diameter caused layer defects which led to 
the need of printing each scaffold individually. 
 
8.1.4. FFF of PLLA/AW composites 
• Both polymer and biocomposites showed a good biocompatibility, and mechanical 
properties equivalent to cancellous bone with the fibre reinforced composite 
performing better as produced.  
• All three materials promoted osteogenesis, however the biocomposites induced a 
higher degree of biomineralisation.  
• Both composite materials have potential for use in bone defects, with the AWf 
composite showing greater levels of ion release, stimulating more rapid cell 
proliferation and greater levels of mineralisation during cell assays.  
 
8.2 Future recommendations 
The worked developed in this project showed that both techniques, binder jetting and FFF, 
have the capability to manufacture devices for bone repair, and that different applications can 
be targeted for each. In the future, further analysis should be performed so that the next steps 
can be taken towards the industrialisation of the processes and the commercialisation of the 
devices.  
 
8.2.1 Doping of AW powders with alumina for crystallisation control 
Several steps should be taken in the future to further address the effects of alumina in the 
crystallisation process of AW parts, and to explore the benefits of this dopant in the 
mechanical properties of future bone implants.  
• Here the AW powders contaminated at the surface with more than 0.68 wt% presented 




extended to the nanoscale to confirm the presence of nanocrystals and understand how 
the nucleation mechanism changes.  
• Surface doping of the powders should be explored, whilst adopting a change in the 
milling process into an alumina free one. By surface doping the powder, the amount of 
crystallisation can be controlled in a repeatable way. 
• Further studying how the alumina content affects the generation of glassy phase, and 
the cracking mechanism, can lead to the improvement of the process by inserting steps 
aiming to reduce internal stresses, and possibly to attain crystal orientation. 
• Different protocols should be tried for the newly developed AW/alumina powders, to 
attempt an ideal balance between nucleation and crystal growth, and to in the future be 
able to improve the mechanical properties of the parts.  
 
8.2.2 Binder Jetting of AW scaffolds for bone repair 
The process of producing scaffolds using AW and MD is vastly reported, and a respectable 
catalogue of blends have been attempted and printed so far. Within the work developed in this 
project, and based on previous studies, a couple of parameters could be further optimised and 
understood.  
• Explore how the crystallisation of the material is affecting the microstructure of the 
printed parts which are porous, by using doped powders as feedstock. 
• Study the contribution of the crystallisation to the mechanical properties, to ensure it 
can be used as positive effect. 
• Attempt to process the implants using different solid binders, and combinations of 
particle size and shape to avoid the drying step involved in the use of MD. 
• Design different shapes and possibly combine other glasses in attempt to create 
ceramic on ceramic composites, proved to be useful in load bearing applications. 
 
8.2.3 FFF of PLLA/AW biocomposites for bone repair 
The composites developed in this work are unique, and so is their processing. For the first 
time these materials were 3D printed using FFF, to create scaffolds for bone repair. Being a 
first study on these, several issues must be addressed regarding the processing and also 
material and biological characterisation. 
• The material blending process is limited in terms of filler amount usable. A new 




• The filament manufacturing must be improved, and if possible, more controlled so that 
a consistent size is attained, matching the industry standards. This is particularly 
important for the acceleration of the manufacturing process. Several scaffolds could be 
made simultaneously, without the concern of excessive/insufficient deposition. 
• Topographical studies would allow a better understanding of cell behaviour in 
different composites, namely targeting their migration and the influence on the 
proliferation. 
• Genetic assay, namely PCR, would be an asset to further confirm the expression of 
genes related to differentiation and mineralisation, validating the previous results. 
• Different filler shapes could be tested, in different amounts, to complete the repertoire 
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